Companies:
10,660
total market cap:
$140.341 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Morgan Stanley
MS
#52
Rank
$286.01 B
Marketcap
๐บ๐ธ
United States
Country
$179.96
Share price
2.34%
Change (1 day)
30.49%
Change (1 year)
๐ฆ Banks
๐ณ Financial services
๐ฐ Investment
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Morgan Stanley
Quarterly Reports (10-Q)
Financial Year FY2020 Q1
Morgan Stanley - 10-Q quarterly report FY2020 Q1
Text size:
Small
Medium
Large
false
--12-31
Q1
2020
true
false
0000895421
MORGAN STANLEY
0.37
0.16
0.20
0.24
0.07
0.07
7809000000
6897000000
0.0124
0.0111
0.0117
0.0161
0.0101
0.0106
0.0030
0.0121
0.0086
128386000000
103637000000
16
0.17
24
1.00
7
0.08
7
0.75
11
0.15
11
0.99
17
0.16
22
1.00
7
0.11
7
0.50
12
0.14
9
0.99
0.01
0.01
3500000000
3500000000
2038893979
2038893979
1593973680
1575500507
64461000000
57162000000
0.07
0.44
0.94
0.26
0.10
0.00
0.07
0.05
0.38
0.75
0.26
0.02
0.21
0.78
0.25
0.00
0.05
0.55
0.98
0.17
0.07
0.00
0.05
0.05
0.39
0.75
0.27
0.02
0.31
0.81
0.32
0.00
1.08
0.96
1.00
0.80
0.0039
0.09
0.11
0.00
0.69
0.15
0.0009
0.01
0.84
0.47
0.93
0.28
0.0019
0.02
0.54
1.08
0.62
0.87
1.00
0.89
0.0109
0.10
1.17
0.51
0.10
0.51
0.00
0.71
0.13
0.0012
0.01
0.18
0.85
0.43
0.92
0.58
0.0041
0.02
0.86
2099000000
4052000000
0.18
0.94
0.10
0.46
0.63
0.13
0.44
0.72
0.63
1.83
0.99
182
1.04
0.62
0.0117
0.0469
0.90
0.98
0.60
0.44
0.00
0.95
0.11
0.56
1.56
0.15
0.63
0.90
1.56
0.16
0.95
0.10
0.46
0.59
0.14
0.41
0.72
0.59
0.07
0.43
3
0.00
0.29
0.0047
0.0009
0.09
0.05
0.79
0.11
0.02
0.85
0.10
0.32
0.24
0.04
0.24
0.47
0.24
0.18
0.93
28
0.45
0.36
0.0084
0.0081
0.36
0.70
0.37
0.01
0.06
0.19
0.38
0.68
0.25
0.44
0.71
0.68
1.45
0.99
137
0.98
0.78
0.0278
0.0488
0.78
0.96
0.55
0.44
0.00
0.58
1.83
0.35
0.63
0.88
1.83
0.18
0.38
0.70
0.25
0.41
0.73
0.70
0.08
0.05
1
0.00
0.40
0.0204
0.0020
0.17
0.05
0.79
0.07
0.04
0.21
0.02
0.06
0.24
0.46
0.02
0.18
0.93
26
0.52
0.50
0.0267
0.0114
0.45
0.76
0.39
0.01
0.06
0.95
0.10
0.00
4000000
5000000
3204000000
3281000000
0.0446
0.0318
0.0069
0.0287
0.0225
0.0297
0.0600
0.0743
0.0044
0.0159
0.0367
0.0313
733000000
775000000
444920299
463393472
0000895421
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesEPreferredStockMember
2020-01-01
2020-03-31
0000895421
ms:GlobalMediumTermNotesSeriesAFixedRateStepUpSeniorNotesDue2026ofMorganStanleyFinanceLLCMember
2020-01-01
2020-03-31
0000895421
ms:SeriesLPreferredStockMember
2020-01-01
2020-03-31
0000895421
ms:SeriesKPreferredStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesAPreferredStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesFPreferredStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:CommonClassAMember
2020-01-01
2020-03-31
0000895421
ms:SeriesIPreferredStockMember
2020-01-01
2020-03-31
0000895421
ms:MorganStanleyCushingMLPHighIncomeIndexETNsdueMarch212031Member
2020-01-01
2020-03-31
0000895421
2020-04-30
0000895421
2019-01-01
2019-03-31
0000895421
2020-03-31
0000895421
2019-12-31
0000895421
us-gaap:RetainedEarningsMember
2020-01-01
2020-03-31
0000895421
us-gaap:CommonStockMember
2019-03-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2019-01-01
0000895421
us-gaap:TreasuryStockMember
2020-03-31
0000895421
us-gaap:PreferredStockMember
2019-03-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2018-12-31
0000895421
us-gaap:TreasuryStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:TreasuryStockMember
2018-12-31
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2019-12-31
0000895421
2019-03-31
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2019-03-31
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2019-01-01
2019-03-31
0000895421
us-gaap:TreasuryStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2019-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2020-03-31
0000895421
us-gaap:PreferredStockMember
2020-03-31
0000895421
us-gaap:RetainedEarningsMember
2019-03-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-03-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2019-03-31
0000895421
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0000895421
us-gaap:RetainedEarningsMember
2019-12-31
0000895421
us-gaap:TreasuryStockMember
2019-03-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2020-01-01
2020-03-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2020-03-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2019-12-31
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2020-01-01
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2020-01-01
2020-03-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2020-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:NoncontrollingInterestMember
2019-12-31
0000895421
us-gaap:TrustForBenefitOfEmployeesMember
2018-12-31
0000895421
us-gaap:CommonStockMember
2020-03-31
0000895421
us-gaap:TreasuryStockMember
2019-12-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0000895421
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0000895421
ms:CommonStockIssuedToEmployeeTrustMember
2018-12-31
0000895421
us-gaap:RetainedEarningsMember
2018-12-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2019-12-31
0000895421
us-gaap:RetainedEarningsMember
2020-03-31
0000895421
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0000895421
2018-12-31
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:AccountingStandardsUpdate201613Member
ms:AllowanceforCreditLossesonEmployeeLoansMember
2020-01-01
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:AccountingStandardsUpdate201613Member
us-gaap:RetainedEarningsMember
2020-01-01
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:AccountingStandardsUpdate201613Member
ms:AllowanceforCreditLossesMember
2020-01-01
0000895421
ms:AccountsReceivableAndOtherReceivablesNetMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FutureMember
2019-12-31
0000895421
ms:AccountsReceivableAndOtherReceivablesNetMember
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:FutureMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
ms:LendingCommitmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:AssetsMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:LiabilityMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:OtherLiabilitiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:OtherLiabilitiesMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:LiabilityMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
ms:PropertyPlantAndEquipmentAndCapitalizedSoftwareCostsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
ms:LendingCommitmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:OtherInvestmentsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:OtherInvestmentsMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:AssetsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsNonrecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000895421
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000895421
us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
ms:CorporateandOtherDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
ms:CorporateEquitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-01-01
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-01-01
2019-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-01-01
2019-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:DepositsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2018-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-01-01
2019-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2020-01-01
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2018-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:NonderivativeTradingLiabilitiesMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:BorrowingsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InvestmentsMember
2018-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
ms:OtherSecuredFinancingsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:ResidentialPortfolioSegmentMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:CommercialPortfolioSegmentMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-03-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2019-12-31
0000895421
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000895421
us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputRecoveryRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
2019-12-31
0000895421
us-gaap:RealEstateFundsMember
2020-03-31
0000895421
us-gaap:PrivateEquityFundsMember
2020-03-31
0000895421
us-gaap:FairValueMeasurementsNonrecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsNonrecurringMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateEquitiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel12And3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:PrivateEquityFundsMember
2019-12-31
0000895421
us-gaap:HedgeFundsMember
2020-03-31
0000895421
us-gaap:HedgeFundsMember
2019-12-31
0000895421
us-gaap:RealEstateFundsMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputContingencyProbabilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputContingencyProbabilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCashSyntheticBasisMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCashSyntheticBasisMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputContingencyProbabilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputRecoveryRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputContingencyProbabilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputContingencyProbabilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputRecoveryRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputRecoveryRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCrossCommodityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
ms:MeasurementInputVolatilitySkewMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateCurveMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputLoanPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputRecoveryRateMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MortgageAndAssetBackedSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputEbitdaMultipleMember
us-gaap:MarketApproachValuationTechniqueMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputAtTheMoneyVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputFundingSpreadMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputWeightedAverageCostOfCapitalMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignExchangeContractMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputExitMultipleMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputCreditCorrelationMember
ms:ValuationTechniqueCorrelationModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInflationVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:ArithmeticAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputInterestRateForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputForwardPowerPriceMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:MeasurementInputSharePriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueCorporateLoanModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputDiscountRateMember
ms:ValuationTechniqueMarginLoanMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputForeignExchangeCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:SeniorDebtObligationsMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueMarginLoanMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CorporateandOtherDebtSecuritiesMember
ms:MeasurementInputBondPriceMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:CommodityAndOtherContractsMember
ms:MeasurementInputCommodityVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateCurveCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MedianMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputInterestRateVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputVolatilitySkewMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputEquityCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:InterestRateContractMember
ms:MeasurementInputBondVolatilityMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:EquityContractMember
ms:MeasurementInputInterestRateCorrelationMember
us-gaap:ValuationTechniqueOptionPricingModelMember
2020-03-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CreditRiskContractMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueComparablePricingMember
2019-12-31
0000895421
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
ms:MeasurementInputFundingSpreadMember
us-gaap:ValuationTechniqueDiscountedCashFlowMember
2019-12-31
0000895421
srt:WeightedAverageMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsNonrecurringMember
us-gaap:MeasurementInputCreditSpreadMember
ms:ValuationTechniqueWarehouseModelMember
2020-03-31
0000895421
us-gaap:DebtMember
us-gaap:InterestExpenseMember
2020-01-01
2020-03-31
0000895421
us-gaap:DebtMember
2020-01-01
2020-03-31
0000895421
us-gaap:DebtMember
us-gaap:InterestExpenseMember
2019-01-01
2019-03-31
0000895421
us-gaap:DebtMember
us-gaap:TradingRevenueMember
2020-01-01
2020-03-31
0000895421
us-gaap:DebtMember
us-gaap:TradingRevenueMember
2019-01-01
2019-03-31
0000895421
us-gaap:DebtMember
2019-01-01
2019-03-31
0000895421
us-gaap:DepositsMember
us-gaap:TradingRevenueMember
2020-01-01
2020-03-31
0000895421
ms:LoansAndOtherDebtMember
us-gaap:TradingRevenueMember
2019-01-01
2019-03-31
0000895421
us-gaap:DepositsMember
us-gaap:TradingRevenueMember
2019-01-01
2019-03-31
0000895421
ms:LoansAndOtherDebtMember
us-gaap:TradingRevenueMember
2020-01-01
2020-03-31
0000895421
us-gaap:WrittenLoanCommitmentFairValueOptionMember
us-gaap:TradingRevenueMember
2019-01-01
2019-03-31
0000895421
us-gaap:WrittenLoanCommitmentFairValueOptionMember
us-gaap:TradingRevenueMember
2020-01-01
2020-03-31
0000895421
ms:LoansAndOtherDebtMember
us-gaap:OtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000895421
ms:LoansAndOtherDebtMember
us-gaap:OtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:WrittenLoanCommitmentFairValueOptionMember
us-gaap:OtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:DepositsMember
us-gaap:OtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:DebtMember
us-gaap:OtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:WrittenLoanCommitmentFairValueOptionMember
us-gaap:OtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:DebtMember
us-gaap:OtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:DepositsMember
us-gaap:OtherComprehensiveIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueMeasurementsRecurringMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueMeasurementsRecurringMember
2020-03-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
2019-12-31
0000895421
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:NondesignatedMember
2019-12-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2019-12-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2019-12-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2020-01-01
2020-03-31
0000895421
us-gaap:DepositsMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2020-01-01
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:InterestIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:DepositsMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2020-01-01
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:InterestIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2019-01-01
2019-03-31
0000895421
us-gaap:BorrowingsMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-03-31
0000895421
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FairValueHedgingMember
us-gaap:InterestIncomeMember
2019-01-01
2019-03-31
0000895421
us-gaap:BorrowingsMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2020-01-01
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:InterestExpenseMember
2019-01-01
2019-03-31
0000895421
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FairValueHedgingMember
us-gaap:InterestIncomeMember
2020-01-01
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000895421
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:NondesignatedMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:ExchangeTradedMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:ExchangeClearedMember
2020-03-31
0000895421
us-gaap:ForeignExchangeContractMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2019-12-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2019-12-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
us-gaap:InternalInvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:SingleNameCreditDefaultSwapMember
us-gaap:InternalNoninvestmentGradeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
ms:TotalIndexAndBasketCreditDefaultSwapsMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:CreditDerivativesSellingProtectionMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
2019-12-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:IndexAndBasketCreditDefaultSwapMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:TranchedIndexAndBasketCreditDefaultSwapMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2019-12-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:SingleNameCreditDefaultSwapMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:IndexAndBasketCreditDefaultSwapMember
2019-12-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
ms:TranchedIndexAndBasketCreditDefaultSwapMember
2019-12-31
0000895421
us-gaap:DepositsMember
2019-12-31
0000895421
us-gaap:DepositsMember
2020-03-31
0000895421
us-gaap:AvailableforsaleSecuritiesMember
2020-03-31
0000895421
us-gaap:AvailableforsaleSecuritiesMember
2019-12-31
0000895421
us-gaap:BorrowingsMember
2019-12-31
0000895421
us-gaap:BorrowingsMember
2020-03-31
0000895421
us-gaap:CollaborativeArrangementMember
2020-03-31
0000895421
ms:DerivativeCreditRiskRelatedContingentFeaturestriggeringCircumstancesTwoNotchCreditRatingDowngradeMember
2020-03-31
0000895421
ms:DerivativeCreditRiskRelatedContingentFeaturesTriggeringCircumstancesOneNotchCreditRatingDowngradeMember
2020-03-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
us-gaap:CreditDefaultSwapMember
2019-12-31
0000895421
us-gaap:CreditDefaultSwapBuyingProtectionMember
us-gaap:CreditDefaultSwapMember
2020-03-31
0000895421
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:CorporateBondSecuritiesMember
2020-03-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember
2020-03-31
0000895421
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
us-gaap:USTreasurySecuritiesMember
2019-12-31
0000895421
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember
2019-12-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember
2019-12-31
0000895421
us-gaap:CorporateBondSecuritiesMember
2019-12-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember
2020-03-31
0000895421
us-gaap:USTreasurySecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:CorporateBondSecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:USTreasuryAndGovernmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember
2020-01-01
2020-03-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-01-01
2020-03-31
0000895421
us-gaap:USGovernmentAgenciesDebtSecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:USTreasurySecuritiesMember
2020-03-31
0000895421
ms:CorporateandOtherDebtSecuritiesMember
2020-01-01
2020-03-31
0000895421
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-01-01
2020-03-31
0000895421
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
ms:AssetBackedSecuritiesFederalFamilyEducationLoanProgramMember
2020-01-01
2020-03-31
0000895421
us-gaap:Maturity30To90DaysMember
2019-12-31
0000895421
us-gaap:MaturityOver90DaysMember
2019-12-31
0000895421
us-gaap:MaturityOvernightMember
2019-12-31
0000895421
us-gaap:MaturityUpTo30DaysMember
2019-12-31
0000895421
us-gaap:MaturityUpTo30DaysMember
2020-03-31
0000895421
us-gaap:MaturityOvernightMember
2020-03-31
0000895421
us-gaap:MaturityOver90DaysMember
2020-03-31
0000895421
us-gaap:Maturity30To90DaysMember
2020-03-31
0000895421
us-gaap:CollateralizedSecuritiesOtherMember
2019-12-31
0000895421
us-gaap:AssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-12-31
0000895421
us-gaap:AssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:ForeignGovernmentDebtSecuritiesMember
2020-03-31
0000895421
ms:CorporateEquitiesMember
2019-12-31
0000895421
us-gaap:USTreasuryAndGovernmentMember
2020-03-31
0000895421
us-gaap:CollateralizedSecuritiesOtherMember
2020-03-31
0000895421
ms:CorporateEquitiesMember
2020-03-31
0000895421
us-gaap:USStatesAndPoliticalSubdivisionsMember
2020-03-31
0000895421
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-12-31
0000895421
ms:CorporateandOtherDebtSecuritiesMember
2020-03-31
0000895421
us-gaap:USTreasuryAndGovernmentMember
2019-12-31
0000895421
ms:CorporateandOtherDebtSecuritiesMember
2019-12-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2019Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2020Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2017Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2016Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2018Member
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioLessthanorEqualto80PercentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
ms:DebttoValueRatioGreaterthan80PercentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
ms:FICOScoreBetween680and739Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
ms:FICOScoreGreaterthanorEqualto740Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
ms:FICOScoreLessthan680Member
us-gaap:ResidentialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2019-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2019-12-31
0000895421
ms:OriginationYear2017Member
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:ConsumerPortfolioSegmentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
us-gaap:SubstandardMember
2019-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
us-gaap:PassMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
us-gaap:PassMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
us-gaap:DoubtfulMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
us-gaap:SpecialMentionMember
2019-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
us-gaap:SubstandardMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
us-gaap:DoubtfulMember
2019-12-31
0000895421
us-gaap:PassMember
2019-12-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
us-gaap:SpecialMentionMember
2019-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
us-gaap:SpecialMentionMember
2019-12-31
0000895421
us-gaap:SpecialMentionMember
2019-12-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
us-gaap:PassMember
2019-12-31
0000895421
us-gaap:SubstandardMember
2019-12-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
us-gaap:DoubtfulMember
2019-12-31
0000895421
us-gaap:DoubtfulMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
us-gaap:SubstandardMember
2019-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
us-gaap:DoubtfulMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
us-gaap:SubstandardMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
us-gaap:PassMember
2019-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
us-gaap:SpecialMentionMember
2019-12-31
0000895421
us-gaap:UnlikelyToBeCollectedFinancingReceivableMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2018-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2019-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2019-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2019-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
2018-12-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2019-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
2018-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2018-12-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
2019-01-01
2019-03-31
0000895421
ms:TerminatedfromEmploymentMember
2020-03-31
0000895421
ms:CurrentlyEmployedMember
2020-03-31
0000895421
2019-01-01
2019-12-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2016Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:PriorOriginationYearMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2019Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2018Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2019Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2016Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2016Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2017Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2020Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationRevolvingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2019Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:OriginationYear2020Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBRatingMember
ms:PriorOriginationYearMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2020Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2018Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
ms:OriginationYear2017Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalBBBRatingMember
ms:OriginationYear2018Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalOtherNoninvestmentGradeRatingMember
ms:OriginationRevolvingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:InternalAARatingtoARatingMember
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
ms:OriginationYear2017Member
us-gaap:CommercialPortfolioSegmentMember
2020-03-31
0000895421
srt:AsiaMember
2019-12-31
0000895421
ms:EuropeMiddleEastAndAfricaMember
2019-12-31
0000895421
srt:AmericasMember
2019-12-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
ms:FinancialAssetPastDueMember
2020-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
ms:FinancialAssetPastDueMinusCurrentMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
us-gaap:FinancingReceivables1To29DaysPastDueMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
ms:FinancialAssetPastDueMember
2020-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
ms:FinancialAssetPastDueMember
2020-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
ms:FinancialAssetPastDueMinusCurrentMember
2020-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
us-gaap:FinancingReceivables1To29DaysPastDueMember
2020-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
ms:FinancialAssetPastDueMinusCurrentMember
2020-03-31
0000895421
us-gaap:CommercialRealEstatePortfolioSegmentMember
us-gaap:FinancingReceivables1To29DaysPastDueMember
2020-03-31
0000895421
us-gaap:CommercialPortfolioSegmentMember
us-gaap:FinancingReceivables1To29DaysPastDueMember
2020-03-31
0000895421
us-gaap:ConsumerPortfolioSegmentMember
ms:FinancialAssetPastDueMember
2020-03-31
0000895421
us-gaap:ResidentialPortfolioSegmentMember
ms:FinancialAssetPastDueMinusCurrentMember
2020-03-31
0000895421
ms:InvestmentManagementSegmentMember
2020-01-01
2020-03-31
0000895421
ms:InvestmentManagementSegmentMember
2019-01-01
2019-03-31
0000895421
ms:MitsubishiUfjFinancialGroupIncMember
ms:MorganStanleyMufgSecuritiesCoLtdMember
2020-03-31
0000895421
ms:MorganStanleyMufgSecuritiesCoLtdMember
ms:InstitutionalSecuritiesSegmentMember
2020-03-31
0000895421
ms:MorganStanleyMufgSecuritiesCoLtdMember
2020-03-31
0000895421
ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember
2020-03-31
0000895421
ms:InvestmentManagementSegmentMember
2020-03-31
0000895421
ms:InvestmentManagementSegmentMember
2019-12-31
0000895421
ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember
2020-01-01
2020-03-31
0000895421
ms:MitsubishiUfjMorganStanleySecuritiesCoLtdMember
2019-01-01
2019-03-31
0000895421
ms:WholeLoanSalesRepresentationsAndWarrantiesMember
2020-03-31
0000895421
ms:ClearingMemberGuaranteeMember
2020-03-31
0000895421
ms:LiquidityFacilitiesGuaranteeMember
2020-03-31
0000895421
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:SecuritizationsRepresentationsAndGuaranteesMember
2020-03-31
0000895421
us-gaap:StandbyLettersOfCreditMember
2020-03-31
0000895421
ms:GeneralPartnerGuaranteeMember
2020-03-31
0000895421
us-gaap:DerivativeMember
2020-03-31
0000895421
us-gaap:MarketValueGuaranteeMember
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
ms:UsBankNationalAssociation20072axVMorganStanleyMortgageCapitalHoldingsLlcMember
srt:MaximumMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:CaseNumber153637AndCaseNumber154353Member
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:CaseNumber153637AndCaseNumber154353Member
srt:MaximumMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:FinancialGuarantyInsuranceCompanyVMorganStanleyAbsCapitalIIncEtAlTrust2007Nc4Member
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember
srt:MaximumMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:ChinaDevelopmentIndustrialBankVersusMorganStanleyCoIncorporatedEtAliiMember
us-gaap:PendingLitigationMember
2020-01-01
2020-03-31
0000895421
ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember
srt:MaximumMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:UsBankNationalAssociation20072axVMorganStanleyMortgageCapitalHoldingsLlcMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:DeutscheBankNationalTrustCompany2007Nc4VMorganStanleyMortgageCapitalHoldingsLlcMember
us-gaap:PendingLitigationMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
us-gaap:StandbyLettersOfCreditMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
us-gaap:DerivativeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:LiquidityFacilitiesGuaranteeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
us-gaap:StandbyLettersOfCreditMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:WholeLoanSalesRepresentationsAndWarrantiesMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:LiquidityFacilitiesGuaranteeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:GeneralPartnerGuaranteeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
us-gaap:StandbyLettersOfCreditMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:LiquidityFacilitiesGuaranteeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:GeneralPartnerGuaranteeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:SecuritizationsRepresentationsAndGuaranteesMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:SecuritizationsRepresentationsAndGuaranteesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
us-gaap:StandbyLettersOfCreditMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:WholeLoanSalesRepresentationsAndWarrantiesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:GeneralPartnerGuaranteeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:SecuritizationsRepresentationsAndGuaranteesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
us-gaap:DerivativeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:ClearingMemberGuaranteeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
us-gaap:MarketValueGuaranteeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
ms:LiquidityFacilitiesGuaranteeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
us-gaap:MarketValueGuaranteeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:WholeLoanSalesRepresentationsAndWarrantiesMember
2020-03-31
0000895421
ms:MorganStanleyPrivateBankNationalAssociationMember
2020-01-01
2020-03-31
0000895421
ms:MorganStanleySmithBarneyLlcMember
2020-01-01
2020-03-31
0000895421
ms:MorganStanleyBankNationalAssociationMember
2020-01-01
2020-03-31
0000895421
ms:MSAndCoMember
2020-01-01
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:ClearingMemberGuaranteeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:ClearingMemberGuaranteeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
ms:ClearingMemberGuaranteeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:GeneralPartnerGuaranteeMember
2020-03-31
0000895421
ms:MoreThanFiveYearsFromBalanceSheetDateMember
us-gaap:MarketValueGuaranteeMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
ms:WholeLoanSalesRepresentationsAndWarrantiesMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
us-gaap:CreditRiskContractMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
us-gaap:DerivativeMember
2020-03-31
0000895421
ms:LessThanTwelveMonthsFromBalanceSheetDateMember
us-gaap:DerivativeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
us-gaap:OtherCreditDerivativesMember
2020-03-31
0000895421
ms:MoreThanOneAndWithinThreeYearsFromBalanceSheetDateMember
us-gaap:MarketValueGuaranteeMember
2020-03-31
0000895421
ms:MoreThanThreeAndWithinFiveYearsFromBalanceSheetDateMember
ms:SecuritizationsRepresentationsAndGuaranteesMember
2020-03-31
0000895421
ms:CentralCounterpartyCommitmentMember
2020-03-31
0000895421
us-gaap:CommercialLoanMember
2020-03-31
0000895421
us-gaap:RealEstateMember
2020-03-31
0000895421
ms:CommitmentsForwardStartingReverseRepurchaseAgreementsMember
2020-03-31
0000895421
ms:CommitmentsLettersOfCreditAndOtherFinancialGuaranteesObtainedToSatisfyCollateralRequirementsMember
2020-03-31
0000895421
us-gaap:ConsumerLoanMember
2020-03-31
0000895421
ms:FirmCommitmentContractMember
2020-03-31
0000895421
ms:CommitmentsInvestmentActivitiesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:CreditLinkedNotesAndOtherMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
ms:CreditLinkedNotesAndOtherMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
ms:CreditLinkedNotesAndOtherMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:ResidentialMortgageMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:ResidentialMortgageMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:ResidentialMortgageMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:FairValueInputsLevel3Member
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:FairValueInputsLevel3Member
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:FairValueInputsLevel2Member
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:FairValueInputsLevel3Member
2019-12-31
0000895421
us-gaap:EquityContractMember
us-gaap:OverTheCounterMember
2020-03-31
0000895421
us-gaap:EquityContractMember
us-gaap:OverTheCounterMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:ResidentialMortgageMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:ResidentialMortgageMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:ResidentialMortgageMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
ms:CreditLinkedNotesAndOtherMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:CreditLinkedNotesAndOtherMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
ms:CreditLinkedNotesAndOtherMember
2019-12-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-12-31
0000895421
ms:OtherConsumerAndCommercialLoansMember
2020-03-31
0000895421
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
ms:OtherConsumerAndCommercialLoansMember
2019-12-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
2020-03-31
0000895421
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-12-31
0000895421
ms:OtherConsumerAndCommercialLoansMember
2019-12-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:CommercialMortgageBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
2019-12-31
0000895421
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:SecuritiesAssetsMember
ms:OtherConsumerAndCommercialLoansMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember
2019-12-31
0000895421
us-gaap:ResidentialMortgageBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:SecuritiesAssetsMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2020-03-31
0000895421
ms:DebtandEquityInterestsMember
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
us-gaap:AssetsMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:AssetsMember
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
ms:DebtandEquityInterestsMember
ms:OtherVariableInterestsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:OtherVariableInterestsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:OtherVariableInterestsMember
2020-03-31
0000895421
ms:DebtandEquityInterestsMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
ms:DebtandEquityInterestsMember
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
us-gaap:AssetsMember
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
us-gaap:AssetsMember
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
ms:DebtandEquityInterestsMember
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
ms:OtherVariableInterestsMember
2020-03-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:MortgageAndAssetBackedSecuritiesMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:MunicipalTenderOptionBondsMember
2020-03-31
0000895421
us-gaap:StructuredFinanceMember
2020-03-31
0000895421
us-gaap:AssetsMember
ms:OtherVariableInterestsMember
2020-03-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
us-gaap:CollateralizedDebtObligationsMember
2020-03-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:OtherVariableInterestsMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:FairValueInputsLevel2Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:FairValueInputsLevel3Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
us-gaap:FairValueInputsLevel2Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:FairValueInputsLevel3Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:InvestmentGradeMember
us-gaap:FairValueInputsLevel2Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
us-gaap:FairValueInputsLevel3Member
2020-03-31
0000895421
ms:SpecialPurposeEntitiesMember
ms:NoninvestmentGradeMember
2020-03-31
0000895421
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2019-12-31
0000895421
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-03-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
ms:DebtandEquityInterestsMember
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
ms:DebtandEquityInterestsMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:AssetsMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
ms:OtherVariableInterestsMember
2019-12-31
0000895421
ms:DebtandEquityInterestsMember
ms:OtherVariableInterestsMember
2019-12-31
0000895421
ms:DebtandEquityInterestsMember
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
ms:DebtandEquityInterestsMember
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
us-gaap:AssetsMember
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
us-gaap:AssetsMember
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:MunicipalTenderOptionBondsMember
2019-12-31
0000895421
us-gaap:AssetsMember
ms:OtherVariableInterestsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:MortgageAndAssetBackedSecuritiesMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsAssetsMember
ms:OtherVariableInterestsMember
2019-12-31
0000895421
us-gaap:AssetsMember
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
ms:OtherVariableInterestsMember
2019-12-31
0000895421
ms:CommitmentsGuaranteesAndOtherMember
ms:OtherVariableInterestsMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
us-gaap:StructuredFinanceMember
2019-12-31
0000895421
us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember
us-gaap:CollateralizedDebtObligationsMember
2019-12-31
0000895421
ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember
us-gaap:CommercialLoanMember
2020-01-01
2020-03-31
0000895421
ms:CollateralizedLoanObligationsEntitiesSponsoredByNonAffiliatesMember
us-gaap:CommercialLoanMember
2019-01-01
2019-03-31
0000895421
ms:OtherVariableInterestsMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2019-12-31
0000895421
ms:MortgageAndAssetBackedSecuritiesMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-03-31
0000895421
us-gaap:StructuredFinanceMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-03-31
0000895421
us-gaap:StructuredFinanceMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2019-12-31
0000895421
ms:OtherVariableInterestsMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2020-03-31
0000895421
ms:MortgageAndAssetBackedSecuritiesMember
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2019-12-31
0000895421
ms:MorganStanleySmithBarneyLlcMember
2020-03-31
0000895421
ms:MorganStanleySmithBarneyLlcMember
2019-12-31
0000895421
ms:MorganStanleyPrivateBankNationalAssociationMember
2020-03-31
0000895421
ms:MSAndCoMember
2019-12-31
0000895421
ms:MSAndCoMember
2020-03-31
0000895421
ms:MorganStanleyBankNationalAssociationMember
2020-03-31
0000895421
ms:MorganStanleyPrivateBankNationalAssociationMember
2019-12-31
0000895421
ms:MorganStanleyBankNationalAssociationMember
2019-12-31
0000895421
ms:CumulativeEffectPeriodofAdoptionAdjustmentMember
us-gaap:AccountingStandardsUpdate201602Member
us-gaap:RetainedEarningsMember
2019-01-01
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesHPreferredStockMember
2020-03-31
0000895421
us-gaap:SeriesCPreferredStockMember
2019-12-31
0000895421
ms:SeriesJPreferredStockMember
2020-03-31
0000895421
ms:SeriesKPreferredStockMember
2020-03-31
0000895421
ms:SeriesLPreferredStockMember
2020-03-31
0000895421
ms:SeriesLPreferredStockMember
2019-12-31
0000895421
us-gaap:SeriesFPreferredStockMember
2020-03-31
0000895421
us-gaap:SeriesEPreferredStockMember
2019-12-31
0000895421
us-gaap:SeriesAPreferredStockMember
2020-03-31
0000895421
ms:SeriesIPreferredStockMember
2019-12-31
0000895421
us-gaap:SeriesCPreferredStockMember
2020-03-31
0000895421
ms:SeriesKPreferredStockMember
2019-12-31
0000895421
ms:SeriesIPreferredStockMember
2020-03-31
0000895421
us-gaap:SeriesAPreferredStockMember
2019-12-31
0000895421
us-gaap:SeriesEPreferredStockMember
2020-03-31
0000895421
us-gaap:SeriesHPreferredStockMember
2019-12-31
0000895421
ms:SeriesJPreferredStockMember
2019-12-31
0000895421
us-gaap:SeriesFPreferredStockMember
2019-12-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
ms:AOCIDebtValuationAdjustmentIncludingNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
ms:AOCIDebtValuationAdjustmentNoncontrollingInterestMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesGPreferredStockMember
2020-01-01
2020-03-31
0000895421
ms:SeriesJPreferredStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesCPreferredStockMember
2020-01-01
2020-03-31
0000895421
ms:SeriesJPreferredStockMember
2019-01-01
2019-03-31
0000895421
ms:SeriesLPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesEPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesGPreferredStockMember
2019-01-01
2019-03-31
0000895421
ms:SeriesIPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesHPreferredStockMember
2020-01-01
2020-03-31
0000895421
us-gaap:SeriesCPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesFPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesAPreferredStockMember
2019-01-01
2019-03-31
0000895421
ms:SeriesKPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:SeriesHPreferredStockMember
2019-01-01
2019-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-03-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2019-12-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2020-03-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0000895421
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2020-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-12-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2019-12-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-12-31
0000895421
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-03-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2018-12-31
0000895421
ms:AOCIDebtValuationAdjustmentParentMember
2019-03-31
0000895421
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-31
0000895421
ms:MitsubishiUfjFinancialGroupIncMember
2020-01-01
2020-03-31
0000895421
ms:CapitalPlan2019Member
2020-01-01
2020-03-31
0000895421
ms:MitsubishiUfjFinancialGroupIncMember
us-gaap:SeriesCPreferredStockMember
2020-03-31
0000895421
ms:CapitalPlan2019Member
2020-03-31
0000895421
srt:AsiaMember
2020-01-01
2020-03-31
0000895421
srt:AmericasMember
2019-01-01
2019-03-31
0000895421
us-gaap:EMEAMember
2019-01-01
2019-03-31
0000895421
us-gaap:EMEAMember
2020-01-01
2020-03-31
0000895421
srt:AsiaMember
2019-01-01
2019-03-31
0000895421
srt:AmericasMember
2020-01-01
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:InstitutionalSecuritiesSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:IntersegmentEliminationMember
2019-01-01
2019-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:WealthManagementSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:InvestmentManagementSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:ForeignExchangeContractMember
2020-01-01
2020-03-31
0000895421
us-gaap:CreditRiskContractMember
2019-01-01
2019-03-31
0000895421
ms:CommodityAndOtherContractsMember
2019-01-01
2019-03-31
0000895421
us-gaap:CreditRiskContractMember
2020-01-01
2020-03-31
0000895421
us-gaap:InterestRateContractMember
2019-01-01
2019-03-31
0000895421
ms:EquityAndIndexContractMember
2019-01-01
2019-03-31
0000895421
us-gaap:ForeignExchangeContractMember
2019-01-01
2019-03-31
0000895421
us-gaap:InterestRateContractMember
2020-01-01
2020-03-31
0000895421
ms:EquityAndIndexContractMember
2020-01-01
2020-03-31
0000895421
ms:CommodityAndOtherContractsMember
2020-01-01
2020-03-31
0000895421
ms:InstitutionalSecuritiesSegmentMember
2020-03-31
0000895421
ms:InstitutionalSecuritiesSegmentMember
2019-12-31
0000895421
ms:WealthManagementSegmentMember
2019-12-31
0000895421
ms:WealthManagementSegmentMember
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:InstitutionalSecuritiesSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:IntersegmentEliminationMember
2020-01-01
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:InvestmentManagementSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:WealthManagementSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccountingStandardsUpdate201409Member
2020-01-01
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
us-gaap:InvestmentAdviceMember
ms:InstitutionalSecuritiesSegmentMember
2019-01-01
2019-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:UnderwritingMember
ms:InstitutionalSecuritiesSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:OperatingSegmentsMember
us-gaap:InvestmentAdviceMember
ms:InstitutionalSecuritiesSegmentMember
2020-01-01
2020-03-31
0000895421
us-gaap:AccountingStandardsUpdate201409Member
2019-01-01
2019-03-31
0000895421
us-gaap:OperatingSegmentsMember
ms:UnderwritingMember
ms:InstitutionalSecuritiesSegmentMember
2019-01-01
2019-03-31
xbrli:shares
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:pure
iso4217:EUR
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2020
Commission File Number
1-11758
(Exact name of Registrant as specified in its charter)
Delaware
1585 Broadway
36-3145972
(212)
761-4000
(State or other jurisdiction of
incorporation or organization)
New York,
NY
10036
(I.R.S. Employer Identification No.)
(Registrant’s telephone number, including area code)
(Address of principal executive offices, including zip code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of exchange on
which registered
Common Stock, $0.01 par value
MS
New York Stock Exchange
Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate
MS/PA
New York Stock Exchange
Non-Cumulative Preferred Stock, Series A, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PE
New York Stock Exchange
Non-Cumulative Preferred Stock, Series E, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PF
New York Stock Exchange
Non-Cumulative Preferred Stock, Series F, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PI
New York Stock Exchange
Non-Cumulative Preferred Stock, Series I, $0.01 par value
Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate
MS/PK
New York Stock Exchange
Non-Cumulative Preferred Stock, Series K, $0.01 par value
Depository Shares, each representing 1/1000th interest in a share of 4.875%
MS/PL
New York Stock Exchange
Non-Cumulative Preferred Stock, Series L, $0.01 par value
Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026
MS/26C
New York Stock Exchange
of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto)
Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031
MLPY
NYSE Arca, Inc.
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
As of April 30, 2020, there were
1,575,656,380
shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.
Table of Contents
QUARTERLY REPORT ON FORM 10-Q
For the quarter ended
March 31, 2020
Table of Contents
Part
Item
Page
Risk Factors
II
1A
1
Financial Information
I
2
Management’s Discussion and Analysis of Financial Condition and Results of Operations
I
2
2
Introduction
2
Executive Summary
3
Business Segments
7
Supplemental Financial Information
15
Other Matters
15
Accounting Development Updates
15
Critical Accounting Policies
16
Liquidity and Capital Resources
16
Balance Sheet
16
Regulatory Requirements
21
Quantitative and Qualitative Disclosures about Risk
I
3
28
Market Risk
28
Credit Risk
30
Country and Other Risks
35
Report of Independent Registered Public Accounting Firm
38
Consolidated Financial Statements and Notes
I
1
39
Consolidated Income Statements (Unaudited)
39
Consolidated Comprehensive Income Statements (Unaudited)
40
Consolidated Balance Sheets (Unaudited at March 31, 2020)
41
Consolidated Statements of Changes in Total Equity (Unaudited)
42
Consolidated Cash Flow Statements (Unaudited)
43
Notes to Consolidated Financial Statements (Unaudited)
44
1.
Introduction and Basis of Presentation
44
2.
Significant Accounting Policies
45
3.
Cash and Cash Equivalents
47
4.
Fair Values
47
5.
Fair Value Option
54
6.
Derivative Instruments and Hedging Activities
55
7.
Investment Securities
59
8.
Collateralized Transactions
62
9.
Loans, Lending Commitments and Related Allowance for Credit Losses
63
10.
Other Assets—Equity Method Investments
67
11.
Deposits
67
12.
Borrowings and Other Secured Financings
67
13.
Commitments, Guarantees and Contingencies
68
14.
Variable Interest Entities and Securitization Activities
71
15.
Regulatory Requirements
73
16.
Total Equity
76
17.
Interest Income and Interest Expense
78
18.
Income Taxes
78
19.
Segment, Geographic and Revenue Information
78
Financial Data Supplement (Unaudited)
81
Glossary of Common Terms and Acronyms
82
Other Information
II
84
Legal Proceedings
II
1
84
Unregistered Sales of Equity Securities and Use of Proceeds
II
2
84
Controls and Procedures
I
4
84
Exhibits
II
6
84
Signatures
S-
1
i
Table of Contents
Available Information
We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website,
www.sec.gov
, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC’s website.
Our website is
www.morganstanley.com
. You can access our Investor Relations webpage at
www.morganstanley.com/about-us-ir
. We make available free of charge, on or through our Investor Relations webpage, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (“Exchange Act”), as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the SEC’s website, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Exchange Act.
You can access information about our corporate governance at
www.morganstanley.com/about-us-governance
and our sustainability initiatives at
www.morganstanley.com/about-us/sustainability-at-morgan-stanley.
Our webpages include:
•
Amended and Restated Certificate of Incorporation;
•
Amended and Restated Bylaws;
•
Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating and Governance Committee, Operations and Technology Committee, and Risk Committee;
•
Corporate Governance Policies;
•
Policy Regarding Corporate Political Activities;
•
Policy Regarding Shareholder Rights Plan;
•
Equity Ownership Commitment;
•
Code of Ethics and Business Conduct;
•
Code of Conduct;
•
Integrity Hotline Information;
•
Environmental and Social Policies; and
•
Sustainability Report.
Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer, Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (“NYSE”) on our website. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations, 1585 Broadway, New York, NY 10036 (212-761-4000). The information on our website is not incorporated by reference into this report.
ii
Table of Contents
Risk Factors
In addition to “Risk Factors” in Part I, Item 1A of the 2019 Form 10-K, please refer to the risk factor under Item 8.01. “Other Matters,” in the Current Report on Form 8-K filed with the SEC on April 16, 2020 and the additional risk factors under “Risk Factors” in the Registration Statement on Form S-4 filed with the SEC on April 17, 2020.
1
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Introduction
Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley,” “Firm,” “us,” “we” or “our” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this
Form 10-Q
.
A description of the clients and principal products and services of each of our business segments is as follows:
Institutional Securities
provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in equity and fixed income products, including foreign exchange and commodities. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research.
Wealth Management
provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services.
Investment Management
provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.
Management’s Discussion and Analysis includes certain metrics which we believe to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an additional means of assessing, our financial condition and operating results. Such metrics, when used, are defined and may be different from or inconsistent with metrics used by other companies.
The results of operations in the past have been, and in the future may continue to be, materially affected by: competition; risk factors; legislative, legal and regulatory developments; and other factors. These factors also may have an adverse impact on our ability to achieve our strategic objectives. Additionally, the discussion of our results of operations herein may contain forward-looking statements. These statements, which reflect management’s beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of the risks and uncertainties that may affect our future results, see “Forward-Looking Statements,” “Business—Competition,” “Business—Supervision and Regulation,”
and “
Risk Factors
” in the
2019 Form 10-K
, and “
Liquidity and Capital Resources—Regulatory Requirements
” herein. In addition, see “Executive Summary” herein and “
Risk Factors
” for information on the current and possible future effects of the COVID-19 pandemic on our results.
March 2020 Form 10-Q
2
Table of Contents
Management’s Discussion and Analysis
Executive Summary
Overview of Financial Results
Consolidated Results
Net Revenues
($ in millions)
Net Income Applicable to Morgan Stanley
($ in millions)
Earnings per Common Share
1
1.
For further information on basic and diluted EPS, see
Note 16
to the financial statements.
We reported net revenues of
$9,487 million
in the quarter ended
March 31, 2020
(“current quarter,” or “
1Q 2020
”), compared with
$10,286 million
in the quarter ended
March 31, 2019
(“prior year quarter,” or “
1Q 2019
”). For the current quarter, net income applicable to Morgan Stanley was
$1,698 million
, or
$1.01
per diluted common share, compared with
$2,429 million
or
$1.39
per diluted common share, in the prior year quarter.
See “Coronavirus Disease (COVID-19) Pandemic” herein for information on the current and possible future effects of the COVID-19 pandemic on our results.
Non-interest Expenses
1
($ in millions)
1.
The percentages on the bars in the chart represent the contribution of compensation and benefits expenses and non-compensation expenses to the total.
•
Compensation and benefits expenses of
$4,283 million
in the current quarter decreased
8%
from
$4,651 million
in the prior year quarter.
The decrease was primarily due to decreases in the fair value of investments to which certain deferred compensation plans are referenced and compensation associated with carried interest, partially offset by increases in discretionary incentive compensation, and the formulaic payout to Wealth Management representatives driven by the mix of revenues.
•
Non-compensation expenses of
$3,058 million
in the current quarter increased
14%
from
$2,680 million
in the prior year quarter.
The increase was primarily due to higher volume-related expenses and an increase in the provision for credit losses for lending commitments.
Income Taxes
The prior year quarter included intermittent net discrete tax benefits of
$101 million
,
primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
For further information, see “
Supplemental Financial Information—Income Tax Matters
” herein.
3
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Selected Financial Information and Other Statistical Data
Three Months Ended March 31,
$ in millions
2020
2019
Net income applicable to Morgan Stanley
$
1,698
$
2,429
Preferred stock dividends
108
93
Earnings applicable to Morgan Stanley common shareholders
$
1,590
$
2,336
Expense efficiency ratio
1
77.4
%
71.3
%
ROE
2
8.5
%
13.1
%
Adjusted ROE
3
8.3
%
12.5
%
ROTCE
2,3
9.7
%
14.9
%
Adjusted ROTCE
3
9.5
%
14.2
%
Pretax margin
4
22.6
%
28.7
%
Pre-tax margin by segment
4
Institutional Securities
19
%
31
%
Wealth Management
26
%
27
%
Investment Management
21
%
22
%
in millions, except per share and employee data
At
March 31,
2020
At
December 31,
2019
Liquidity resources
5
$
255,134
$
215,868
Loans
6
$
148,697
$
130,637
Total assets
$
947,795
$
895,429
Deposits
$
235,239
$
190,356
Borrowings
$
194,856
$
192,627
Common shares outstanding
1,576
1,594
Common shareholders' equity
$
77,340
$
73,029
Tangible common shareholders’ equity
3
$
68,194
$
63,780
Book value per common share
7
$
49.09
$
45.82
Tangible book value per common share
3,7
$
43.28
$
40.01
Worldwide employees
60,670
60,431
At
March 31,
2020
At
December 31,
2019
Capital ratios
8
Common Equity Tier 1 capital
15.2
%
16.4
%
Tier 1 capital
17.3
%
18.6
%
Total capital
19.6
%
21.0
%
Tier 1 leverage
8.1
%
8.3
%
SLR
6.2
%
6.4
%
1.
The expense efficiency ratio represents total non-interest expenses as a percentage of net revenues.
2.
ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively.
3.
Represents a non-GAAP measure. See “
Selected Non-GAAP Financial Information
” herein.
4.
Pre-tax margin represents income from continuing operations before income taxes as a percentage of net revenues.
5.
For a discussion of Liquidity resources, see “
Liquidity and Capital Resources—Liquidity Risk Management Framework—Liquidity Resources
” herein.
6.
Amounts include loans held for investment (net of allowance) and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see
Note 9
to the financial statements).
7.
Book value per common share and tangible book value per common share equal common shareholders’ equity and tangible common shareholders’ equity, respectively, divided by common shares outstanding.
8.
At
March 31, 2020
and
December 31, 2019
, our risk-based capital ratios are based on the Advanced Approach and the Standardized Approach rules, respectively. For a discussion of our capital ratios, see “
Liquidity and Capital Resources—Regulatory Requirements
” herein.
Business Segment Results
Net Revenues by Segment
1
($ in millions)
Net Income Applicable to Morgan Stanley by Segment
1
($ in millions)
1.
The percentages on the bars in the charts represent the contribution of each business segment to the total of the applicable financial category and may not total to 100% due to intersegment eliminations.
See
Note 19
to the financial statements for details of intersegment eliminations.
•
Institutional Securities net revenues of
$4,905 million
in the current quarter decreased
6%
from
$5,196 million
in the prior year quarter
primarily reflecting losses on loans and lending commitments held for sale and an increase in the provision for credit losses on loans and lending commitments held for investment, as well as losses related to investments associated with certain employee deferred cash-based compensation plans, partially offset by increases in Fixed Income and Equity sales and trading revenues driven by increased volumes and volatility.
•
Wealth Management net revenues of
$4,037 million
in the current quarter decreased
8%
from
$4,389 million
in the prior year quarter,
primarily reflecting losses related to investments associated with certain employee deferred cash-based compensation plans, partially offset by higher Asset management revenues and higher commissions driven by market volatility.
March 2020 Form 10-Q
4
Table of Contents
Management’s Discussion and Analysis
•
Investment Management net revenues of
$692 million
in the current quarter decreased
14%
from
$804 million
in the prior year quarter,
primarily reflecting lower Investments revenues, partially offset by higher Asset management revenues.
Net Revenues by Region
1, 2
($ in millions)
1.
The percentages on the bars in the charts represent the contribution of each region to the total.
2.
For a discussion of how the geographic breakdown of net revenues is determined, see
Note 19
to the financial statements.
Both the
34% increase in revenues in Asia and the 33% decrease in revenues in EMEA were primarily attributable to Equity sales and trading within the Institutional Securities business segment. The Equity sales and trading revenues increase in Asia reflects higher client volumes, while in EMEA market volatility and reduced dividend expectations weighed on revenues in the derivatives and financing businesses. Additionally, EMEA results reflected markdowns of held-for-sale loans and lending commitments.
Coronavirus Disease (COVID-19) Pandemic
The coronavirus disease (“COVID-19”) pandemic and related government-imposed shelter-in-place restrictions have had, and will likely continue to have, a severe impact on global economic conditions and the environment in which we operate our businesses.
In responding to this unprecedented situation, we have taken measures to prioritize the health of our employees and their families, and to be prepared operationally to serve our clients, leveraging our business continuity planning and historical investments in technology. More than 90% of our employees are currently working from home, and to date, we have not experienced any significant loss of operational capability, as we have implemented our pandemic-related responses. We believe we are prepared to continue to operate with the vast majority of our workforce working remotely for as long as health guidelines and prudence require, with limited impact to our operational capabilities.
The coronavirus disease has impacted many people’s health around the world, including many of our employees. Our
Chairman and CEO was diagnosed with the coronavirus in March, but has fully recovered. The rest of the Firm’s Operating Committee remain healthy and are sheltering in place.
With the COVID-19 impacts on individuals, communities and organizations continuing to evolve, governments around the world have reacted to the health crisis caused by the pandemic, and central banks have taken steps to proactively address market disruptions by cutting interest rates and providing liquidity sources and other stimulus programs. See “Regulatory Developments in Response to COVID-19” herein for further details.
We also have taken several direct steps to provide assistance. Our balance sheet has increased as we: support market and client activity; take in increased deposits from our Wealth Management clients; extend credit to our institutional and retail clients to provide them with additional liquidity; and provide financing to support COVID-19 impacted clients across multiple sectors. Along with the seven other U.S. Banks comprising the Financial Services Forum, we voluntarily ceased our Share Repurchase Program to keep this capital available to help clients and took action on the Federal Reserve's encouragement to use its discount window by borrowing from it. We have also taken steps to participate in other Federal Reserve programs, notably the Primary Dealer Credit Facility (“PDCF”).
Our financial condition, balance sheet, capital and liquidity have remained strong. In March 2020, we saw deposit inflows of $38 billion as customers sought relative safety away from volatile markets, and we raised more than $5 billion in new long-term debt supplementing our liquidity position.
As further discussed in “Business Segments” herein, towards the end of the current quarter, we observed the impact of the pandemic on our business. The
decline of asset prices, reduction in interest rates, widening of credit spreads, borrower and counterparty credit deterioration, market volatility and reduced investment banking activity had the most immediate negative impacts on our current quarter performance. Related to these effects, the Firm experienced mark-to-market losses, net of economic hedges of $610 million on loans and lending commitments held for sale, provisions of $407 million for credit losses on loans and lending commitments held for investment, and losses of $384 million on fund and business-related investments, net of hedges.
At the same time, high levels of client trading activity, related to market volatility, significantly increased revenues for global macro products and Commodities in Institutional Securities, and the transactional businesses in Wealth Management.
Though we are unable to estimate the extent of the impact, the continuing pandemic and related global economic crisis will adversely impact our future operating results. Additionally, with the continuance of many of the same negative impacts, without the benefit of higher client trading activity experienced in the
5
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
current quarter, it is uncertain that our financial objectives will be attained within the originally stated two year time frame.
We continue to use the elements of our Enterprise Risk Management framework manage the significant uncertainty in the present economic and market conditions. See “Quantitative and Qualitative Disclosures about Risk” in the 2019 Form 10-K for further information about our Enterprise Risk Management Framework.
In addition, refer to
“Risk Factors”
herein and Forward Looking Statements in the 2019 Form 10-K.
Selected Non-GAAP Financial Information
We prepare our financial statements using U.S. GAAP. From time to time, we may disclose certain “non-GAAP financial measures” in this document or in the course of our earnings releases, earnings and other conference calls, financial presentations, definitive proxy statement and otherwise. A “non-GAAP financial measure” excludes, or includes, amounts from the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We consider the non-GAAP financial measures we disclose to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an alternate means of assessing, our financial condition, operating results, prospective regulatory capital requirements or capital adequacy.
These measures are not in accordance with, or a substitute for, U.S. GAAP and may be different from or inconsistent with non-GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, along with a reconciliation of the differences between the U.S. GAAP financial measure and the non-GAAP financial measure.
The principal non-GAAP financial measures presented in this document are set forth in the following tables.
Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures
Three Months Ended
March 31,
$ in millions, except per share data
2020
2019
Net income applicable to Morgan Stanley
$
1,698
$
2,429
Impact of adjustments
(31
)
(101
)
Adjusted net income applicable to Morgan Stanley—non-GAAP
1
$
1,667
$
2,328
Earnings per diluted common share
$
1.01
$
1.39
Impact of adjustments
(0.02
)
(0.06
)
Adjusted earnings per diluted common share—non-GAAP
1
$
0.99
$
1.33
Effective income tax rate
17.1
%
16.5
%
Impact of adjustments
1.4
%
3.4
%
Adjusted effective income tax rate—
non-GAAP
1
18.5
%
19.9
%
Average Monthly Balance
Three Months Ended March 31,
$ in millions
2020
2019
Tangible equity
Morgan Stanley shareholders' equity
$
83,244
$
80,115
Less: Goodwill and net intangible assets
(9,200
)
(8,806
)
Tangible Morgan Stanley shareholders' equity—Non-GAAP
$
74,044
$
71,309
Common shareholders' equity
$
74,724
$
71,595
Less: Goodwill and net intangible assets
(9,200
)
(8,806
)
Tangible common shareholders' equity—Non-GAAP
$
65,524
$
62,789
Three Months Ended
March 31,
$ in billions
2020
2019
Average common equity
Unadjusted—GAAP
$
74.7
$
71.6
Adjusted
1
—Non-GAAP
74.7
71.5
ROE
2
Unadjusted—GAAP
8.5
%
13.1
%
Adjusted—Non-GAAP
1, 3
8.3
%
12.5
%
Average tangible common equity—Non-GAAP
Unadjusted
$
65.5
$
62.8
Adjusted
1
65.5
62.7
ROTCE
2
—Non-GAAP
Unadjusted
9.7
%
14.9
%
Adjusted
1, 3
9.5
%
14.2
%
March 2020 Form 10-Q
6
Table of Contents
Management’s Discussion and Analysis
Non-GAAP Financial Measures by Business Segment
Three Months Ended
March 31,
$ in billions
2020
2019
Average common equity
4, 5
Institutional Securities
$
42.8
$
40.4
Wealth Management
18.2
18.2
Investment Management
2.6
2.5
Average tangible common equity
4, 5
Institutional Securities
$
42.3
$
39.9
Wealth Management
10.4
10.2
Investment Management
1.7
1.5
ROE
6
Institutional Securities
6.3
%
12.9
%
Wealth Management
18.5
%
19.8
%
Investment Management
11.7
%
21.9
%
ROTCE
6
Institutional Securities
6.4
%
13.0
%
Wealth Management
32.3
%
35.6
%
Investment Management
18.1
%
35.3
%
1.
Adjusted amounts exclude net discrete tax provisions (benefits) that are intermittent and include those that are recurring. Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items. For further information on the net discrete tax provisions (benefits), see
“
Supplemental Financial Information—Income Tax Matters
” herein.
2.
ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively. When excluding intermittent net discrete tax provisions (benefits), both the numerator and average denominator are adjusted
.
3.
The calculations used in determining our “ROE and ROTCE Targets” referred to in the following section are the Adjusted ROE and Adjusted ROTCE amounts shown in this table.
4.
Average common equity and average tangible common equity for each business segment is determined using our Required Capital framework (see
"
Liquidity and Capital Resources—Regulatory Requirements—Attribution of Average Common Equity According to the Required Capital Framework
” herein).
5.
The sums of the segments' Average common equity and Average tangible common equity do not equal the Consolidated measures due to Parent equity.
6.
The calculation of ROE and ROTCE by segment uses annualized net income applicable to Morgan Stanley by segment less preferred dividends allocated to each segment as a percentage of average common equity and average tangible common equity, respectively, allocated to each segment.
Return on Tangible Common Equity Target
In January 2020, we established an ROTCE Target of 13% to 15% to be achieved over the next two years.
Our ROTCE Target is a forward-looking statement that was based on a normal market environment and may be materially affected by many factors, including, among other things: macroeconomic and market conditions; legislative and regulatory developments; industry trading and investment banking volumes; equity market levels; interest rate environment; outsized legal expenses or penalties; the ability to maintain a reduced level of expenses; and capital levels.
With the COVID–19 pandemic, and the current global economic crisis that includes negative impacts from many of the aforementioned factors, it is uncertain that the ROTCE Target will be met within the originally stated time frame.
See “Coronavirus Disease (COVID–19) Pandemic” herein and
“Risk Factors”
for further information on market and economic conditions and their effects on our financial results.
For further information on non-GAAP measures (ROTCE excluding intermittent net discrete tax items), see “Selected Non-GAAP Financial Information” herein. For information on the impact of intermittent net discrete tax items, see “Supplemental Financial Information—Income Tax Matters” herein.
Business Segments
Substantially all of our operating revenues and operating expenses are directly attributable to our business segments. Certain revenues and expenses have been allocated to each business segment, generally in proportion to its respective net revenues, non-interest expenses or other relevant measures.
For an overview of the components of our business segments, net revenues, compensation expense and income taxes, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments
” in the
2019 Form 10-K
.
7
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Institutional Securities
Income Statement Information
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Revenues
Investment banking
$
1,144
$
1,151
(1
)%
Trading
3,416
3,130
9
%
Investments
(25
)
81
(131
)%
Commissions and fees
874
621
41
%
Asset management
113
107
6
%
Other
(1,079
)
222
N/M
Total non-interest revenues
4,443
5,312
(16
)%
Interest income
2,423
3,056
(21
)%
Interest expense
1,961
3,172
(38
)%
Net interest
462
(116
)
N/M
Net revenues
4,905
5,196
(6
)%
Compensation and benefits
1,814
1,819
—
%
Non-compensation expenses
2,141
1,782
20
%
Total non-interest expenses
3,955
3,601
10
%
Income before provision for income taxes
950
1,595
(40
)%
Provision for income taxes
151
190
(21
)%
Net income
799
1,405
(43
)%
Net income applicable to noncontrolling interests
42
34
24
%
Net income applicable to Morgan Stanley
$
757
$
1,371
(45
)%
Results in the Institutional Securities business segment reflect constructive markets in January and February 2020 and the significant effects of COVID-19 on markets in March. In particular, in March:
•
Uncertainty, driven by market volatility and the overall environment, resulted in lower activity in Advisory and Equity underwriting.
•
Market volumes and volatility were significantly higher than in the prior year quarter resulting in increased client activity across the Sales and Trading businesses and widened bid-offer spreads. Valuations were negatively impacted, and client balances declined significantly in the Equity Financing business.
•
Credit deteriorated rapidly, the results of which are reflected in losses on held-for-sale loans and lending commitments recorded in Other revenues, partially offset by positive hedge results in Other Sales and Trading, aggregating to $610 million for the current quarter; provisions for loan losses recorded in Other revenues, and lending commitments shown in Non-compensation expenses, aggregating to $388 million for the current quarter; Trading losses in certain Credit
products within Fixed Income; and losses on certain counterparties’ failure to meet margin requirements in Equity sales and trading.
These effects, in the context of the full quarter’s results, are further discussed herein.
Investment Banking
Investment Banking Revenues
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Advisory
$
362
$
406
(11
)%
Underwriting:
Equity
336
339
(1
)%
Fixed income
446
406
10
%
Total Underwriting
782
745
5
%
Total Investment banking
$
1,144
$
1,151
(1
)%
Investment Banking Volumes
Three Months Ended
March 31,
$ in billions
2020
2019
Completed mergers and acquisitions
1
$
109
$
195
Equity and equity-related offerings
2, 3
13
14
Fixed income offerings
2, 4
82
58
Source: Refinitiv data as of April 1, 2020. Transaction volumes may not be indicative of net revenues in a given period. In addition, transaction volumes for prior periods may vary from amounts previously reported due to the subsequent withdrawal, change in value or change in timing of certain transactions.
1.
Includes transactions of $100 million or more. Based on full credit to each of the advisors in a transaction.
2.
Based on full credit for single book managers and equal credit for joint book managers.
3.
Includes Rule 144A issuances and registered public offerings of common stock, convertible securities and rights offerings.
4.
Includes Rule 144A and publicly registered issuances, non-convertible preferred stock, mortgage-backed and asset-backed securities, and taxable municipal debt. Excludes leveraged loans and self-led issuances.
Investment banking revenues of
$1,144 million
in the current quarter were relatively unchanged from the prior year quarter, reflecting lower results in our advisory business offset by higher results in our fixed income underwriting business.
•
Advisory revenues
decreased
in the current quarter primarily as a result of lower volumes of completed M&A activity, particularly large transactions.
•
Equity underwriting revenues were relatively unchanged compared with subdued results in the prior year quarter as lower revenues in secondary block share trades were offset by higher revenues in initial public offerings and follow-on offerings.
March 2020 Form 10-Q
8
Table of Contents
Management’s Discussion and Analysis
•
Fixed income underwriting revenues
increased
in the current quarter primarily due to higher overall volumes compared to the prior year quarter, with higher revenues in investment grade bond and non-investment grade loan issuances, partially offset by lower revenues from investment grade loan issuances.
See “Investment Banking Volumes” herein.
Sales and Trading Net Revenues
By Income Statement Line Item
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Trading
$
3,416
$
3,130
9
%
Commissions and fees
874
621
41
%
Asset management
113
107
6
%
Net interest
462
(116
)
N/M
Total
$
4,865
$
3,742
30
%
By Business
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Equity
$
2,422
$
2,015
20
%
Fixed Income
2,203
1,710
29
%
Other
240
17
N/M
Total
$
4,865
$
3,742
30
%
Sales and Trading Revenues—Equity and Fixed Income
Three Months Ended
March 31, 2020
Net
$ in millions
Trading
Fees
1
Interest
2
Total
Financing
$
1,034
$
101
$
(37
)
$
1,098
Execution services
579
783
(38
)
1,324
Total Equity
$
1,613
$
884
$
(75
)
$
2,422
Total Fixed Income
$
1,773
$
102
$
328
$
2,203
Three Months Ended
March 31, 2019
Net
$ in millions
Trading
Fees
1
Interest
2
Total
Financing
$
1,115
$
98
$
(258
)
$
955
Execution services
551
553
(44
)
1,060
Total Equity
$
1,666
$
651
$
(302
)
$
2,015
Total Fixed Income
$
1,727
$
78
$
(95
)
$
1,710
1.
Includes Commissions and fees and Asset management revenues.
2.
Includes funding costs, which are allocated to the businesses based on funding usage.
Equity
Equity sales and trading net revenues of
$2,422 million
in the current quarter
increased
20%
from the prior year quarter, reflecting higher results in both our financing and execution services businesses.
•
Financing increased from the prior year quarter, primarily due to higher average client balances, partially offset by the impact of reduced dividend expectations on the valuation of certain hedges. Net interest increased reflecting a reduction in funding costs.
•
Execution services increased from the prior year quarter, reflecting an increase in market volumes in cash equities resulting in higher Commissions and fees, and higher client trading activity in derivatives products, which was partially offset by the impact of losses on certain counterparties’ failure to meet margin requirements and the impact of reduced dividend expectations on derivative valuations.
Fixed Income
Fixed Income sales and trading net revenues of
$2,203 million
in the current quarter were
29%
higher than the prior year quarter, primarily driven by higher results in global macro products, partially offset by lower results in credit products.
•
Global macro products Trading revenues increased primarily due to higher client activity in both foreign exchange and rates products, and the widening of bid-offer spreads from higher market volatility. Higher average balances and lower funding costs contributed to an increase in Net interest revenues.
•
Credit products Trading revenues decreased primarily due to the widening of credit spreads which resulted in losses in securitized products and municipal securities, partially offset by increased revenues from client activity in corporate credit products from higher volumes and widening bid-offer spreads. Net interest revenues increased, primarily driven by higher spreads on Agency products and higher average balances in secured lending facilities.
•
Trading revenues from Commodities products and Other decreased as a result of lower client structuring activity within derivatives counterparty credit risk management, partially offset by improved inventory management in commodities due to higher market volatility in energy and metals. Net interest revenues increased, reflecting lower funding costs.
Other
•
Other sales and trading revenues of
$240 million
in the current quarter increased from the prior year quarter reflecting gains on hedges associated with loans and lending commitments compared with losses in the prior year quarter, partially offset by losses related to investments associated with certain employee deferred cash-based compensation plans.
9
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Investments, Other Revenues, Non-interest Expenses, and Income Tax Items
Investments
•
Net investment losses of
$25 million
in the current quarter compared to gains in the prior year quarter, were primarily driven by losses in the current quarter on an energy-related investment and lower revenues from fund-related distributions.
Other Revenues
•
Other net losses of
$1,079 million
in the current quarter were primarily as a result of mark-to-market losses on loans and lending commitments held for sale due to the widening of credit spreads, compared with gains in the prior year quarter, as well as an increase in the provision for credit losses on loans held for investment.
Non-interest Expenses
Non-interest expenses of
$3,955 million
in the current quarter
increased
from the prior year quarter, primarily reflecting a
20%
increase
in Non-compensation expenses.
•
Compensation and benefits expenses remained relatively unchanged in the current quarter as the benefit from a decrease in the fair value of investments to which certain deferred compensation plans are referenced was offset by an increase in discretionary incentive compensation reflecting baseline annual compensation estimates, exclusive of the benefit noted.
•
Non-compensation expenses increased in the current quarter primarily due to higher volume-related expenses as well as an increase in the provision for credit losses for lending commitments held for investment.
Income Tax Items
Intermittent net discrete tax benefits of
$101 million
were recognized in Provision for income taxes in the prior year quarter. For further information, see “
Supplemental Financial Information—Income Tax Matters
” herein.
March 2020 Form 10-Q
10
Table of Contents
Management’s Discussion and Analysis
Wealth Management
Income Statement Information
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Revenues
Investment banking
$
158
$
109
45
%
Trading
(347
)
302
N/M
Investments
—
1
(100
)%
Commissions and fees
588
406
45
%
Asset management
2,680
2,361
14
%
Other
62
80
(23
)%
Total non-interest revenues
3,141
3,259
(4
)%
Interest income
1,193
1,413
(16
)%
Interest expense
297
283
5
%
Net interest
896
1,130
(21
)%
Net revenues
4,037
4,389
(8
)%
Compensation and benefits
2,212
2,462
(10
)%
Non-compensation expenses
770
739
4
%
Total non-interest expenses
2,982
3,201
(7
)%
Income before provision for income taxes
$
1,055
$
1,188
(11
)%
Provision for income taxes
191
264
(28
)%
Net income applicable to Morgan Stanley
$
864
$
924
(6
)%
Results in the Wealth Management business segment reflect the significant effects of COVID-19 on the economy and markets in March 2020. In particular, in March:
•
The decline in global asset prices contributed to losses on investments associated with certain employee deferred cash-based compensation plans of $426 million in the current quarter.
•
Already elevated market volumes and volatility compared to the prior year quarter increased further, resulting in increased commissions from client activity.
These effects, in the context of the full quarter’s results, are further discussed herein.
Financial Information and Statistical Data
At
March 31,
2020
At
December 31,
2019
$ in billions, except employee data
Client assets
$
2,397
$
2,700
Fee-based client assets
1
$
1,134
$
1,267
Fee-based client assets as a percentage of total client assets
47
%
47
%
Client liabilities
2
$
92
$
90
Investment securities portfolio
$
75.5
$
67.2
Loans and lending commitments
$
95.9
$
93.2
Wealth Management representatives
15,432
15,468
Three Months Ended
March 31,
2020
2019
Per representative:
Annualized revenues ($ in thousands)
3
$
1,045
$
1,118
Client assets ($ in millions)
4
$
155
$
158
Fee-based asset flows ($ in billions)
5
$
18.4
$
14.8
1.
Fee-based client assets represent the amount of assets in client accounts where the fee for services is calculated based on those assets.
2.
Client liabilities include securities-based and tailored lending, residential real estate loans and margin lending.
3.
Revenues per representative equal Wealth Management’s annualized net revenues divided by the average number of representatives.
4.
Client assets per representative equal total period-end client assets divided by period-end number of representatives.
5.
For a description of the Inflows and Outflows included within Fee-based asset flows, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management—Fee-Based Client Assets” in the 2019 Form 10-K.
Excludes institutional cash management-related activity.
Transactional Revenues
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Investment banking
$
158
$
109
45
%
Trading
(347
)
302
N/M
Commissions and fees
588
406
45
%
Total
$
399
$
817
(51
)%
Transactional revenues as a % of Net revenues
10
%
19
%
11
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Net Revenues
Transactional Revenues
Transactional revenues of
$399 million
in the current quarter
decreased
51%
from the prior year quarter as negative Trading revenues were partially offset by higher Commissions and fees and Investment banking revenues.
•
Investment banking revenues
increased
in the current quarter primarily due to higher revenues from structured products and closed-end fund issuances.
•
Trading revenues
decreased
in the current quarter principally due to losses related to investments associated with certain employee deferred cash-based compensation plans, compared with gains in the prior year quarter.
•
Commissions and fees
increased
in the current quarter primarily due to increased client activity in equities.
Asset Management
Asset management revenues of
$2,680 million
in the current quarter
increased
14%
from the prior year quarter primarily due to higher fee-based assets levels at the beginning of the monthly billing cycles in 2020 due to market appreciation and positive net flows, partially offset by lower average fee rates.
See “
Fee-Based Client Assets—Rollforwards
” herein.
Other
Other revenues of
$62 million
in the current quarter decreased
23%
from the prior year quarter primarily due to an increase in the provision for credit losses.
Net Interest
Net interest of
$896 million
in the current quarter decreased
21%
from the prior year quarter primarily due to lower interest rates on Loans and the investment portfolio, changes in our funding mix, and higher prepayment amortization expense related to mortgage-backed securities. These decreases were partially offset by the impact of lower rates paid on brokerage sweep deposits and higher Loan balances.
Non-interest Expenses
Non-interest expenses of
$2,982 million
in the current quarter
decreased
7%
from the prior year quarter primarily as a result of lower Compensation and benefits expenses, partially offset by higher Non-compensation expenses.
•
Compensation and benefits expenses
decreased
in the current quarter, primarily due to decreases in the fair value of investments to which certain deferred compensation plans are referenced, partially offset by an increase in the formulaic
payout to Wealth Management representatives driven by the mix of revenues.
•
Non-compensation expenses
increased
in the current quarter primarily due to incremental expenses related to Solium Capital, Inc., which was acquired in the second quarter of 2019.
Fee-Based Client Assets
Rollforwards
$ in billions
At
December 31,
2019
Inflows
Outflows
Market
Impact
At
March 31,
2020
Separately managed
1
$
322
$
12
$
(7
)
$
2
$
329
Unified managed
313
16
(13
)
(53
)
263
Advisor
155
10
(9
)
(25
)
131
Portfolio manager
435
27
(18
)
(65
)
379
Subtotal
$
1,225
$
65
$
(47
)
$
(141
)
$
1,102
Cash management
42
4
(14
)
—
32
Total fee-based client assets
$
1,267
$
69
$
(61
)
$
(141
)
$
1,134
$ in billions
At
December 31,
2018
Inflows
Outflows
Market
Impact
At
March 31,
2019
Separately managed
1
$
279
$
14
$
(5
)
$
(12
)
$
276
Unified managed
257
13
(11
)
24
283
Advisor
137
8
(9
)
11
147
Portfolio manager
353
19
(14
)
33
391
Subtotal
$
1,026
$
54
$
(39
)
$
56
$
1,097
Cash management
20
4
(5
)
—
19
Total fee-based client assets
$
1,046
$
58
$
(44
)
$
56
$
1,116
Average Fee Rates
Three Months Ended
March 31,
Fee rate in bps
2020
2019
Separately managed
14
14
Unified managed
99
101
Advisor
85
88
Portfolio manager
94
96
Subtotal
72
74
Cash management
5
6
Total fee-based client assets
71
73
1.
Includes non-custody account values reflecting prior quarter-end balances due to a lag in the reporting of asset values by third-party custodians.
For a description of fee-based client assets and rollforward items in the previous tables, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management—Fee-Based Client Assets
” in the 2019 Form 10-K.
March 2020 Form 10-Q
12
Table of Contents
Management’s Discussion and Analysis
Investment Management
Income Statement Information
Three Months Ended
March 31,
$ in millions
2020
2019
% Change
Revenues
Trading
$
(37
)
$
(3
)
N/M
Investments
63
191
(67
)%
Asset management
665
617
8
%
Other
7
3
133
%
Total non-interest revenues
698
808
(14
)%
Interest income
8
4
100
%
Interest expense
14
8
75
%
Net interest
(6
)
(4
)
(50
)%
Net revenues
692
804
(14
)%
Compensation and benefits
257
370
(31
)%
Non-compensation expenses
292
260
12
%
Total non-interest expenses
549
630
(13
)%
Income before provision for income taxes
143
174
(18
)%
Provision for income taxes
25
33
(24
)%
Net income
118
141
(16
)%
Net income applicable to noncontrolling interests
40
5
N/M
Net income applicable to Morgan Stanley
$
78
$
136
(43
)%
Results in the Investment Management business segment reflect the significant effects of COVID-19 on the economy and markets in March 2020. In particular, in March:
•
The decline in global asset prices led to losses of $326 million in the current quarter related to the reversal of accrued carried interest, and losses on investments in certain of our funds, net of economic hedges, and net losses in Trading revenues.
These effects, in the context of the full quarter’s results, are further discussed herein.
Net Revenues
Investments
Investments revenues of
$63 million
in the current quarter
decreased
67%
from the prior year quarter primarily as a result of the reversal of accrued carried interest and investment losses in certain private equity, real estate, and infrastructure funds and losses on seed investments in certain funds. Partially offsetting these decreases were higher carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment, which is subject to certain sales restrictions.
Asset Management
Asset management revenues of
$665 million
in the current quarter
increased
8%
from the prior year quarter primarily as a result of higher average AUM.
See “Assets Under Management or Supervision” herein.
Non-interest Expenses
Non-interest expenses of
$549 million
in the current quarter
decreased
13%
from the prior year quarter primarily as a result of lower compensation and benefits expenses, partially offset by higher non-compensation expenses.
•
Compensation and benefits expenses
decreased
in the current quarter primarily due to lower compensation associated with carried interest and a decrease in the fair value of investments to which certain deferred compensation plans are referenced.
•
Non-compensation expenses in the current quarter
increased
from the prior year quarter primarily as a result of higher fee sharing paid to intermediaries driven by higher average AUM.
13
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Assets Under Management or Supervision
Rollforwards
$ in billions
At
December 31, 2019
Inflows
Outflows
Market
Impact
Other
At
March 31,
2020
Equity
$
138
$
14
$
(12
)
$
(18
)
$
(1
)
$
121
Fixed income
79
10
(9
)
(4
)
(1
)
75
Alternative/Other
139
8
(4
)
(7
)
5
141
Long-term AUM subtotal
356
32
(25
)
(29
)
3
337
Liquidity
196
446
(395
)
1
(1
)
247
Total AUM
$
552
$
478
$
(420
)
$
(28
)
$
2
$
584
Shares of minority stake assets
6
6
$ in billions
At
December 31, 2018
Inflows
Outflows
Market
Impact
Other
At
March 31,
2019
Equity
$
103
$
9
$
(8
)
$
16
$
—
$
120
Fixed income
68
6
(7
)
1
—
68
Alternative/Other
128
5
(4
)
5
(1
)
133
Long-term AUM subtotal
299
20
(19
)
22
(1
)
321
Liquidity
164
343
(348
)
1
(1
)
159
Total AUM
$
463
$
363
$
(367
)
$
23
$
(2
)
$
480
Shares of minority stake assets
7
6
Average AUM
Three Months Ended
March 31,
$ in billions
2020
2019
Equity
$
133
$
113
Fixed income
79
68
Alternative/Other
139
131
Long-term AUM subtotal
351
312
Liquidity
206
163
Total AUM
$
557
$
475
Shares of minority stake assets
6
6
Average Fee Rates
Three Months Ended
March 31,
Fee rate in bps
2020
2019
Equity
77
76
Fixed income
31
32
Alternative/Other
60
68
Long-term AUM
60
63
Liquidity
17
17
Total AUM
44
47
For a description of the asset classes and rollforward items in the previous tables, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments
—Investment Management—Assets Under Management or Supervision” in the 2019 Form 10-K.
March 2020 Form 10-Q
14
Table of Contents
Management’s Discussion and Analysis
Supplemental Financial Information
Income Tax Matters
Effective Tax Rate from Continuing Operations
Three Months Ended
March 31,
$ in millions
2020
2019
U.S. GAAP
17.1
%
16.5
%
Adjusted effective income tax rate—non-GAAP
1
18.5
%
19.9
%
Net discrete tax provisions/(benefits)
Recurring
2
$
(99
)
$
(107
)
Intermittent
3
$
(31
)
$
(101
)
1.
The adjusted effective income tax rate is a non-GAAP measure that excludes net discrete tax provisions (benefits) that are intermittent and includes those that are recurring. For further information on non-GAAP measures, see
“
Selected Non-GAAP Financial Information
” herein.
2.
Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items.
3.
Includes all tax provisions (benefits) that have been determined to be discrete, other than Recurring items as defined above.
The current quarter includes intermittent net discrete tax benefits associated with the remeasurement of prior years’ tax liabilities. The prior year quarter includes intermittent net discrete tax benefits
primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
See
Note 18
to the financial statements for further information.
U.S. Bank Subsidiaries
Our U.S. bank subsidiaries, Morgan Stanley Bank N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, “U.S. Bank Subsidiaries”) accept deposits; provide loans to a variety of customers, from large corporate and institutional clients to high net worth individuals; and invest in securities. Lending activity recorded in the U.S. Bank subsidiaries from the Institutional Securities business segment primarily includes loans and lending commitments to corporate clients. Lending activity recorded in the U.S. Bank subsidiaries from the Wealth Management business segment primarily includes securities-based lending, which allows clients to borrow money against the value of qualifying securities, and residential real estate loans.
For a further discussion of our credit risks, see
“
Quantitative and Qualitative Disclosures about Risk—Credit Risk
.” For a further discussion about loans and lending commitments, see
Notes 9
and
13
to the financial statements.
U.S. Bank Subsidiaries’ Supplemental Financial Information
1
$ in billions
At
March 31,
2020
At
December 31,
2019
Assets
$
265.4
$
219.6
Investment securities portfolio:
Investment securities—AFS
49.0
42.4
Investment securities—HTM
28.7
26.1
Total investment securities
$
77.7
$
68.5
Deposits
2
$
234.1
$
189.3
Wealth Management Loans
Securities-based lending and other
3
$
51.4
$
49.9
Residential real estate
31.1
30.2
Total
$
82.5
$
80.1
Institutional Securities Loans
Corporate
4
:
Corporate relationship and event-driven lending
$
15.4
$
5.6
Secured lending facilities
28.4
26.8
Securities-based lending and other
5.1
5.4
Commercial and residential real estate
10.3
12.0
Total
$
59.2
$
49.8
1.
Amounts exclude transactions between the bank subsidiaries, as well as deposits from the Parent Company and affiliates.
2.
For further information on deposits, see
“
Liquidity and Capital Resources—Funding Management—Unsecured Financing
” herein.
3.
Other loans primarily include tailored lending.
4.
For a further discussion of corporate loans in the Institutional Securities business segment, see
“
Credit Risk—Institutional Securities Corporate Loans
” herein.
Other Matters
Planned Acquisition of E*TRADE
On February 20, 2020, we entered into a definitive agreement under which we will acquire E*TRADE Financial Corporation (“E*TRADE”) in an all-stock transaction. In the current quarter, we filed our application with the Federal Reserve and in early April the Hart-Scott-Rodino Antitrust waiting period expired. The acquisition is subject to customary closing conditions, including regulatory approvals and approval by E*TRADE shareholders, and we continue to expect the acquisition to close in the fourth quarter of 2020.
Accounting Development Updates
The Financial Accounting Standards Board has issued certain accounting updates that apply to us. Accounting updates not listed below were assessed and either determined to be not applicable or are not expected to have a significant impact on our financial statements.
15
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
The following accounting update is currently being evaluated to determine the potential impact of adoption:
•
Reference Rate Reform.
This accounting update provides optional accounting relief to entities with contracts, hedge accounting relationships or other transactions that reference LIBOR or other interest rate benchmarks for which the referenced rate is expected to be discontinued or replaced. This optional relief generally allows for contract modifications solely related to the replacement of the reference rate to be accounted for as a continuation of the existing contract instead of as an extinguishment of the contract, and would therefore not trigger certain accounting impacts that would otherwise be required. The relief also allows entities to change certain critical terms of existing hedge accounting relationships that are affected by reference rate reform, and these changes would not require de-designating the hedge accounting relationship. The optional relief can be applied beginning January 1, 2020, and ending December 31, 2022. We plan to apply the accounting relief as relevant contract and hedge accounting relationship modifications are made during the course of the reference rate reform transition period.
Critical Accounting Policies
Our financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions
(see
Note 1
to the financial statements).
We believe that of our significant accounting policies
(see
Note 2
to the financial statements in the
2019 Form 10-K
and
Note 2
to the financial statements), the fair value, goodwill and intangible assets, legal and regulatory contingencies and income taxes
policies involve a higher degree of judgment and complexity
. For a further discussion about our critical accounting policies, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies
” in the
2019 Form 10-K
.
Liquidity and Capital Resources
Senior management, with oversight by the Asset/Liability Management Committee and the Board of Directors (“Board”), establishes and maintains our liquidity and capital policies. Through various risk and control committees, senior management reviews business performance relative to these policies, monitors the availability of alternative sources of financing, and oversees the liquidity, interest rate and currency sensitivity of our asset and liability position. Our Treasury department, Firm Risk Committee, Asset/Liability Management Committee, and other committees and control groups assist in evaluating, monitoring and controlling the impact that our business activities have on our balance sheet, liquidity and capital structure. Liquidity and capital matters are reported regularly to the Board and the Risk Committee of the Board.
Balance Sheet
We monitor and evaluate the composition and size of our balance sheet on a regular basis. Our balance sheet management process includes quarterly planning, business-specific thresholds, monitoring of business-specific usage versus key performance metrics and new business impact assessments.
We establish balance sheet thresholds at the consolidated and business segment levels. We monitor balance sheet utilization and review variances resulting from business activity and market fluctuations. On a regular basis, we review current performance versus established thresholds and assess the need to re-allocate our balance sheet based on business unit needs. We also monitor key metrics, including asset and liability size and capital usage.
Total Assets by Business Segment
At March 31, 2020
$ in millions
IS
WM
IM
Total
Assets
Cash and cash equivalents
$
101,615
$
29,803
$
91
$
131,509
Trading assets at fair value
266,781
389
3,746
270,916
Investment securities
40,662
75,495
—
116,157
Securities purchased under agreements to resell
88,008
16,792
—
104,800
Securities borrowed
71,826
474
—
72,300
Customer and other receivables
58,523
15,216
685
74,424
Loans
1
66,171
82,516
10
148,697
Other assets
2
13,903
13,139
1,950
28,992
Total assets
$
707,489
$
233,824
$
6,482
$
947,795
At December 31, 2019
$ in millions
IS
WM
IM
Total
Assets
Cash and cash equivalents
$
67,657
$
14,247
$
267
$
82,171
Trading assets at fair value
293,477
47
3,586
297,110
Investment securities
38,524
67,201
—
105,725
Securities purchased under agreements to resell
80,744
7,480
—
88,224
Securities borrowed
106,199
350
—
106,549
Customer and other receivables
39,743
15,190
713
55,646
Loans
1
50,557
80,075
5
130,637
Other assets
2
14,300
13,092
1,975
29,367
Total assets
$
691,201
$
197,682
$
6,546
$
895,429
IS—Institutional Securities
WM—Wealth Management
IM—Investment Management
1.
Amounts include loans held for investment, net of allowance, and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets
(see
Note 9
to the financial statements).
2.
Other assets primarily includes Goodwill and Intangible assets, premises, equipment and software, ROU assets related to leases, other investments, and deferred tax assets.
A substantial portion of total assets consists of liquid marketable securities and short-term receivables arising principally from sales and trading activities in the Institutional Securities
March 2020 Form 10-Q
16
Table of Contents
Management’s Discussion and Analysis
business segment.
Total assets
increased
to
$948 billion
at March 31, 2020
from
$895 billion
at
December 31, 2019
.
Within Wealth Management, assets increased in the investment portfolio comprising Cash and cash equivalents, Investment securities and Securities purchased under agreements to resell, as a result of significantly higher deposits in this segment, and loans continued to grow.
Institutional Securities’ assets were also higher reflecting increases within Cash and cash equivalents, primarily due to higher initial margin related to derivatives; Customer and other receivables, resulting from higher volumes of unsettled transactions in line with market conditions; and loan growth in March in support of client needs. Additionally, within Institutional Securities, Trading assets and Securities borrowed decreased, predominantly driven by corporate equities as the markets declined. The decrease in Trading assets includes a partial offset related to increased derivative exposures related to market volatility.
Liquidity Risk Management Framework
The core components of our Liquidity Risk Management Framework are the Required Liquidity Framework, Liquidity Stress Tests and Liquidity Resources, which support our target liquidity profile. For a further discussion about the Firm’s Required Liquidity Framework and Liquidity Stress Tests, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Liquidity Risk Management Framework
” in the
2019 Form 10-K
.
At March 31, 2020
and
December 31, 2019
, we maintained sufficient liquidity to meet current and contingent funding obligations as modeled in our Liquidity Stress Tests.
Liquidity Resources
We maintain sufficient liquidity resources, which are comprised of HQLA and cash deposits with banks (“Liquidity Resources”) to cover daily funding needs and to meet strategic liquidity targets sized by the Required Liquidity Framework and Liquidity Stress Tests. The total amount of Liquidity Resources is actively managed by us considering the following components: unsecured debt maturity profile; balance sheet size and composition; funding needs in a stressed environment, inclusive of contingent cash outflows; legal entity, regional and segment liquidity requirements; regulatory requirements; and collateral requirements.
The amount of Liquidity Resources we hold is based on our risk tolerance and is subject to change depending on market and Firm-specific events. The Liquidity Resources are primarily held within the Parent Company and its major operating subsidiaries. The Total HQLA values in the tables immediately following are different from Eligible HQLA which, in
accordance with the LCR rule, also takes into account certain regulatory weightings and other operational considerations.
Liquidity Resources by Type of Investment
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Cash deposits with central banks
$
60,719
$
35,025
Unencumbered HQLA Securities
2
:
U.S. government obligations
95,619
88,754
U.S. agency and agency mortgage-backed securities
58,342
50,732
Non-U.S. sovereign obligations
3
30,255
29,909
Other investment grade securities
700
1,591
Total HQLA
2
$
245,635
$
206,011
Cash deposits with banks (non-HQLA)
9,499
9,857
Total Liquidity Resources
$
255,134
$
215,868
1.
In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.
2.
HQLA is presented prior to applying weightings and includes all HQLA held in subsidiaries.
3.
Primarily composed of unencumbered U.K., French, Japanese, and German government obligations.
Liquidity Resources by Bank and Non-Bank Legal Entities
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Average Daily Balance
Three Months Ended
March 31, 2020
Bank legal entities
Domestic
$
112,126
$
75,894
$
83,117
Foreign
5,265
4,049
4,419
Total Bank legal entities
117,391
79,943
87,536
Non-Bank legal entities
Domestic:
Parent Company
53,548
53,128
49,284
Non-Parent Company
33,665
28,905
36,295
Total Domestic
87,213
82,033
85,579
Foreign
50,530
53,892
54,333
Total Non-Bank legal entities
137,743
135,925
139,912
Total Liquidity Resources
$
255,134
$
215,868
$
227,448
1.
In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation.
Liquidity Resources may fluctuate from period to period based on the overall size and composition of our balance sheet, the maturity profile of our unsecured debt and estimates of funding needs in a stressed environment, among other factors.
During the current quarter, cash deposits at central banks have increased, largely driven by an increase in deposits received from customers.
17
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Regulatory Liquidity Framework
Liquidity Coverage Ratio
We and our U.S. Bank Subsidiaries are subject to LCR requirements, including a requirement to calculate each entity’s LCR on each business day. The requirements are designed to ensure that banking organizations have sufficient Eligible HQLA to cover net cash outflows arising from significant stress over 30 calendar days, thus promoting the short-term resilience of the liquidity risk profile of banking organizations. The LCR calculation applies weightings (or asset haircuts) to HQLA and excludes certain HQLA held in subsidiaries.
As of
March 31, 2020
, we and our U.S. Bank Subsidiaries are compliant with the minimum required LCR of 100%. For further information on regulatory developments that have impacted our LCR, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.
Liquidity Coverage Ratio
Average Daily Balance
Three Months Ended
$ in millions
March 31,
2020
December 31,
2019
Eligible HQLA
1
Cash deposits with central banks
$
32,778
$
29,597
Securities
2
140,336
148,221
Total Eligible HQLA
1
$
173,114
$
177,818
LCR
127
%
134
%
1.
Under the LCR rule, Eligible HQLA is calculated using weightings and excluding certain HQLA held in subsidiaries.
2.
Primarily includes U.S. Treasuries, U.S. agency mortgage-backed securities, sovereign bonds and investment grade corporate bonds.
The reduction in the LCR was driven by lower average Eligible HQLA amounts, which included the removal from Eligible HQLA of certain securities used to secure intraday credit, following a recent regulatory rule clarification.
Net Stable Funding Ratio
The NSFR requires banking organizations to maintain sufficiently stable sources of funding over a one-year horizon. In 2016, the U.S. banking agencies issued a proposal to implement the NSFR in the U.S.; however, a final rule has not yet been issued.
For an additional discussion of the NSFR, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Liquidity Framework—Net Stable Funding Ratio
” in the
2019 Form 10-K
.
Funding Management
We manage our funding in a manner that reduces the risk of disruption to our operations. We pursue a strategy of diversification of secured and unsecured funding sources (by product, investor and region) and attempt to ensure that the tenor
of our liabilities equals or exceeds the expected holding period of the assets being financed.
We fund our balance sheet on a global basis through diverse sources. These sources include our equity capital, borrowings, securities sold under agreements to repurchase, securities lending, deposits, letters of credit and lines of credit. We have active financing programs for both standard and structured products targeting global investors and currencies.
Secured Financing
For a discussion of our secured financing activities, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Funding Management—Secured Financing
” in the
2019 Form 10-K
.
Collateralized Financing Transactions
$ in millions
At
March 31,
2020
At
December 31,
2019
Securities purchased under agreements to resell and Securities borrowed
$
177,100
$
194,773
Securities sold under agreements to repurchase and Securities loaned
$
57,447
$
62,706
Securities received as collateral
1
$
4,711
$
13,022
Average Daily Balance
Three Months Ended
$ in millions
March 31,
2020
December 31,
2019
Securities purchased under agreements to resell and Securities borrowed
$
177,971
$
210,257
Securities sold under agreements to repurchase and Securities loaned
$
61,143
$
64,870
1.
Included within Trading assets—Corporate equities in the balance sheets.
See “Total Assets by Business Segment” herein for more details on the assets shown in the previous table,
Note 2
to the financial statements in the
2019 Form 10-K
and
Note 8
to the financial statements for more details on collateralized financing transactions.
In addition to the collateralized financing transactions shown in the previous table, we engage in financing transactions collateralized by customer-owned securities, which are segregated in accordance with regulatory requirements. Receivables under these financing transactions, primarily margin loans, are included in Customer and other receivables in the balance sheets, and payables under these financing transactions, primarily to prime brokerage customers, are included in Customer and other payables in the balance sheets. Our risk exposure on these transactions is mitigated by collateral maintenance policies. We also hold related liquidity reserves.
Unsecured Financing
For a discussion of our unsecured financing activities, see “
Management’s Discussion and Analysis of Financial Condition
March 2020 Form 10-Q
18
Table of Contents
Management’s Discussion and Analysis
and Results of Operations—Liquidity and Capital Resources—Funding Management—Unsecured Financing
” in the
2019 Form 10-K
.
Deposits
$ in millions
At
March 31,
2020
At
December 31,
2019
Savings and demand deposits:
Brokerage sweep deposits
1
$
151,618
$
121,077
Savings and other
36,886
28,388
Total Savings and demand deposits
188,504
149,465
Time deposits
46,735
40,891
Total
$
235,239
$
190,356
1.
Amounts represent balances swept from client brokerage accounts.
Deposits are primarily sourced from our Wealth Management clients and are considered to have stable, low-cost funding characteristics.
Total deposits at
March 31, 2020
significantly
increased
compared with
December 31, 2019
,
primarily driven by higher brokerage sweep and savings deposits as customers sought relative safety away from volatile markets in March. In addition, total deposits increased as a result of higher time deposits.
See
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
herein for further information on market and economic conditions.
Borrowings by Remaining Maturity at
March 31, 2020
1
$ in millions
Parent Company
Subsidiaries
Total
Original maturities of one year or less
$
8
$
2,203
$
2,211
Original maturities greater than one year
2020
$
8,264
$
2,692
$
10,956
2021
19,575
4,099
23,674
2022
16,116
3,045
19,161
2023
15,155
2,938
18,093
2024
15,678
4,809
20,487
Thereafter
79,688
20,586
100,274
Total
$
154,476
$
38,169
$
192,645
Total Borrowings
$
154,484
$
40,372
$
194,856
Maturities over next 12 months
2
$
17,153
1.
Original maturity in the table is generally based on contractual final maturity. For borrowings with put options, remaining maturity represents the earliest put date.
2.
Includes only borrowings with original maturities greater than one year.
Borrowings of
$195 billion
as of
March 31, 2020
were relatively unchanged when compared with
$193 billion
at
December 31, 2019
.
We believe that accessing debt investors through multiple distribution channels helps provide consistent access to the unsecured markets. In addition, the issuance of borrowings with original maturities greater than one year allows us to reduce reliance on short-term credit sensitive instruments. Borrowings
with original maturities greater than one year are generally managed to achieve staggered maturities, thereby mitigating refinancing risk, and to maximize investor diversification through sales to global institutional and retail clients across regions, currencies and product types.
The availability and cost of financing to us can vary depending on market conditions, the volume of certain trading and lending activities, our credit ratings and the overall availability of credit. We also engage in, and may continue to engage in, repurchases of our borrowings in the ordinary course of business.
For further information on Borrowings, see
Note 12
to the financial statements.
Credit Ratings
We rely on external sources to finance a significant portion of our daily operations. The cost and availability of financing generally are impacted by our credit ratings, among other things. In addition, our credit ratings can have an impact on certain trading revenues, particularly in those businesses where longer-term counterparty performance is a key consideration, such as certain OTC derivative transactions. When determining credit ratings, rating agencies consider both company-specific and industry-wide factors. These include regulatory or legislative changes, the macroeconomic environment and perceived levels of support, among other things.
See also “
Risk Factors— Liquidity Risk
” in the 2019 Form 10-K.
Parent Company and U.S. Bank Subsidiaries' Issuer Ratings at April 30, 2020
Parent Company
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
DBRS, Inc.
R-1 (middle)
A (high)
Stable
Fitch Ratings, Inc.
F1
A
Negative
Moody’s Investors Service, Inc.
P-2
A3
Ratings Under Review
Rating and Investment Information, Inc.
a-1
A
Stable
S&P Global Ratings
A-2
BBB+
Stable
MSBNA
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
Fitch Ratings, Inc.
F1
A+
Negative
Moody’s Investors Service, Inc.
P-1
A1
Ratings Under Review
S&P Global Ratings
A-1
A+
Stable
MSPBNA
Short-Term
Debt
Long-Term
Debt
Rating
Outlook
Moody’s Investors Service, Inc.
P-1
A1
Ratings Under Review
S&P Global Ratings
A-1
A+
Stable
On February 21, 2020, Moody’s Investors Service, Inc. placed the Parent Company and U.S. Bank Subsidiaries on review for
19
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
possible upgrade, changing their outlooks from Positive to Ratings Under Review.
On April 23, 2020, Fitch Ratings, Inc. placed the Parent Company and MSBNA ratings on Negative outlook, a change from Stable, related to their expectation of significant operating environment headwinds due to the disruption to economic activity and financial markets from the COVID-19 pandemic.
Incremental Collateral or Terminating Payments
In connection with certain OTC derivatives and certain other agreements where we are a liquidity provider to certain financing vehicles associated with the Institutional Securities business segment, we may be required to provide additional collateral, immediately settle any outstanding liability balances with certain counterparties or pledge additional collateral to certain clearing organizations in the event of a future credit rating downgrade irrespective of whether we are in a net asset or net liability position.
See
Note 6
to the financial statements for additional information on OTC derivatives that contain such contingent features.
While certain aspects of a credit rating downgrade are quantifiable pursuant to contractual provisions, the impact it would have on our business and results of operations in future periods is inherently uncertain and would depend on a number of interrelated factors, including, among other things, the magnitude of the downgrade, the rating relative to peers, the rating assigned by the relevant agency pre-downgrade, individual client behavior and future mitigating actions we might take. The liquidity impact of additional collateral requirements is included in our Liquidity Stress Tests.
Capital Management
We view capital as an important source of financial strength and actively manage our consolidated capital position based upon, among other things, business opportunities, risks, capital availability and rates of return together with internal capital policies, regulatory requirements and rating agency guidelines. In the future, we may expand or contract our capital base to address the changing needs of our businesses.
Common Stock Repurchases
Three Months Ended
March 31,
in millions, except for per share data
2020
2019
Number of shares
29
28
Average price per share
$
46.01
$
42.19
Total
$
1,347
$
1,180
On March 15, 2020, the Financial Services Forum announced that its eight U.S. Bank members, including us, had voluntarily suspended their share repurchase programs
. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic”
herein for information on the current and possible future effects of the COVID-19 pandemic on our results.
For further information on our common stock repurchases, see
Note 16
to the financial statements.
For a description of our capital plan, see “
Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests
.”
Common Stock Dividend Announcement
Announcement date
April 16, 2020
Amount per share
$0.35
Date to be paid
May 15, 2020
Shareholders of record as of
April 30, 2020
Preferred Stock Dividend Announcement
Announcement date
March 16, 2020
Date paid
April 15, 2020
Shareholders of record as of
March 31, 2020
For additional information on common and preferred stock, see
Note 16
to the financial statements.
Off-Balance Sheet Arrangements and Contractual Obligations
Off-Balance Sheet Arrangements
We enter into various off-balance sheet arrangements, including through unconsolidated SPEs and lending-related financial instruments (
e.g.
, guarantees and commitments), primarily in connection with the Institutional Securities and Investment Management business segments.
We utilize SPEs primarily in connection with securitization activities. For information on our securitization activities, see
Note 14
to the financial statements.
For information on our commitments, obligations under certain guarantee arrangements and indemnities, see
Note 13
to the financial statements. For a further discussion of our lending commitments, see “
Quantitative and Qualitative Disclosures about Risk—Credit Risk—Loans and Lending Commitments
.”
Contractual Obligations
For a discussion about our contractual obligations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Contractual Obligations” in the 2019 Form 10-K.
March 2020 Form 10-Q
20
Table of Contents
Management’s Discussion and Analysis
Regulatory Requirements
Regulatory Capital Framework
We are an FHC under the Bank Holding Company Act of 1956, as amended (“BHC Act”), and are subject to the regulation and oversight of the Federal Reserve. The Federal Reserve establishes capital requirements for us, including “well-capitalized” standards, and evaluates our compliance with such capital requirements. Regulatory capital requirements established by the Federal Reserve are largely based on the Basel III capital standards established by the Basel Committee and also implement certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”). The OCC establishes similar capital requirements and standards for our U.S. Bank Subsidiaries. For us to remain an FHC, we must remain well-capitalized in accordance with standards established by the Federal Reserve and our U.S. Bank Subsidiaries must remain well-capitalized in accordance with standards established by the OCC. For additional information on regulatory capital requirements for our U.S. Bank Subsidiaries,
see
Note 15
to the financial statements.
Regulatory Capital Requirements
We are required to maintain minimum risk-based and leverage-based capital, and TLAC ratios.
For more information, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Capital Requirements
” in the
2019 Form 10-K
. For additional information on TLAC, see “Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” herein.
Risk-Based Regulatory Capital.
Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios.
In addition to the minimum risk-based capital ratio requirements, we are subject to the following Common Equity Tier 1 buffers:
•
A greater than 2.5% capital conservation buffer;
•
The G-SIB capital surcharge, currently at 3%; and
•
Up to a 2.5% CCyB, currently set by U.S. banking agencies at zero.
For a further discussion of the G-SIB capital surcharge, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—G-SIB Capital Surcharge
” in the
2019 Form 10-K
.
Our risk-based capital ratios for purposes of determining regulatory compliance are the lower of the capital ratios computed under (i) the standardized approaches for calculating credit risk and market risk RWA (“Standardized Approach”) or (ii) the applicable advanced approaches for calculating credit risk, market risk and operational risk RWA (“Advanced Approach”). The credit risk RWA calculations between the two approaches differ in that the Standardized Approach requires calculation of RWA using prescribed risk weights, whereas the Advanced Approach utilizes models to calculate exposure amounts and risk weights.
At
March 31, 2020
and
December 31, 2019
, our ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.
Leverage-Based Regulatory Capital
. Minimum leverage-based capital requirements include a Tier 1 leverage ratio and an SLR. We are required to maintain an SLR of 5%, inclusive of an enhanced SLR capital buffer of at least 2%.
As of March 31, 2020, our risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein.
21
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Regulatory Capital Ratios
At March 31, 2020
$ in millions
Required
Ratio
1
Standardized
Advanced
Risk-based capital
Common Equity Tier 1 capital
$
65,195
$
65,195
Tier 1 capital
73,896
73,896
Total capital
84,121
83,847
Total RWA
415,002
427,782
Common Equity Tier 1 capital ratio
10.0
%
15.7
%
15.2
%
Tier 1 capital ratio
11.5
%
17.8
%
17.3
%
Total capital ratio
13.5
%
20.3
%
19.6
%
$ in millions
Required
Ratio
1
At
March 31,
2020
Leverage-based capital
Adjusted average assets
2
$
910,499
Tier 1 leverage ratio
4.0
%
8.1
%
Supplementary leverage exposure
3
$
1,185,734
SLR
5.0
%
6.2
%
At December 31, 2019
$ in millions
Required
Ratio
1
Standardized
Advanced
Risk-based capital
Common Equity Tier 1 capital
$
64,751
$
64,751
Tier 1 capital
73,443
73,443
Total capital
82,708
82,423
Total RWA
394,177
382,496
Common Equity Tier 1 capital ratio
10.0
%
16.4
%
16.9
%
Tier 1 capital ratio
11.5
%
18.6
%
19.2
%
Total capital ratio
13.5
%
21.0
%
21.5
%
$ in millions
Required
Ratio
1
At
December 31,
2019
Leverage-based capital
Adjusted average assets
2
$
889,195
Tier 1 leverage ratio
4.0
%
8.3
%
Supplementary leverage exposure
3
$
1,155,177
SLR
5.0
%
6.4
%
1.
Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments, certain deferred tax assets and other capital deductions.
3.
Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.
Regulatory Capital
$ in millions
At
March 31,
2020
At
December 31,
2019
Change
Common Equity Tier 1 capital
Common stock and surplus
$
3,727
$
5,228
$
(1,501
)
Retained earnings
71,718
70,589
1,129
AOCI
2,095
(2,788
)
4,883
Regulatory adjustments and deductions:
Net goodwill
(7,058
)
(7,081
)
23
Net intangible assets
(1,924
)
(2,012
)
88
Other adjustments and deductions
1
(3,363
)
815
(4,178
)
Total Common Equity Tier 1 capital
$
65,195
$
64,751
$
444
Additional Tier 1 capital
Preferred stock
$
8,520
$
8,520
$
—
Noncontrolling interests
536
607
(71
)
Additional Tier 1 capital
$
9,056
$
9,127
$
(71
)
Deduction for investments in covered funds
(355
)
(435
)
80
Total Tier 1 capital
$
73,896
$
73,443
$
453
Standardized Tier 2 capital
Subordinated debt
$
9,090
$
8,538
$
552
Noncontrolling interests
126
143
(17
)
Eligible allowance for credit losses
1,013
590
423
Other adjustments and deductions
(4
)
(6
)
2
Total Standardized Tier 2 capital
$
10,225
$
9,265
$
960
Total Standardized capital
$
84,121
$
82,708
$
1,413
Advanced Tier 2 capital
Subordinated debt
$
9,090
$
8,538
$
552
Noncontrolling interests
126
143
(17
)
Eligible credit reserves
739
305
434
Other adjustments and deductions
(4
)
(6
)
2
Total Advanced Tier 2 capital
$
9,951
$
8,980
$
971
Total Advanced capital
$
83,847
$
82,423
$
1,424
1.
Other adjustments and deductions used in the calculation of Common Equity Tier 1 capital primarily includes net after-tax DVA, the credit spread premium over risk-free rate for derivative liabilities, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments and certain deferred tax assets.
March 2020 Form 10-Q
22
Table of Contents
Management’s Discussion and Analysis
RWA Rollforward
Three Months Ended
March 31, 2020
$ in millions
Standardized
Advanced
Credit risk RWA
Balance at December 31, 2019
$
342,684
$
228,927
Change related to the following items:
Derivatives
12,902
31,104
Securities financing transactions
(13,755
)
837
Securitizations
(768
)
(600
)
Investment securities
1,626
2,559
Commitments, guarantees and loans
11,162
3,652
Cash
919
591
Equity investments
953
1,003
Other credit risk
1
4,652
4,925
Total change in credit risk RWA
$
17,691
$
44,071
Balance at March 31, 2020
$
360,375
$
272,998
Market risk RWA
Balance at December 31, 2019
$
51,493
$
51,597
Change related to the following items:
Regulatory VaR
1,971
1,971
Regulatory stressed VaR
287
287
Incremental risk charge
1,737
1,737
Comprehensive risk measure
216
112
Specific risk:
Non-securitization
2,034
2,034
Securitization
(3,111
)
(3,111
)
Total change in market risk RWA
$
3,134
$
3,030
Balance at March 31, 2020
$
54,627
$
54,627
Operational risk RWA
Balance at December 31, 2019
N/A
$
101,972
Change in operational risk RWA
N/A
(1,815
)
Balance at March 31, 2020
N/A
$
100,157
Total RWA
$
415,002
$
427,782
Regulatory VaR—VaR for regulatory capital requirements
1.
Amounts reflect assets not in a defined category, non-material portfolios of exposures and unsettled transactions, as applicable.
Credit risk RWA increased in the current quarter under both the Standardized and Advanced Approaches primarily from an increase in: i) Derivatives exposure, driven by market volatility; ii) Commitments, guarantees and loans, driven by an increase in commitments funded during the current quarter in the Institutional Securities business segment; and iii) Other credit risk, driven by an increase in unsettled transactions. Under the Advanced Approach, the increased exposure in Derivatives and widening credit spreads led to an increase in RWA related to CVA. Partially offsetting the increase in Standardized RWA was a decrease in Securities financing transactions.
Market risk RWA increased in the current quarter under the Standardized Approach and Advanced Approach primarily due to increases in Non-securitization specific risk charges and the Incremental risk charge, both driven by increased exposures in credit products, and an increase in Regulatory VaR mainly as a result of a higher market volatility, partially offset by a decrease
in Securitization specific risk charges due to reduced exposures to mortgage-backed securities.
The decrease in operational risk RWA under the Advanced Approach in the current quarter reflects a decline in the severity of execution-related losses.
Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements
The Federal Reserve has established external TLAC, long-term debt (“LTD”) and clean holding company requirements for top-tier BHCs of U.S. G-SIBs (“covered BHCs”), including the Parent Company. These requirements are designed to ensure that covered BHCs will have enough loss-absorbing resources at the point of failure to be recapitalized through the conversion of eligible LTD to equity or otherwise by imposing losses on eligible LTD or other forms of TLAC where an SPOE resolution strategy is used
. The External TLAC amount and ratios as of March 31, 2020 are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. Our External TLAC ratios that were calculated including the full effect of the adoption of CECL also exceeded each respective required ratio as of March 31, 2020.
Required and Actual TLAC and Eligible LTD Ratios
Actual
Amount/Ratio
$ in millions
Regulatory Minimum
Required
Ratio
1
At
March 31,
2020
At
December 31,
2019
External TLAC
2
$
201,486
$
196,888
External TLAC as a % of RWA
18.0
%
21.5
%
47.1
%
49.9
%
External TLAC as a % of leverage exposure
7.5
%
9.5
%
17.0
%
17.0
%
Eligible LTD
3
$
118,778
$
113,624
Eligible LTD as a % of RWA
9.0
%
9.0
%
27.8
%
28.8
%
Eligible LTD as a % of leverage exposure
4.5
%
4.5
%
10.0
%
9.8
%
1.
Required ratios are inclusive of applicable buffers.The final rule imposes TLAC buffer requirements on top of both the risk-based and leverage exposure-based external TLAC minimum requirements. The risk-based TLAC buffer is equal to the sum of 2.5%, the covered BHC's Method 1 G-SIB surcharge and the CCyB, if any, as a percentage of total RWA. The leverage exposure-based TLAC buffer is equal to 2% of the covered BHC's total leverage exposure. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
External TLAC consists of Common Equity Tier 1 capital and Additional Tier 1 capital (each excluding any noncontrolling minority interests), as well as eligible LTD.
3.
Consists of TLAC-eligible LTD reduced by 50% for amounts of unpaid principal due to be paid in more than one year but less than two years from each respective balance sheet date.
We are in compliance with all relevant TLAC requirements as of
March 31, 2020
and
December 31, 2019
. For a further discussion of TLAC and related requirements, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Regulatory Capital Requirements
23
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
—Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” in the
2019 Form 10-K
.
Capital Plans and Stress Tests
Pursuant to the Dodd-Frank Act, the Federal Reserve has adopted capital planning and stress test requirements for large BHCs, including us, which form part of the Federal Reserve’s annual CCAR framework.
We submitted our
2020
Capital Plan (“Capital Plan”) and company-run stress test results to the Federal Reserve on April 6,
2020
.
We expect that the Federal Reserve will provide its response to our 2020 Capital Plan and publish summary results of the CCAR and Dodd-Frank Act supervisory stress tests of each large BHC, including us, no later than June 30, 2020. We are required to disclose a summary of the results of our company-run stress tests within 15 days of the date that the Federal Reserve discloses the results of the supervisory stress tests. We may be required to resubmit our Capital Plan under certain circumstances, including in the event of a material change in our risk profile, financial condition or corporate structure.
See “Risk Factors” in the 2019 Form 10-K.
For a further discussion of our capital plans and stress tests, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests
” in the
2019 Form 10-K
.
Attribution of Average Common Equity According to the Required Capital Framework
Our required capital (“Required Capital”) estimation is based on the Required Capital framework, an internal capital adequacy measure. Common equity attribution to the business segments is based on capital usage calculated under the Required Capital framework, as well as each business segment’s relative contribution to our total Required Capital.
The Required Capital framework is a risk-based and leverage use-of-capital measure, which is compared with our regulatory capital to ensure that we maintain an amount of going concern capital after absorbing potential losses from stress events, where applicable, at a point in time. The amount of capital allocated to the business segments is generally set at the beginning of each year and remains fixed throughout the year until the next annual reset unless a significant business change occurs (
e.g.
, acquisition or disposition). We define the difference between our total average common equity and the sum of the average common equity amounts allocated to our business segments as Parent common equity. We generally hold Parent common equity for prospective regulatory requirements, organic growth, acquisitions and other capital needs.
The Required Capital framework is expected to evolve over time in response to changes in the business and regulatory
environment, for example, to incorporate changes in stress testing or enhancements to modeling techniques. We will continue to evaluate the framework with respect to the impact of future regulatory requirements, as appropriate.
Average Common Equity Attribution
1
Three Months Ended
March 31,
$ in billions
2020
2019
Institutional Securities
$
42.8
$
40.4
Wealth Management
18.2
18.2
Investment Management
2.6
2.5
Parent
11.1
10.5
Total
$
74.7
$
71.6
1.
The attribution of average common equity to the business segments is a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein.
Resolution and Recovery Planning
Pursuant to the Dodd-Frank Act, we are required to periodically submit to the Federal Reserve and the FDIC a resolution plan that describes our strategy for a rapid and orderly resolution under the U.S. Bankruptcy Code in the event of our material financial distress or failure. Our next resolution plan submission is expected to be a targeted resolution plan in July 2021.
As described in our 2019 resolution plan, which was submitted on June 28, 2019, our preferred resolution strategy is an SPOE strategy. In line with our SPOE strategy, the Parent Company has transferred, and has agreed to transfer on an ongoing basis, certain assets to its wholly owned, direct subsidiary Morgan Stanley Holdings LLC (the “Funding IHC”). In addition, the Parent Company has entered into an amended and restated support agreement with its material entities (including the Funding IHC) and certain other subsidiaries. In the event of a resolution scenario, the Parent Company would be obligated to contribute all of its Contributable Assets to our material entities and/or the Funding IHC. The Funding IHC would be obligated to provide capital and liquidity, as applicable, to our material entities.
The combined implication of the SPOE resolution strategy and the requirement to maintain certain levels of TLAC is that losses in resolution would be imposed on the holders of eligible long-term debt and other forms of eligible TLAC issued by the Parent Company before any losses are imposed on the holders of the debt securities of our operating subsidiaries or before putting U.S. taxpayers at risk.
For more information about resolution and recovery planning requirements and our activities in these areas, including the implications of such activities in a resolution scenario,
see “
Business—Supervision and Regulation—Financial Holding Company—Resolution and Recovery Planning
,” “
Risk Factors—Legal, Regulatory and Compliance Risk
” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Resolution and Recovery Planning” in the
2019 Form 10-K
.
March 2020 Form 10-Q
24
Table of Contents
Management’s Discussion and Analysis
Regulatory Developments
Stress Capital Buffer Final Rule
The Federal Reserve has adopted a final rule to integrate its annual capital planning and stress testing requirements with existing applicable regulatory capital requirements. The final rule, which applies to certain BHCs, including us, introduces a stress capital buffer (“SCB”) and related changes to the capital planning and stress testing processes.
The SCB applies only with respect to Standardized Approach risk-based capital requirements and replaces the existing Common Equity Tier 1 capital conservation buffer, which is 2.5%. The SCB is the greater of (i) the maximum decline in our Common Equity Tier 1 capital ratio under the severely adverse scenario over the supervisory stress test measurement period plus the sum of the four quarters of planned common stock dividends divided by the projected RWAs from the quarter in which the Firm’s projected Common Equity Tier 1 capital ratio reaches its minimum in the supervisory stress test and (ii) 2.5%. Risk-based regulatory capital requirements under the Standardized Approach will include the SCB, as summarized above, as well as our Common Equity Tier 1 GSIB capital surcharge and any applicable Common Equity Tier 1 CCyB.
The final rule makes related changes to capital planning and stress testing processes for BHCs subject to the SCB. In particular, the supervisory stress test will assume that BHCs generally maintain a constant level of assets and RWAs throughout the projection period. In addition, the supervisory stress test will no longer assume that BHCs make all planned capital distributions, although the SCB will incorporate the dollar amount of four quarters of planned common stock dividends, as summarized above.
The final rule does not change regulatory capital requirements under the Advanced Approach, the Tier 1 leverage ratio or the SLR.
The Firm’s initial SCB will be based on the results of the 2020 CCAR supervisory stress test which the Federal Reserve is expected to publish by June 30, 2020. The SCB will take effect on October 1, 2020 and will remain in effect until September 30, 2021, and will be updated annually thereafter based on the results of the annual CCAR supervisory stress test, with a revised SCB taking effect on October 1 each year.
Upon receipt of the SCB, we will evaluate whether to update our Required Capital framework to take into account any changes in our risk-based capital requirements that result from the SCB.
The SCB final rule also includes a transitional arrangement for the third quarter of 2020. Between July 1, 2020 and September 30, 2020, the Firm will be authorized to make capital distributions that do not exceed the four-quarter average of
capital distributions for which the Federal Reserve indicated its non-objection in the 2019 capital plan cycle, unless otherwise determined by the Federal Reserve.
Revisions to Definition of Eligible Retained Income
The U.S. banking agencies have adopted an interim final rule amending the definition of eligible retained income in their respective capital rules. As amended, eligible retained income is defined by the Federal Reserve as the greater of (i) net income for the four preceding calendar quarters, net of any distributions and associated tax effects not already reflected in net income, and (ii) the average of net income over the preceding four quarters. This definition applies with respect to any payout restrictions applicable in the event of a breach of any regulatory capital buffers, including any applicable CCyB, G-SIB capital surcharge, capital conservation buffer, the enhanced SLR and, once effective, SCB, which replaces the capital conservation buffer under the Standardized Approach. The interim final rule became effective March 20, 2020.
Separately, the Federal Reserve has adopted an interim final rule amending the definition of eligible retained income under its TLAC rule to be consistent with the revised definition of eligible retained income in the regulatory capital framework, as summarized above. The interim final rule became effective March 26, 2020.
Regulatory Capital and Stress Testing Developments Related to Implementation of CECL
The U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital and TLAC requirements, the required adoption time period for CECL. Under the interim final rule, banking organizations that implement the new accounting standard before the end of 2020 may elect to follow the three-year transition available under a prior rule or a new five-year transition. This five-year transition involves a two-year delay in recognizing the effects on regulatory capital of the new accounting standard, followed by a three-year transition period during which the electing organization phases out the aggregate capital effects of the two-year delay. The interim final rule became effective March 27, 2020. We have elected to implement the five-year transition for recognizing the potentially adverse effects of the adoption of CECL.
In addition, pursuant to the The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), banking organizations are not required to comply with CECL, for purposes of U.S. GAAP accounting, until the earlier of the end of the COVID-19 national emergency declared by the President of the United States on March 15, 2020 under the National Emergencies Act or December 31, 2020. We have not elected to delay our compliance with CECL for purposes of U.S. GAAP accounting.
25
March 2020 Form 10-Q
Table of Contents
Management’s Discussion and Analysis
Regulatory Developments in Response to COVID-19
In the United States, the Federal Reserve, the other U.S. state and federal financial regulatory agencies and Congress have taken actions to mitigate disruptions to economic activity and financial stability resulting from COVID-19.
Federal Reserve Actions
The Federal Reserve has established, or has taken steps to establish, a range of facilities and programs to support the U.S. economy and U.S. marketplace participants in response to economic disruptions associated with COVID-19. Through these facilities and programs, the Federal Reserve has taken steps to directly or indirectly purchase assets or debt instruments from, or make loans to, U.S. companies, financial institutions, municipalities and other market participants.
In addition, the Federal Reserve has taken a range of other actions to support the flow of credit to households and businesses. For example, on March 15, 2020, the Federal Reserve reduced the target range for the federal funds rate to 0 to 0.25% and announced that it would increase its holdings of U.S. Treasury securities and agency mortgage-backed securities and begin purchasing agency commercial mortgage-backed securities. The Federal Reserve has also encouraged depository institutions to borrow from the discount window and has lowered the primary credit rate for such borrowings by 150 basis points to 0.25% while extending the term of such loans up to 90 days. In addition, effective March 26, 2020, reserve requirements have been reduced to zero.
Acting in concert with the other U.S. banking agencies, the Federal Reserve has also issued statements encouraging banking organizations to use their capital and liquidity buffers as they lend to households and businesses affected by COVID-19. To facilitate banking organizations' use of their capital buffers, the Federal Reserve has revised the definition of eligible retained income applicable in the capital and TLAC frameworks. Additionally, the Federal Reserve has adopted an interim final rule that temporarily excludes U.S. Treasury securities and deposits at Federal Reserve Banks from the calculation of our supplementary leverage exposure used in the SLR. For a further discussion about the revised definition of eligible retained income and changes to the SLR calculation, see “Revisions to Definition of Eligible Retained Income” and “Supplementary Leverage Ratio Interim Final Rule,” respectively, herein.
Further, the Federal Reserve along with the other U.S. banking agencies, issued guidance stating that granting certain concessions to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the coronavirus pandemic, generally would not be considered TDRs under applicable U.S. GAAP. This guidance also clarifies that efforts to work with borrowers of one-to-four family residential mortgages impacted
by the COVID-19 pandemic and meeting certain criteria will not result in such loans being deemed restructured or modified for purposes of U.S. Basel III, and will therefore not be subject to higher regulatory capital requirements.
As of March 31, 2020, we have participated in the PDCF, which provides liquidity to primary dealers through a secured lending facility, and, following the Federal Reserve's statement encouraging banks to use its discount window, we have accessed the discount window. While we continue to assess, we may participate in other of these facilities and programs, including on behalf of clients.
Non-U.S. Central Bank Actions
In addition to actions taken by the Federal Reserve, many non-U.S. central banks have announced similar facilities and programs in response to the economic and market disruptions associated with COVID-19. Firm subsidiaries operating in non-U.S. markets may participate, or perform customer facilitation roles, in such non-U.S. facilities or programs.
The CARES Act
The CARES Act was signed into law on March 27, 2020. Pursuant to the CARES Act, the U.S. Treasury has the authority to provide loans, guarantees and other investments in support of eligible businesses, states and municipalities affected by the economic effects of COVID-19. Some of these funds may also be used to support the several Federal Reserve programs and facilities described in “Federal Reserve Actions” previously or additional programs or facilities that are established by the Federal Reserve under its Section 13(3) authority and meet certain criteria. Among other provisions, the CARES Act also includes funding for the Small Business Administration to expand lending, relief from certain U.S. GAAP requirements to allow COVID-19-related loan modifications to not be categorized as TDRs and a range of incentives to encourage deferment, forbearance or modification of consumer credit and mortgage contracts.
The CARES Act also includes several measures that will temporarily adjust existing laws or regulations. These include providing the FDIC with additional authority to guarantee the deposits of solvent insured depository institutions held in non-interest-bearing business transaction accounts to a maximum amount specified by the FDIC, reinstating the FDIC’s Temporary Liquidity Guarantee Authority to guarantee debt obligations of solvent insured depository institutions or depository institution holding companies, temporarily allowing the U.S. Treasury to fully guarantee money market mutual funds and granting additional authority to the OCC to provide certain exemptions to the lending limits imposed on national banks.
March 2020 Form 10-Q
26
Table of Contents
Management’s Discussion and Analysis
Supplementary Leverage Ratio Interim Final Rule
In response to the COVID-19 pandemic, the Federal Reserve has adopted an interim final rule that excludes, on a temporary basis, U.S. Treasury securities and deposits at Federal Reserve Banks from our SLR exposure measure from April 1, 2020 to March 31, 2021. This interim final rule does not amend our U.S. Bank Subsidiaries’ SLR requirements.
Other Matters
U.K. Withdrawal from the E.U.
On January 31, 2020, the U.K. withdrew from the E.U. under the terms of a withdrawal agreement between the U.K. and the E.U. The withdrawal agreement provides for a transition period to the end of December 2020, during which time the U.K. will continue to apply E.U. law as if it were a member state, and U.K. firms’ rights to provide financial services in E.U. member states will continue. Access to the E.U. market after the transition period remains subject to negotiation.
We have prepared the structure of our European operations for a range of potential outcomes, including for the possibility that U.K. financial firms’ access to E.U. markets after the transition period is limited, and we expect to be able to continue to serve our clients and customers under each of these potential outcomes.
For more information on the U.K.’s withdrawal from the E.U., our related preparations and the potential impact on our operations, see “
Risk Factors— International Risk
” in the
2019 Form 10-K
. For further information regarding our exposure to the U.K., see also “
Quantitative and Qualitative Disclosures about Risk—Country and Other Risks
."
Planned Replacement of London Interbank Offered Rate and Replacement or Reform of Other Interest Rates
Central banks around the world, including the Federal Reserve, have commissioned committees and working groups of market participants and official sector representatives to replace LIBOR and replace or reform other interest rate benchmarks (collectively, the “IBORs”). Accordingly, we have established and are undertaking a Firmwide IBOR transition plan to promote the transition to alternative reference rates, which takes into account the considerable uncertainty regarding the availability of LIBOR beyond 2021.
For a further discussion of the expected replacement of the IBORs and/or reform of interest rate benchmarks, and the related risks and our transition plan, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Regulatory Requirements—Other Matters” and “
Risk Factors—Risk Management
,” respectively, in the
2019 Form 10-K
.
27
March 2020 Form 10-Q
Table of Contents
Quantitative and Qualitative Disclosures about Risk
Management believes effective risk management is vital to the success of our business activities. For a discussion of our Enterprise Risk Management framework and risk management functions, see “
Quantitative and Qualitative Disclosures about Risk—Risk Management
” in the
2019 Form 10-K
.
Market Risk
Market risk refers to the risk that a change in the level of one or more market prices, rates, indices, volatilities, correlations or other market factors, such as market liquidity, will result in losses for a position or portfolio. Generally, we incur market risk as a result of trading, investing and client facilitation activities, principally within the Institutional Securities business segment where the substantial majority of our VaR for market risk exposures is generated. In addition, we incur non-trading market risk, principally within the Wealth Management and Investment Management business segments. The Wealth Management business segment primarily incurs non-trading market risk from lending and deposit-taking activities. The Investment Management business segment primarily incurs non-trading market risk from capital investments in alternative and other funds.
For a further discussion of market risk, see “
Quantitative and Qualitative Disclosures about Risk—Market Risk
” in the
2019 Form 10-K
.
Trading Risks
We are exposed to a wide range of risks related to interest rates, equity prices, foreign exchange rates and commodity prices, and the associated implied volatilities and spreads, related to the global markets in which we conduct our trading activities.
The statistical technique known as VaR is one of the tools we use to measure, monitor and review the market risk exposures of our trading portfolios.
For information regarding our primary risk exposures and market risk management, VaR methodology, assumptions and limitations, see “
Quantitative and Qualitative Disclosures about Risk—Market Risk—Trading Risks
” in the
2019 Form 10-K
.
95%/One-Day Management VaR for the Trading Portfolio
Three Months Ended
March 31, 2020
$ in millions
Period
End
Average
High
2
Low
2
Interest rate and credit spread
$
62
$
32
$
62
$
24
Equity price
22
15
23
12
Foreign exchange rate
11
8
14
5
Commodity price
12
13
19
10
Less: Diversification benefit
1
(65
)
(33
)
N/A
N/A
Primary Risk Categories
$
42
$
35
$
52
$
28
Credit Portfolio
25
15
25
12
Less: Diversification benefit
1
(12
)
(10
)
N/A
N/A
Total Management VaR
$
55
$
40
$
58
$
32
Three Months Ended
December 31, 2019
$ in millions
Period
End
Average
High
2
Low
2
Interest rate and credit spread
$
26
$
28
$
31
$
24
Equity price
11
14
18
11
Foreign exchange rate
10
9
13
6
Commodity price
10
17
22
10
Less: Diversification benefit
1
(27
)
(33
)
N/A
N/A
Primary Risk Categories
$
30
$
35
$
40
$
30
Credit Portfolio
15
15
17
13
Less: Diversification benefit
1
(10
)
(11
)
N/A
N/A
Total Management VaR
$
35
$
39
$
43
$
33
1.
Diversification benefit equals the difference between the total Management VaR and the sum of the component VaRs. This benefit arises because the simulated one-day losses for each of the components occur on different days; similar diversification benefits also are taken into account within each component.
2.
The high and low VaR values for the total Management VaR and each of the component VaRs might have occurred on different days during the quarter, and therefore, the diversification benefit is not an applicable measure.
While Average total Management VaR and average Management VaR for the Primary Risk Categories were relatively unchanged from the three months ended
December 31, 2019
, the period-end balance increased.
The increase in period-end VaR resulted primarily from the interest rate and credit spread and equity price risk categories, which were predominantly driven by increased market volatility related to COVID-19, and reflected increased exposures in the Fixed Income and Equity businesses related to client facilitation activity and market movements in March 2020. These increases were partially offset by an increased diversification benefit.
For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
” herein.
March 2020 Form 10-Q
28
Table of Contents
Risk Disclosures
Distribution of VaR Statistics and Net Revenues
We evaluate the reasonableness of our VaR model by comparing the potential declines in portfolio values generated by the model with corresponding actual trading results for the Firm, as well as individual business units. For days where losses exceed the VaR statistic, we examine the drivers of trading losses to evaluate the VaR model’s accuracy relative to realized trading results.
There were two days with trading losses in the current quarter, one of which exceeded the 95%/one-day Total Management VaR.
Daily 95%/One-Day Total Management VaR for the Current Quarter
($ in millions)
Daily Net Trading Revenues for the Current Quarter
($ in millions)
The previous histogram shows the distribution of daily net trading revenues for the current quarter. Daily net trading revenues include profits and losses from Interest rate and credit spread, Equity price, Foreign exchange rate, Commodity price, and Credit Portfolio positions and intraday trading activities for our trading businesses. Certain items such as fees, commissions
and net interest income are excluded from daily net trading revenues and the VaR model. Revenues required for Regulatory VaR backtesting further exclude intraday trading.
Non-Trading Risks
We believe that sensitivity analysis is an appropriate representation of our non-trading risks. The following sensitivity analyses cover substantially all of the non-trading risk in our portfolio.
Credit Spread Risk Sensitivity
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Derivatives
$
6
$
6
Funding liabilities
2
39
42
1.
Amounts represent the potential gain for each 1 bps widening of our credit spread.
2.
Relates to Borrowings carried at fair value.
U.S. Bank Subsidiaries’ Net Interest Income Sensitivity Analysis
$ in millions
At
March 31,
2020
At
December 31,
2019
Basis point change
+100
$
850
$
151
-100
(495
)
(642
)
The previous table presents an analysis of selected instantaneous upward and downward parallel interest rate shocks (subject to a floor of zero percent in the downward scenario) on net interest income over the next 12 months for our U.S. Bank Subsidiaries. These shocks are applied to our 12-month forecast for our U.S. Bank Subsidiaries, which incorporates market expectations of interest rates and our forecasted business activity.
We do not manage to any single rate scenario but rather manage net interest income in our U.S. Bank Subsidiaries to optimize across a range of possible outcomes, including non-parallel rate change scenarios. The sensitivity analysis assumes that we take no action in response to these scenarios, assumes there are no changes in other macroeconomic variables normally correlated with changes in interest rates, and includes subjective assumptions regarding customer and market re-pricing behavior and other factors.
The change in sensitivity to interest rates between
March 31, 2020
and
December 31, 2019
is primarily driven by lower market rates. Given the current rate environment, the correlation between market rate increases and deposit cost increases is low, and therefore provides an incremental benefit in the +100bps scenario.
29
March 2020 Form 10-Q
Table of Contents
Risk Disclosures
Investments Sensitivity, Including Related Carried Interest
Loss from 10% Decline
$ in millions
At
March 31,
2020
At
December 31,
2019
Investments related to Investment Management activities
$
327
$
367
Other investments:
MUMSS
173
169
Other Firm investments
197
195
MUMSS—Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
We have exposure to public and private companies through direct investments, as well as through funds that invest in these assets. These investments are predominantly equity positions with long investment horizons, a portion of which is for business facilitation purposes. The market risk related to these investments is measured by estimating the potential reduction in net income associated with a 10% decline in investment values and related impact on performance-based fees, as applicable.
The change in investments sensitivity related to Investment Management activities between
March 31, 2020
and
December 31, 2019
is primarily driven by lower valuations in private equity funds, related to the decline of global asset prices due to the effect of COVID-19 on economies and markets around the world. For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
” herein.
Equity Market Sensitivity
In the Wealth Management and Investment Management business segments, certain fee-based revenue streams are driven by the value of clients’ equity holdings. The overall level of revenues for these streams also depends on multiple additional factors that include, but are not limited to, the level and duration of the equity market increase or decline, price volatility, the geographic and industry mix of client assets, the rate and magnitude of client investments and redemptions, and the impact of such market increase or decline and price volatility on client behavior. Therefore, overall revenues do not correlate completely with changes in the equity markets.
For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
” herein.
Credit Risk
Credit risk refers to the risk of loss arising when a borrower, counterparty or issuer does not meet its financial obligations to us. We are primarily exposed to credit risk from institutions and
individuals through our Institutional Securities and Wealth Management business segments.
For a further discussion of our credit risks, see “
Quantitative and Qualitative Disclosures about Risk—Credit Risk
” in the
2019 Form 10-K
.
The credit environment deteriorated rapidly towards the end of the current quarter, driven by the effect of COVID-19 on economic and market conditions. Within Institutional Securities the effects were notable, with mark-to-market losses on held-for-sale loans and lending commitments and increased allowances for credit losses related to held-for-investment loans and lending commitments, as discussed in Management’s Discussion and Analysis. The uncertain environment also caused an increase in client requests to draw down on lending commitments and market volatility led to increased counterparty credit exposures, both of which are further discussed herein.
In addition, we have begun to have discussions with and receive requests from certain clients for forbearance, or deferral of their loan payments to us, driven or exacerbated by the economic environment and following in part from the U.S. government’s enactment of the CARES Act. These requests and discussions primarily relate to commercial and residential real estate loans. Certain clients have also requested modifications of covenant terms.
The forbearance process is different based on loan and borrower type, among other factors. In general, qualifying requests for forbearance related to single family residential real estate loans are immediately granted, whereas commercial real estate loan forbearance requires negotiation and approval. Receiving or granting forbearance or modification requests does not necessarily mean that we will incur credit losses. As of April 30, 2020, the principal amount of loans for which forbearance requests are currently active related to near-term payments on commercial real estate loans and residential real estate loans approximated $2 billion and $800 million, respectively.
These trends could continue in future periods given the present uncertain global economic and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic,” and “Risk Factors” herein for further information. See also "Forward Looking Statements" in the 2019 10-K.
March 2020 Form 10-Q
30
Table of Contents
Risk Disclosures
Loans and Lending Commitments
At March 31, 2020
$ in millions
IS
WM
IM
1
Total
Loans held for investment, before allowance
$
49,358
$
82,589
$
5
$
131,952
Allowance for credit losses
(530
)
(87
)
—
(617
)
Loans held for investment, net of allowance
$
48,828
$
82,502
$
5
$
131,335
Loans held for sale
17,343
14
5
17,362
Loans held at fair value
9,573
—
489
10,062
Total loans
$
75,744
$
82,516
$
499
$
158,759
Lending commitments
2
92,911
13,366
—
106,277
Total loans and lending commitments
2
$
168,655
$
95,882
$
499
$
265,036
Total loans, before allowance
$
76,274
$
82,603
$
499
$
159,376
At December 31, 2019
$ in millions
IS
WM
IM
1
Total
Loans held for investment, before allowance
$
38,290
$
80,114
$
5
$
118,409
Allowance for credit losses
(297
)
(52
)
—
(349
)
Loans held for investment, net of allowance
$
37,993
$
80,062
$
5
$
118,060
Loans held for sale
12,564
13
—
12,577
Loans held at fair value
11,075
—
251
11,326
Total loans
$
61,632
$
80,075
$
256
$
141,963
Lending commitments
2
106,886
13,161
21
120,068
Total loans and lending commitments
2
$
168,518
$
93,236
$
277
$
262,031
Total loans, before allowance
$
61,929
$
80,127
$
256
$
142,312
1.
Investment Management business segment loans are related to certain of our activities as an investment advisor and manager. At
March 31, 2020
and
December 31, 2019
, loans held at fair value are predominantly the result of the consolidation of CLO vehicles, managed by Investment Management, composed primarily of senior secured corporate loans.
2.
Lending commitments represent the notional amount of legally binding obligations to provide funding to clients for lending transactions. Since commitments associated with these business activities may expire unused or may not be utilized to full capacity, they do not necessarily reflect the actual future cash funding requirements.
We provide loans and lending commitments to a variety of customers, from large corporate and institutional clients to high net worth individuals. In addition, we purchase loans in the secondary market. Loans and lending commitments are either held for investment, held for sale or carried at fair value.
For more information on these loan classifications, see
Note 2
to the financial statements in the 2019 Form 10-K.
Total loans and lending commitments
increased
by approximately
$3 billion
since
December 31, 2019
,
primarily due to growth in tailored lending and Residential real estate loans within the Wealth Management business segment. In addition, within the Institutional Securities business segment, there was an increase in Corporate relationship and event-driven lending commitments funded during the current quarter.
See
Notes 4
,
9
and
13
to the financial statements for further information.
Allowance for Credit Losses Rollforward—Loans and Lending Commitments
$ in millions
December 31, 2019
1
$
590
Effect of CECL adoption
(41
)
Gross charge-offs
(32
)
Provision
407
Other
(3
)
March 31, 2020
$
921
Allowance for credit losses—Loans
$
617
Allowance for credit losses—Lending commitments
304
1.
At December 31, 2019, the total allowance for credit losses for Loans and Lending commitments was $349 million and $241 million, respectively.
Credit exposure arising from our loans and lending commitments is measured in accordance with our internal risk management standards. Risk factors considered in determining the aggregate allowance for loan and commitment losses include the borrower’s financial strength, industry, facility structure, loan-to-value ratio, debt service ratio, collateral and covenants. Qualitative and environmental factors such as economic and business conditions, nature and volume of the portfolio and lending terms, and volume and severity of past due loans may also be considered.
The aggregate allowance for loans and lending commitments
increased
in the current quarter
, principally reflecting a provision for credit losses within the Institutional Securities business segment resulting from the economic impact of COVID-19. This provision was primarily the result of higher actual and expected future downgrades, an increase in funded balances, principally in Corporate relationship and event-driven loans, as well as revisions to our forecasts in light of current and expected future market and macroeconomic conditions
. See Note 2 to the financial statements for a discussion of the Firm’s allowance for credit loss methodology under CECL.
Status of Loans Held for Investment
At March 31, 2020
At December 31, 2019
IS
WM
IS
WM
Current
99.5
%
99.9
%
99.0
%
99.9
%
Nonaccrual
1
0.5
%
0.1
%
1.0
%
0.1
%
1.
These loans are on nonaccrual status because the loans were past due for a period of 90 days or more or payment of principal or interest was in doubt.
31
March 2020 Form 10-Q
Table of Contents
Risk Disclosures
Institutional Securities Loans and Lending Commitments
1
At March 31, 2020
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
AA
$
59
$
47
$
14
$
5
$
125
A
931
1,456
554
589
3,530
BBB
3,619
5,872
6,867
574
16,932
BB
12,401
11,430
10,186
1,251
35,268
Other NIG
5,865
5,503
4,313
2,242
17,923
Unrated
2
101
92
286
1,487
1,966
Total loans
22,976
24,400
22,220
6,148
75,744
Lending commitments
AAA
—
50
—
—
50
AA
2,831
818
2,562
30
6,241
A
3,994
7,477
9,150
279
20,900
BBB
8,407
12,732
15,460
731
37,330
BB
3,635
3,986
7,219
1,067
15,907
Other NIG
2,064
2,754
6,604
1,056
12,478
Unrated
2
3
—
—
2
5
Total lending commitments
20,934
27,817
40,995
3,165
92,911
Total exposure
$
43,910
$
52,217
$
63,215
$
9,313
$
168,655
At December 31, 2019
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
AA
$
7
$
50
$
—
$
5
$
62
A
955
923
516
277
2,671
BBB
2,297
5,589
3,592
949
12,427
BB
9,031
11,189
9,452
1,449
31,121
Other NIG
4,020
5,635
2,595
1,143
13,393
Unrated
2
117
82
131
1,628
1,958
Total loans
16,427
23,468
16,286
5,451
61,632
Lending commitments
AAA
—
50
—
—
50
AA
2,838
908
2,509
—
6,255
A
6,461
7,287
9,371
298
23,417
BBB
7,548
13,780
20,560
753
42,641
BB
2,464
5,610
8,333
1,526
17,933
Other NIG
2,193
4,741
7,062
2,471
16,467
Unrated
2
—
9
107
7
123
Total lending commitments
21,504
32,385
47,942
5,055
106,886
Total exposure
$
37,931
$
55,853
$
64,228
$
10,506
$
168,518
NIG–Non-investment grade
1.
Counterparty credit ratings are internally determined by CRM.
2.
Unrated loans and lending commitments are primarily trading positions that are measured at fair value and risk-managed as a component of market risk.
For a further discussion of our market risk, see “
Market Risk
” herein.
As a result of the economic impacts of COVID-19, there was an increase in lending commitments funded during the current quarter in the Institutional Securities business segment. The increase was primarily driven by clients with non-investment grade and BBB internal credit ratings, who sought liquidity in
a period where, given the economic backdrop, capital markets alternatives to drawing on lines of credit were less available.
Institutional Securities Loans and Lending Commitments by Industry
$ in millions
At
March 31,
2020
At
December 31,
2019
Industry
Financials
$
40,142
$
40,992
Real estate
27,190
28,348
Industrials
16,100
13,136
Healthcare
13,582
14,113
Communications services
10,839
12,165
Utilities
10,231
9,905
Information technology
10,019
9,201
Consumer discretionary
9,993
9,589
Energy
9,856
9,461
Consumer staples
9,415
9,724
Materials
5,469
5,577
Insurance
3,961
3,755
Other
1,858
2,552
Total
$
168,655
$
168,518
The decline in economic activity, driven by the effects of COVID-19, and recent decline in oil prices, have currently impacted borrowers in many industries. The future developments of COVID-19 and its related effect on the economic environment are uncertain and may continue to impact certain sectors and industries, in which we have, or may in the future have, exposure in the form of loans or lending commitments. In addition, refer to “Risk Factors” herein.
The Institutional Securities business segment lending activities include Corporate relationship and event-driven lending, Secured lending facilities, Commercial real estate lending and Securities-based lending and other.
Corporate relationship and event-driven loans and lending commitments typically consist of revolving lines of credit, term loans and bridge loans; may have varying terms; may be senior or subordinated; may be secured or unsecured; are generally contingent upon representations, warranties and contractual conditions applicable to the borrower; and may be syndicated, traded or hedged. For additional information on event-driven loans, see “Institutional Securities Event-Driven Loans and Lending Commitments” herein.
Secured lending facilities include loans provided to clients, which are primarily secured by loans on underlying real estate or other assets. The underlying loans are associated with various types of collateral, including residential real estate, commercial real estate, corporate and financial assets. These facilities generally provide for overcollateralization. Credit risk with respect to these loans and lending commitments arises from the failure of a borrower to perform according to the terms of the loan agreement and/or a decline in the underlying collateral
March 2020 Form 10-Q
32
Table of Contents
Risk Disclosures
value. The Firm monitors collateral levels against the requirements of lending agreements.
Commercial real estate loans are primarily senior, secured by underlying real estate and typically in term loan form.
Securities-based lending and other includes financing extended to sales and trading customers and corporate loans purchased in the secondary market.
Institutional Securities Loans
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Corporate relationship and
event-driven lending
$
27,058
$
11,638
Secured lending facilities
30,493
29,654
Commercial & residential real estate
11,604
13,198
Securities-based lending and other
7,119
7,439
Total Institutional Securities loans
$
76,274
$
61,929
1.
Amounts include loans held for investment, before the allowance for credit losses, loans held for sale and loans at fair value.
Institutional Securities Event-Driven Loans and Lending Commitments
1
At March 31, 2020
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
$
3,284
$
1,205
$
1,527
$
1,132
$
7,148
Lending commitments
7,312
2,317
1,921
1,507
13,057
Total loans and lending commitments
$
10,596
$
3,522
$
3,448
$
2,639
$
20,205
At December 31, 2019
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Loans
$
1,194
$
1,024
$
839
$
390
$
3,447
Lending commitments
7,921
5,012
2,285
3,090
18,308
Total loans and lending commitments
$
9,115
$
6,036
$
3,124
$
3,480
$
21,755
1.
Amounts include loans and lending commitments held for investment, before the allowance for credit losses, and held for sale.
Event-driven loans and lending commitments are associated with a particular event or transaction, such as to support client merger, acquisition, recapitalization or project finance activities. Balances may fluctuate as such lending is related to transactions that vary in timing and size from period to period. In the current quarter, credit spreads in the market for these loans and commitments widened significantly, resulting in a substantial slowdown in the volume of sales and syndications, which is a trend that could continue in the future given the current uncertain economic and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic” and “Risk Factors” herein, and Forward Looking Statements in the 2019 Form 10-K.
Institutional Securities Loans and Lending Commitments Held for Investment
At March 31, 2020
At December 31, 2019
$ in millions
Loans
Lending Commitments
Loans
Lending Commitments
Corporate relationship and event-driven lending
$
15,457
$
55,365
$
5,426
$
61,716
Secured lending facilities
25,805
5,987
24,502
6,105
Commercial & residential real estate
1
7,430
730
7,859
425
Securities-based lending and other
2
666
461
503
832
Total, before allowance for credit losses
$
49,358
$
62,543
$
38,290
$
69,078
Allowance for credit losses
(530
)
(298
)
(297
)
(236
)
1.
Amounts principally comprise Commercial real estate loans and lending commitments.
2.
Amounts principally comprise Other loans and lending commitments.
Institutional Securities Allowance for Credit Losses Rollforward—Loans
$ in millions
Corporate relationship and event-driven lending
Secured lending facilities
Commercial & residential real estate
Securities-based lending and other
Total
December 31, 2019
$
115
$
101
$
75
$
6
$
297
Effect of CECL adoption
(2
)
(42
)
34
3
(7
)
Gross charge-offs
(32
)
—
—
—
(32
)
Provision
177
29
66
1
273
Other
—
—
(1
)
—
(1
)
March 31, 2020
$
258
$
88
$
174
$
10
$
530
Institutional Securities Allowance for Credit Losses Rollforward—Lending Commitments
$ in millions
Corporate relationship and event-driven lending
Secured lending facilities
Commercial & residential real estate
Securities-based lending and other
Total
December 31, 2019
$
201
$
27
$
7
$
1
$
236
Effect of CECL adoption
(41
)
(11
)
1
—
(51
)
Provision
91
16
5
3
115
Other
(2
)
—
—
—
(2
)
March 31, 2020
$
249
$
32
$
13
$
4
$
298
33
March 2020 Form 10-Q
Table of Contents
Risk Disclosures
Institutional Securities HFI Loans—Ratios of Allowance for Credit Losses to Balance Before Allowance
At
March 31,
2020
At
December 31,
2019
Corporate relationship and event-driven lending
1.7
%
2.1
%
Secured lending facilities
0.3
%
0.4
%
Commercial & residential real estate
2.3
%
1.0
%
Securities-based lending and other
1.5
%
1.2
%
Total Institutional Securities loans
1.1
%
0.8
%
Wealth Management Loans and Lending Commitments
At March 31, 2020
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Securities-based lending and other loans
$
43,158
$
4,709
$
2,141
$
1,441
$
51,449
Residential real estate loans
14
7
—
31,046
31,067
Total loans
$
43,172
$
4,716
$
2,141
$
32,487
$
82,516
Lending commitments
10,397
2,382
326
261
13,366
Total loans and lending commitments
$
53,569
$
7,098
$
2,467
$
32,748
$
95,882
At December 31, 2019
Contractual Years to Maturity
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Securities-based lending and other loans
$
41,863
$
3,972
$
2,783
$
1,284
$
49,902
Residential real estate loans
13
11
—
30,149
30,173
Total loans
$
41,876
$
3,983
$
2,783
$
31,433
$
80,075
Lending commitments
10,219
2,564
71
307
13,161
Total loans and lending commitments
$
52,095
$
6,547
$
2,854
$
31,740
$
93,236
The principal Wealth Management business segment lending activities include securities-based lending and residential real estate loans.
Securities-based lending allows clients to borrow money against the value of qualifying securities, generally for any purpose other than purchasing, trading or carrying securities, or refinancing margin debt. For more information about our securities-based lending and residential real estate loans, see “
Quantitative and Qualitative Disclosures about Risk—Credit Risk
” in the
2019 Form 10-K
.
For the current quarter, Loans and Lending commitments associated with the Wealth Management business segment
increased
primarily due to growth in tailored lending and Residential real estate loans.
Wealth Management Allowance for Credit Losses Rollforward—Loans and Lending Commitments
$ in millions
December 31, 2019
1
$
57
Effect of CECL adoption
17
Provision
19
March 31, 2020
$
93
Allowance for credit losses—Loans
$
87
Allowance for credit losses—Lending commitments
6
1.
At December 31, 2019, the total Allowance for credit losses for Loans and Lending commitments was $52 million and $5 million, respectively.
At March 31, 2020, approximately 75% of Wealth Management residential real estate loans were to borrowers with "Exceptional" or "Very Good" FICO scores (
i.e.
, exceeding 740). Additionally, Wealth Management's securities-based lending portfolio remains well-collateralized and subject to daily client margining, which includes requiring customers to deposit additional collateral, or reduce debt positions, when necessary.
Customer and Other Receivables
Margin Loans
At March 31, 2020
$ in millions
IS
WM
Total
Customer receivables representing margin loans
$
16,635
$
9,546
$
26,181
At December 31, 2019
$ in millions
IS
WM
Total
Customer receivables representing margin loans
$
22,216
$
9,700
$
31,916
The Institutional Securities and Wealth Management business segments provide margin lending arrangements, which allow customers to borrow against the value of qualifying securities, primarily for the purpose of purchasing additional securities, as well as to collateralize short positions. Margin lending activities generally have lower credit risk due to the value of collateral held and their short-term nature. Amounts may fluctuate from period to period as overall client balances change as a result of market levels, client positioning and leverage.
Employee Loans
$ in millions
At
March 31,
2020
At
December 31,
2019
Currently employed by the Firm
$
2,867
N/A
No longer employed by the Firm
150
N/A
Balance
$
3,017
$
2,980
Allowance for credit losses
1
(180
)
(61
)
Balance, net
$
2,837
$
2,919
Remaining repayment term, weighted average in years
5.0
4.8
1.
The change in Allowance for credit losses includes a $124 million increase due to the adoption of CECL on January 1, 2020.
March 2020 Form 10-Q
34
Table of Contents
Risk Disclosures
Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives and are full recourse and generally require periodic repayments.
The allowance for credit losses as of March 31, 2020 was calculated under CECL, while the allowance for credit losses at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See
Note 2
for a description of the CECL allowance methodology, including credit quality indicators, for employee loans. For additional information on employee loans, see
Note 9
.
Derivatives
Fair Value of OTC Derivative Assets
Counterparty Credit Rating
1
$ in millions
AAA
AA
A
BBB
NIG
Total
At March 31, 2020
<1 year
$
2,046
$
26,829
$
55,668
$
38,756
$
19,369
$
142,668
1-3 years
536
6,458
22,788
18,243
13,104
61,129
3-5 years
521
5,952
14,442
10,521
4,718
36,154
Over 5 years
4,257
32,785
93,165
68,387
17,506
216,100
Total, gross
$
7,360
$
72,024
$
186,063
$
135,907
$
54,697
$
456,051
Counterparty netting
(3,472
)
(55,991
)
(150,333
)
(104,343
)
(30,638
)
(344,777
)
Cash and securities collateral
(3,336
)
(12,216
)
(29,345
)
(23,461
)
(16,979
)
(85,337
)
Total, net
$
552
$
3,817
$
6,385
$
8,103
$
7,080
$
25,937
Counterparty Credit Rating
1
$ in millions
AAA
AA
A
BBB
NIG
Total
At December 31, 2019
<1 year
$
371
$
9,195
$
31,789
$
22,757
$
6,328
$
70,440
1-3 years
378
5,150
17,707
11,495
9,016
43,746
3-5 years
502
4,448
9,903
6,881
3,421
25,155
Over 5 years
3,689
24,675
70,765
40,542
14,587
154,258
Total, gross
$
4,940
$
43,468
$
130,164
$
81,675
$
33,352
$
293,599
Counterparty netting
(2,172
)
(33,521
)
(103,452
)
(62,345
)
(19,514
)
(221,004
)
Cash and securities collateral
(2,641
)
(8,134
)
(22,319
)
(14,570
)
(10,475
)
(58,139
)
Total, net
$
127
$
1,813
$
4,393
$
4,760
$
3,363
$
14,456
$ in millions
At
March 31,
2020
At
December 31,
2019
Industry
Financials
$
8,343
$
3,448
Utilities
5,226
4,275
Industrials
2,877
914
Healthcare
1,558
991
Regional governments
1,089
791
Not-for-profit organizations
936
657
Sovereign governments
900
403
Energy
891
524
Materials
826
325
Consumer staples
725
129
Information technology
686
659
Communications services
684
381
Consumer discretionary
463
370
Insurance
391
214
Real estate
215
315
Other
127
60
Total
$
25,937
$
14,456
1.
Counterparty credit ratings are determined internally by CRM.
We are exposed to credit risk as a dealer in OTC derivatives. Credit risk with respect to derivative instruments arises from the possibility that a counterparty may fail to perform according to the terms of the contract.
In the current quarter, our exposure to credit risk arising from OTC derivatives has increased, primarily as a function of the effect of market factors and volatility on the valuation of our positions. For more information on derivatives, see “
Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives
” in the
2019 Form 10-K
and
Note 6
to the financial statements.
Country Risk
Country risk exposure is the risk that events in, or that affect, a foreign country (any country other than the U.S.) might adversely affect us. We actively manage country risk exposure through a comprehensive risk management framework that combines credit and market fundamentals and allows us to effectively identify, monitor and limit country risk
. For a further discussion of our country risk exposure see, “
Quantitative and Qualitative Disclosures about Risk—Country and Other Risks
” in the
2019 Form 10-K
.
Our sovereign exposures consist of financial contracts and obligations entered into with sovereign and local governments. Our non-sovereign exposures consist of financial contracts and obligations entered into primarily with corporations and financial institutions. Index credit derivatives are included in the following country risk exposure table. Each reference entity within an index is allocated to that reference entity’s country of risk. Index exposures are allocated to the underlying reference entities in proportion to the notional weighting of each reference entity in the index, adjusted for any fair value receivable or
35
March 2020 Form 10-Q
Table of Contents
Risk Disclosures
payable for that reference entity. Where credit risk crosses multiple jurisdictions, for example, a CDS purchased from an issuer in a specific country that references bonds issued by an entity in a different country, the fair value of the CDS is reflected in the Net Counterparty Exposure row based on the country of the CDS issuer. Further, the notional amount of the CDS adjusted for the fair value of the receivable or payable is reflected in the Net Inventory row based on the country of the underlying reference entity
.
Top 10 Non-U.S. Country Exposures
at March 31, 2020
United Kingdom
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
(238
)
$
1,327
$
1,089
Net counterparty exposure
2
88
13,314
13,402
Loans
—
2,822
2,822
Lending commitments
—
6,547
6,547
Exposure before hedges
(150
)
24,010
23,860
Hedges
3
(311
)
(1,266
)
(1,577
)
Net exposure
$
(461
)
$
22,744
$
22,283
Germany
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
1,080
$
281
$
1,361
Net counterparty exposure
2
127
5,539
5,666
Loans
—
1,649
1,649
Lending commitments
—
3,492
3,492
Exposure before hedges
1,207
10,961
12,168
Hedges
3
(285
)
(874
)
(1,159
)
Net exposure
$
922
$
10,087
$
11,009
Japan
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
1,501
$
431
$
1,932
Net counterparty exposure
2
78
4,559
4,637
Loans
—
714
714
Lending commitments
—
3
3
Exposure before hedges
1,579
5,707
7,286
Hedges
3
(92
)
(130
)
(222
)
Net exposure
$
1,487
$
5,577
$
7,064
France
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
(427
)
$
(476
)
$
(903
)
Net counterparty exposure
2
14
3,734
3,748
Loans
—
935
935
Lending commitments
—
2,919
2,919
Exposure before hedges
(413
)
7,112
6,699
Hedges
3
(6
)
(712
)
(718
)
Net exposure
$
(419
)
$
6,400
$
5,981
Canada
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
587
$
369
$
956
Net counterparty exposure
2
57
3,221
3,278
Loans
—
629
629
Lending commitments
—
985
985
Exposure before hedges
644
5,204
5,848
Hedges
3
—
(97
)
(97
)
Net exposure
$
644
$
5,107
$
5,751
Spain
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
360
$
(139
)
$
221
Net counterparty exposure
2
3
383
386
Loans
—
3,623
3,623
Lending commitments
—
713
713
Exposure before hedges
363
4,580
4,943
Hedges
3
—
(132
)
(132
)
Net exposure
$
363
$
4,448
$
4,811
China
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
(432
)
$
1,487
$
1,055
Net counterparty exposure
2
135
460
595
Loans
—
1,965
1,965
Lending commitments
—
770
770
Exposure before hedges
(297
)
4,682
4,385
Hedges
3
(82
)
(82
)
(164
)
Net exposure
$
(379
)
$
4,600
$
4,221
Australia
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
1,464
$
359
$
1,823
Net counterparty exposure
2
16
1,346
1,362
Loans
—
355
355
Lending commitments
—
647
647
Exposure before hedges
1,480
2,707
4,187
Hedges
3
—
(107
)
(107
)
Net exposure
$
1,480
$
2,600
$
4,080
Brazil
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
2,384
$
79
$
2,463
Net counterparty exposure
2
—
924
924
Loans
—
237
237
Lending commitments
—
64
64
Exposure before hedges
2,384
1,304
3,688
Hedges
3
(12
)
(16
)
(28
)
Net exposure
$
2,372
$
1,288
$
3,660
March 2020 Form 10-Q
36
Table of Contents
Risk Disclosures
India
$ in millions
Sovereigns
Non-sovereigns
Total
Net inventory
1
$
1,571
$
680
$
2,251
Net counterparty exposure
2
—
612
612
Loans
—
235
235
Exposure before hedges
1,571
1,527
3,098
Net exposure
$
1,571
$
1,527
$
3,098
1.
Net inventory represents exposure to both long and short single-name and index positions (
i.e.
, bonds and equities at fair value and CDS based on a notional amount assuming zero recovery adjusted for the fair value of any receivable or payable)
.
2.
Net counterparty exposure (
e.g.
, repurchase transactions, securities lending and OTC derivatives) is net of the benefit of collateral received and also is net by counterparty when legally enforceable master netting agreements are in place. For more information, see
“
Additional Information—Top 10 Non-U.S. Country Exposures
” herein.
3.
Amounts represent net CDS hedges (purchased and sold) on net counterparty exposure and lending executed by trading desks responsible for hedging counterparty and lending credit risk exposures. Amounts are based on the CDS notional amount assuming zero recovery adjusted for any fair value receivable or payable. For further description of the contractual terms for purchased credit protection and whether they may limit the effectiveness of our hedges, see
“
Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives
” in the
2019 Form 10-K
.
Additional Information—Top 10 Non-U.S. Country Exposures
Collateral Held against Net Counterparty Exposure
1
$ in millions
At
March 31,
2020
Counterparty credit exposure
Collateral
2
United Kingdom
U.K., U.S. and Spain
$
14,985
Germany
Italy and Germany
13,356
Other
Japan, U.S. and Canada
27,025
1.
The benefit of collateral received is reflected in the Top 10 Non-U.S. Country Exposures
at March 31, 2020
.
2.
Collateral primarily consists of cash and government obligations
.
Country Risk Exposures Related to the U.K.
At March 31, 2020
, our country risk exposures in the U.K. included net exposures of
$22,283 million
(as shown in the Top 10 Non-U.S. Country Exposures table) and overnight deposits of
$5,163 million
. The
$22,744 million
of exposures to non-sovereigns were diversified across both names and sectors and include
$7,253 million
to U.K.-focused counterparties that generate more than one-third of their revenues in the U.K.,
$5,845 million
to geographically diversified counterparties, and
$8,361 million
to exchanges and clearinghouses.
Operational Risk
Operational risk refers to the risk of loss, or of damage to our reputation, resulting from inadequate or failed processes or systems, from human factors or from external events (
e.g.
, fraud, theft, legal and compliance risks, cyber attacks or damage to physical assets). We may incur operational risk across the full scope of our business activities, including revenue-generating activities (
e.g
., sales and trading) and support and control groups (
e.g.
, information technology and trade processing).
For a further discussion about our operational risk, see “
Quantitative
and Qualitative Disclosures about Risk—Operational Risk
” in the
2019 Form 10-K
. In addition, for further information on market and economic conditions and their effects on risk in general, see "
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
" and “
Risk Factors
” herein.
Model Risk
Model risk refers to the potential for adverse consequences from decisions based on incorrect or misused model outputs. Model risk can lead to financial loss, poor business and strategic decision making or damage to our reputation. The risk inherent in a model is a function of the materiality, complexity and uncertainty around inputs and assumptions.
Model risk is generated from the use of models impacting financial statements, regulatory filings, capital adequacy assessments and the formulation of strategy.
For a further discussion about our model risk, see “
Quantitative and Qualitative Disclosures about Risk—Model Risk
” in the
2019 Form 10-K
.
Liquidity Risk
Liquidity risk refers to the risk that we will be unable to finance our operations due to a loss of access to the capital markets or difficulty in liquidating our assets. Liquidity risk also encompasses our ability (or perceived ability) to meet our financial obligations without experiencing significant business disruption or reputational damage that may threaten our viability as a going concern.
For a further discussion about our liquidity risk, see “
Quantitative and Qualitative Disclosures about Risk—Liquidity Risk
” in the
2019 Form 10-K
and “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources
” herein. In addition, for further information on market and economic conditions and their effects on risk in general, see “
Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic
” and “
Risk Factors
” herein.
Legal and Compliance Risk
Legal and compliance risk includes the risk of legal or regulatory sanctions, material financial loss, including fines, penalties, judgments, damages and/or settlements, or loss to reputation that we may suffer as a result of failure to comply with laws, regulations, rules, related self-regulatory organization standards and codes of conduct applicable to our business activities. This risk also includes contractual and commercial risk, such as the risk that a counterparty’s performance obligations will be unenforceable. It also includes compliance with AML, terrorist financing, and anti-corruption rules and regulations.
For a further discussion about our legal and compliance risk, see “
Quantitative and Qualitative Disclosures about Risk—Legal and Compliance Risk
” in the
2019 Form 10-K
.
37
March 2020 Form 10-Q
Table of Contents
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Morgan Stanley:
Results of Review of Interim Financial Information
We have reviewed the accompanying condensed consolidated balance sheet of Morgan Stanley and subsidiaries (the “Firm”) as of
March 31, 2020
, and the related condensed consolidated income statements, comprehensive income statements, cash flow statements and statements of changes in total equity for the three-month periods ended
March 31, 2020
and
2019
, and the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Firm as of December 31,
2019
, and the related consolidated income statement, comprehensive income statement, cash flow statement and statement of changes in total equity for the year then ended (not presented herein) included in the Firm’s Annual Report on Form 10-K; and in our report dated February 27, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31,
2019
is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
Basis for Review Results
This interim financial information is the responsibility of the Firm’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Firm in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
/s/ Deloitte & Touche LLP
New York, New York
May 5, 2020
March 2020 Form 10-Q
38
Table of Contents
Consolidated Income Statements
(Unaudited)
Three Months Ended
March 31,
in millions, except per share data
2020
2019
Revenues
Investment banking
$
1,271
$
1,242
Trading
3,056
3,441
Investments
38
273
Commissions and fees
1,360
966
Asset management
3,417
3,049
Other
(
1,011
)
301
Total non-interest revenues
8,131
9,272
Interest income
3,503
4,290
Interest expense
2,147
3,276
Net interest
1,356
1,014
Net revenues
9,487
10,286
Non-interest expenses
Compensation and benefits
4,283
4,651
Brokerage, clearing and exchange fees
740
593
Information processing and communications
563
532
Professional services
449
514
Occupancy and equipment
365
347
Marketing and business development
132
141
Other
809
553
Total non-interest expenses
7,341
7,331
Income before provision for income taxes
2,146
2,955
Provision for income taxes
366
487
Net income
$
1,780
$
2,468
Net income applicable to noncontrolling interests
82
39
Net income applicable to Morgan Stanley
$
1,698
$
2,429
Preferred stock dividends
108
93
Earnings applicable to Morgan Stanley common shareholders
$
1,590
$
2,336
Earnings per common share
Basic
$
1.02
$
1.41
Diluted
$
1.01
$
1.39
Average common shares outstanding
Basic
1,555
1,658
Diluted
1,573
1,677
See Notes to Consolidated Financial Statements
39
March 2020 Form 10-Q
Table of Contents
Consolidated Comprehensive Income Statements
(Unaudited)
Three Months Ended
March 31,
$ in millions
2020
2019
Net income
$
1,780
$
2,468
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments
(
132
)
(
22
)
Change in net unrealized gains (losses) on available-for-sale securities
1,325
429
Pension, postretirement and other
25
1
Change in net debt valuation adjustment
3,803
(
620
)
Total other comprehensive income (loss)
$
5,021
$
(
212
)
Comprehensive income
$
6,801
$
2,256
Net income applicable to noncontrolling interests
82
39
Other comprehensive income (loss) applicable to noncontrolling interests
138
(
31
)
Comprehensive income applicable to Morgan Stanley
$
6,581
$
2,248
March 2020 Form 10-Q
40
See Notes to Consolidated Financial Statements
Table of Contents
Consolidated Balance Sheets
$ in millions, except share data
(Unaudited) At
March 31, 2020
At
December 31, 2019
Assets
Cash and cash equivalents
$
131,509
$
82,171
Trading assets at fair value (
$103,637
and $128,386 were pledged to various parties)
270,916
297,110
Investment securities (includes
$68,871
and $62,223 at fair value)
116,157
105,725
Securities purchased under agreements to resell (includes
$5
and $4 at fair value)
104,800
88,224
Securities borrowed
72,300
106,549
Customer and other receivables
74,424
55,646
Loans:
Held for investment (net of allowance of
$617
and $349)
131,335
118,060
Held for sale
17,362
12,577
Goodwill
7,125
7,143
Intangible assets (net of accumulated amortization of
$3,281
and $3,204)
2,021
2,107
Other assets
19,846
20,117
Total assets
$
947,795
$
895,429
Liabilities
Deposits (includes
$4,052
and $2,099 at fair value)
$
235,239
$
190,356
Trading liabilities at fair value
142,076
133,356
Securities sold under agreements to repurchase (includes
$775
and $733 at fair value)
45,816
54,200
Securities loaned
11,631
8,506
Other secured financings (includes
$6,897
and $7,809 at fair value)
13,058
14,698
Customer and other payables
198,074
197,834
Other liabilities and accrued expenses
19,817
21,155
Borrowings (includes
$57,162
and $64,461 at fair value)
194,856
192,627
Total liabilities
860,567
812,732
Commitments and contingent liabilities (see Note 13)
Equity
Morgan Stanley shareholders’ equity:
Preferred stock
8,520
8,520
Common stock, $0.01 par value:
Shares authorized:
3,500,000,000
; Shares issued:
2,038,893,979
; Shares outstanding:
1,575,500,507
and 1,593,973,680
20
20
Additional paid-in capital
23,428
23,935
Retained earnings
71,518
70,589
Employee stock trusts
3,088
2,918
Accumulated other comprehensive income (loss)
2,095
(
2,788
)
Common stock held in treasury at cost, $0.01 par value (
463,393,472
and 444,920,299 shares)
(
19,721
)
(
18,727
)
Common stock issued to employee stock trusts
(
3,088
)
(
2,918
)
Total Morgan Stanley shareholders’ equity
85,860
81,549
Noncontrolling interests
1,368
1,148
Total equity
87,228
82,697
Total liabilities and equity
$
947,795
$
895,429
See Notes to Consolidated Financial Statements
41
March 2020 Form 10-Q
Table of Contents
Consolidated Statements of Changes in Total Equity
(Unaudited)
Three Months Ended
March 31,
$ in millions
2020
2019
Preferred Stock
Beginning and ending balance
$
8,520
$
8,520
Common Stock
Beginning and ending balance
20
20
Additional Paid-in Capital
Beginning balance
23,935
23,794
Share-based award activity
(
507
)
(
618
)
Other net increases
—
2
Ending balance
23,428
23,178
Retained Earnings
Beginning balance
70,589
64,175
Cumulative adjustments for accounting changes
1
(
100
)
63
Net income applicable to Morgan Stanley
1,698
2,429
Preferred stock dividends
2
(
108
)
(
93
)
Common stock dividends
2
(
561
)
(
513
)
Ending balance
71,518
66,061
Employee Stock Trusts
Beginning balance
2,918
2,836
Share-based award activity
170
164
Ending balance
3,088
3,000
Accumulated Other Comprehensive Income (Loss)
Beginning balance
(
2,788
)
(
2,292
)
Net change in Accumulated other comprehensive income (loss)
4,883
(
181
)
Ending balance
2,095
(
2,473
)
Common Stock Held In Treasury at Cost
Beginning balance
(
18,727
)
(
13,971
)
Share-based award activity
788
1,034
Repurchases of common stock and employee tax withholdings
(
1,782
)
(
1,645
)
Ending balance
(
19,721
)
(
14,582
)
Common Stock Issued to Employee Stock Trusts
Beginning balance
(
2,918
)
(
2,836
)
Share-based award activity
(
170
)
(
164
)
Ending balance
(
3,088
)
(
3,000
)
Non-Controlling Interests
Beginning balance
1,148
1,160
Net income applicable to non-controlling interests
82
39
Net change in Accumulated other comprehensive income (loss)
138
(
31
)
Ending balance
1,368
1,168
Total Equity
$
87,228
$
81,892
1.
See
Notes 2
and
16
for further information regarding cumulative adjustments for accounting changes.
2.
See
Note 16
for information regarding dividends per share for each class of stock.
See Notes to Consolidated Financial Statements
42
March 2020 Form 10-Q
Table of Contents
Consolidated Cash Flow Statements
(Unaudited)
Three Months Ended
March 31,
$ in millions
2020
2019
Cash flows from operating activities
Net income
$
1,780
$
2,468
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Stock-based compensation expense
154
293
Depreciation and amortization
824
658
Provision for (Release of) credit losses on lending activities
407
36
Other operating adjustments
1,044
(
92
)
Changes in assets and liabilities:
Trading assets, net of Trading liabilities
35,079
23,977
Securities borrowed
34,249
(
22,578
)
Securities loaned
3,125
600
Customer and other receivables and other assets
(
23,619
)
1,567
Customer and other payables and other liabilities
(
4,247
)
9,971
Securities purchased under agreements to resell
(
16,576
)
1,952
Securities sold under agreements to repurchase
(
8,384
)
(
1,811
)
Net cash provided by (used for) operating activities
23,836
17,041
Cash flows from investing activities
Proceeds from (payments for):
Other assets—Premises, equipment and software, net
(
354
)
(
529
)
Changes in loans, net
(
13,243
)
(
1,329
)
Investment securities:
Purchases
(
12,924
)
(
15,895
)
Proceeds from sales
3,128
7,875
Proceeds from paydowns and maturities
2,378
2,663
Other investing activities
(
93
)
(
12
)
Net cash provided by (used for) investing activities
(
21,108
)
(
7,227
)
Cash flows from financing activities
Net proceeds from (payments for):
Other secured financings
259
(
1,575
)
Deposits
44,694
(
8,089
)
Proceeds from issuance of Borrowings
20,601
8,091
Payments for:
Borrowings
(
14,967
)
(
11,927
)
Repurchases of common stock and employee tax withholdings
(
1,782
)
(
1,645
)
Cash dividends
(
688
)
(
663
)
Other financing activities
(
163
)
(
56
)
Net cash provided by (used for) financing activities
47,954
(
15,864
)
Effect of exchange rate changes on cash and cash equivalents
(
1,344
)
(
464
)
Net increase (decrease) in cash and cash equivalents
49,338
(
6,514
)
Cash and cash equivalents, at beginning of period
82,171
87,196
Cash and cash equivalents, at end of period
$
131,509
$
80,682
Supplemental Disclosure of Cash Flow Information
Cash payments for:
Interest
$
2,123
$
2,896
Income taxes, net of refunds
342
245
See Notes to Consolidated Financial Statements
43
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
1
.
Introduction and Basis of Presentation
The Firm
Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments—Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley” or the “Firm” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form
10-Q.
A description of the clients and principal products and services of each of the Firm’s business segments is as follows:
Institutional Securities
provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in equity and fixed income products, including foreign exchange and commodities. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research.
Wealth Management
provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services.
Investment Management
provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds,
insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors.
Basis of Financial Information
The financial statements are prepared in accordance with U.S. GAAP, which requires the Firm to make estimates and assumptions regarding the valuations of certain financial instruments, the valuations of goodwill and intangible assets, the outcome of legal and tax matters, deferred tax assets, allowance for credit losses, and other matters that affect its financial statements and related disclosures. The Firm believes that the estimates utilized in the preparation of its financial statements are prudent and reasonable. Actual results could differ materially from these estimates.
Certain reclassifications have been made to prior periods to conform to the current presentation. The Notes are an integral part of the Firm's financial statements. The Firm has evaluated subsequent events for adjustment to or disclosure in these financial statements through the date of this report and has not identified any recordable or disclosable events not otherwise reported in these financial statements or the notes thereto.
The accompanying financial statements should be read in conjunction with the Firm’s financial statements and notes thereto included in the
2019 Form 10-K
. Certain footnote disclosures included in the
2019 Form 10-K
have been condensed or omitted from these financial statements as they are not required for interim reporting under U.S. GAAP. The financial statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for the fair presentation of the results for the interim period. The results of operations for interim periods are not necessarily indicative of results for the entire year.
Consolidation
The financial statements include the accounts of the Firm, its wholly owned subsidiaries and other entities in which the Firm has a controlling financial interest, including certain VIEs (see
Note 14
).
Intercompany balances and transactions have been eliminated. For consolidated subsidiaries that are not wholly owned, the third-party holdings of equity interests are referred to as noncontrolling interests. The net income attributable to noncontrolling interests for such subsidiaries is presented as Net income applicable to noncontrolling interests in the income statements. The portion of shareholders’ equity that is attributable to noncontrolling interests for such subsidiaries is presented as noncontrolling interests, a component of Total equity, in the balance sheets.
For a discussion of the Firm’s significant regulated U.S. and international subsidiaries and its involvement with VIEs, see
Note 1
to the financial statements in the
2019 Form 10-K
.
March 2020 Form 10-Q
44
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
2
.
Significant Accounting Policies
For a detailed discussion about the Firm’s significant accounting policies and for further information on accounting updates adopted in the prior year, see
Note 2
to the financial statements in the
2019 Form 10-K
.
During the
three months ended
March 31, 2020
(“current quarter”), there were no significant revisions to the Firm’s significant accounting policies, other than for the accounting updates adopted.
Accounting Updates Adopted in 2020
See
Note 16
for a summary of the Retained earnings impact of this adoption.
Financial Instruments — Credit Losses
The Firm adopted the
Financial Instruments - Credit Losses
accounting update on January 1, 2020.
This accounting update impacted the impairment model for certain financial assets measured at amortized cost by requiring a CECL methodology to estimate expected credit losses over the entire life of the financial asset, recorded at inception or purchase. CECL replaced the loss model currently applicable to loans held for investment, HTM securities and other receivables carried at amortized cost, such as employee loans.
The update also eliminated the concept of other-than-temporary impairment for AFS securities and instead requires impairments on AFS securities to be recognized in earnings through an allowance when the fair value is less than amortized cost and a credit loss exists, and through a permanent reduction of the amortized cost basis when the securities are expected to be sold before recovery of amortized cost.
For certain portfolios, we determined that there are
de minimus
or zero expected credit losses; for example, for lending and financing transactions, such as Securities borrowed, Securities purchased under agreements to resell and certain other portfolios where collateral arrangements are being followed. Also, we have zero expected credit losses for certain financial assets based on the credit quality of the borrower or issuer, such as U.S. government and agency securities.
At transition on January 1, 2020, the adoption of this accounting standard resulted in an increase in the allowance for credit losses of $
131
million with a corresponding reduction in Retained earnings of $
100
million, net of tax. The adoption impact was primarily attributable to a
$
124
million
increase in the allowance for credit losses on employee loans.
The following discussion highlights changes to the Firm’s accounting policies as a result of this adoption.
Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures
Allowance for Credit Losses (“ACL”)
The ACL for financial instruments measured at amortized cost and certain off-balance sheet exposures (
e.g.,
HFI loans and lending commitments, HTM securities, customer and other receivables and certain guarantees) represents an estimate of expected credit losses over the entire life of the financial instrument.
Factors considered by management when determining the ACL include payment status, fair value of collateral, expected payments of principal and interest, as well as internal or external information relating to past events, current conditions and reasonable and supportable forecasts. The Firm’s forecasts include assumptions about certain macroeconomic variables including, but not limited to, U.S. gross domestic product, equity market indices, unemployment rates, as well as commercial real estate and home price indices. At the conclusion of the Firm’s reasonable and supportable forecast period of three years, there is a gradual reversion back to historical averages.
The ACL is measured on a collective basis when similar risk characteristics exist for multiple instruments considering all available information relevant to assessing the collectability of cash flows. Generally, the Firm applies a probability of default (“PD”)/loss given default (“LGD”) model (“PD/LGD model”) for instruments that are collectively assessed, under which the ACL is calculated as the product of PD, LGD and exposure at default (“EAD”). These parameters are forecast for each collective group of loans using a scenario-based statistical model and at the conclusion of the Firm’s reasonable and supportable forecast period, the parameters gradually revert back to historical averages.
If the instrument does not share similar risk characteristics with other instruments, including when it is probable that the Firm will be unable to collect the full payment of principal and interest on the instrument when due, the ACL is measured on an individual basis. The Firm typically applies a discounted cash flow (“DCF”) method for instruments that are individually assessed.
The Firm may also elect to use an approach that considers the fair value of the collateral when measuring the ACL if the loan is collateral dependent (
i.e.,
repayment of the loan is expected to be provided substantially by the sale or operation of the underlying collateral and the borrower is experiencing financial difficulty).
Additionally, the Firm can elect to use an approach to measure the ACL using the fair value of collateral where the borrower is required to, and reasonably expected to, continually adjust and replenish the amount of collateral securing the instrument to reflect changes in the fair value of such collateral. The Firm has
45
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
elected to use this approach for certain securities-based loans, customer receivables representing margin loans, Securities purchased under agreements to resell and Securities borrowed.
Credit quality indicators considered in developing the ACL include:
•
Corporate loans and Commercial real estate loans and securities: Internal risk ratings developed by CRM which are refreshed at least annually, and more frequently as necessary. These ratings generally correspond to external ratings published by S&P. The Firm also considers transaction structure, including type of collateral, collateral terms, and position of the obligation within the capital structure. In addition, for Commercial real estate, the Firm considers property type and location, net operating income, LTV ratios, among others, as well as commercial real estate price and credit spread indices and capitalization rates.
•
Residential real estate loans: Loan origination Fair Isaac Corporation (“FICO”) credit scores as determined by independent credit agencies in the United States and loan-to-value (“LTV”) ratios.
•
Employee loans: Employment status, which includes those currently employed by the Firm and for which the Firm can deduct any unpaid amounts due to it through certain compensation arrangements; and those no longer employed by the Firm where such compensation arrangements are no longer applicable.
Consumer loans primarily comprise securities-based loans and therefore the Firm generally measures the ACL on such loans based on the fair value of collateral.
Qualitative and environmental factors such as economic and business conditions, the nature and volume of the portfolio, and lending terms and the volume and severity of past due loans are also considered in the ACL calculations.
Recognition
. The Firm recognizes its ACL and provision for credit losses in its balance sheets and income statements, respectively, for on– and off–balance sheet instruments as follows.
ACL
Provision for credit losses
Instruments measured at amortized cost (
e.g.,
HFI loans, HTM securities and customer and other receivables)
Contra asset
Other revenue
Employee loans
Contra asset
Compensation and benefits expense
Off-balance sheet instruments (
e.g.,
HFI lending commitments and certain guarantees)
Other liabilities and accrued expenses
Other expense
Troubled Debt Restructurings (“TDRs”)
The Firm may modify the terms of certain loans for economic or legal reasons related to a borrower’s financial difficulties by granting one or more concessions that the Firm would not
otherwise consider. Such modifications are accounted for and reported as a TDR, except for certain modifications related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. A loan that has been modified in a TDR is generally considered to be impaired and is evaluated individually. TDRs are also generally classified as nonaccrual and may be returned to accrual status only after the Firm expects repayment of the remaining contractual principal and interest and there is sustained repayment performance for a reasonable period.
Nonaccrual
The Firm places financial instruments on nonaccrual status if principal or interest is past due for a period of 90 days or more or payment of principal or interest is in doubt unless the obligation is well-secured and in the process of collection, or in certain cases when related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. For any instrument placed on nonaccrual status, the Firm reverses any unpaid interest accrued with an offsetting reduction to Interest income. Principal and interest payments received on nonaccrual instruments are applied to principal if there is doubt regarding the ultimate collectability of principal. If collection of the principal is not in doubt, interest income is realized on a cash basis. If neither principal nor interest collection is in doubt and the instruments are brought current, instruments are generally placed on accrual status and interest income is recognized using the effective interest method.
Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19
In the first quarter of 2020, the Firm elected to apply the guidance issued by Congress in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) as well as by the U.S. banking agencies stating that certain concessions granted to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the coronavirus pandemic, generally would not be considered TDRs or nonaccrual.
ACL Write-offs
The Firm writes-off a financial instrument in the period that it is deemed uncollectible and records a reduction in the ACL and the balance of the financial instrument in the balance sheet. However, for accrued interest receivable balances that are separately recorded from the related financial instruments, the Firm's nonaccrual policy requires that accrued interest receivable be written off against Interest income when the related financial instrument is placed in nonaccrual status. Accordingly, the Firm elected not to measure an ACL for accrued interest receivables.
March 2020 Form 10-Q
46
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Available-for-Sale (“AFS”) Investment Securities
Unrealized Losses on AFS Securities
AFS securities are analyzed as part of the Firm's periodic assessment of credit losses at the individual security level. When considering if a credit loss exists, the Firm considers relevant information as discussed in Note 2 of the 2019 Form 10-K. Upon the adoption of
Financial Instruments—Credit Losses
, the Firm no longer considers the length of time the fair value has been less than the amortized cost basis in determining whether a credit loss exists.
Recognition
. The Firm recognizes its ACL and provision for credit losses for AFS securities in its balance sheets and income statements, respectively, as follows.
ACL
Provision for credit losses
AFS securities
Contra asset
Other revenue
The Firm recognizes the non-credit loss component of the unrealized loss as an adjustment to the security’s asset balance with an offsetting entry to AOCI in the balance sheets.
For AFS securities in an unrealized loss position as of the balance sheet date that the Firm either has the intent to sell or that the Firm is likely to be required to sell before recovery of its amortized cost basis, any allowance for credit losses previously established is written off and the amortized cost basis is written down to the security’s fair value with any incremental unrealized losses reported in Other revenues.
Nonaccrual & ACL Write-Offs on AFS Securities
AFS securities follow the same nonaccrual and write-off guidance as discussed in “Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures” herein.
3
.
Cash and Cash Equivalents
Cash and cash equivalents consist of Cash and due from banks and Interest bearing deposits with banks. Cash equivalents are highly liquid investments with remaining maturities of three months or less from the acquisition date that are readily convertible to cash and are not held for trading purposes.
$ in millions
At
March 31,
2020
At
December 31,
2019
Cash and due from banks
$
11,570
$
6,763
Interest bearing deposits with banks
119,939
75,408
Total Cash and cash equivalents
$
131,509
$
82,171
Restricted cash
$
56,064
$
32,512
Cash and cash equivalents also include Restricted cash such as cash in banks subject to withdrawal restrictions, restricted deposits held as compensating balances and cash segregated in
compliance with federal or other regulations, including the minimum reserve requirement set by the Federal Reserve Bank and other central banks.
4
.
Fair Values
Recurring Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
At March 31, 2020
$ in millions
Level 1
Level 2
Level 3
Netting
1
Total
Assets at fair value
Trading assets:
U.S. Treasury and agency securities
$
42,231
$
29,105
$
99
$
—
$
71,435
Other sovereign government obligations
29,493
5,017
17
—
34,527
State and municipal securities
—
2,226
1
—
2,227
MABS
—
838
483
—
1,321
Loans and lending commitments
2
—
4,082
5,980
—
10,062
Corporate and other debt
—
23,448
1,708
—
25,156
Corporate equities
3
66,409
582
146
—
67,137
Derivative and other contracts:
Interest rate
14,025
253,646
1,367
—
269,038
Credit
—
12,605
753
—
13,358
Foreign exchange
26
112,711
76
—
112,813
Equity
1,041
93,175
1,560
—
95,776
Commodity and other
1,070
17,813
3,384
—
22,267
Netting
1
(
12,720
)
(
376,568
)
(
1,301
)
(
69,653
)
(
460,242
)
Total derivative and other contracts
3,442
113,382
5,839
(
69,653
)
53,010
Investments
4
562
204
725
—
1,491
Physical commodities
—
960
—
—
960
Total trading assets
4
142,137
179,844
14,998
(
69,653
)
267,326
Investment securities—AFS
35,899
32,972
—
—
68,871
Securities purchased under agreements to resell
—
5
—
—
5
Total assets at fair value
$
178,036
$
212,821
$
14,998
$
(
69,653
)
$
336,202
47
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
At March 31, 2020
$ in millions
Level 1
Level 2
Level 3
Netting
1
Total
Liabilities at fair value
Deposits
$
—
$
3,935
$
117
$
—
$
4,052
Trading liabilities:
U.S. Treasury and agency securities
13,273
201
16
—
13,490
Other sovereign government obligations
20,273
836
2
—
21,111
Corporate and other debt
—
9,341
6
—
9,347
Corporate equities
3
57,134
85
40
—
57,259
Derivative and other contracts:
Interest rate
14,655
242,840
494
—
257,989
Credit
—
12,631
555
—
13,186
Foreign exchange
20
112,552
226
—
112,798
Equity
1,090
89,344
2,936
—
93,370
Commodity and other
1,438
15,280
1,535
—
18,253
Netting
1
(
12,720
)
(
376,568
)
(
1,301
)
(
64,138
)
(
454,727
)
Total derivative and other contracts
4,483
96,079
4,445
(
64,138
)
40,869
Total trading liabilities
95,163
106,542
4,509
(
64,138
)
142,076
Securities sold under agreements to repurchase
—
775
—
—
775
Other secured financings
—
6,508
389
—
6,897
Borrowings
—
53,164
3,998
—
57,162
Total liabilities at fair value
$
95,163
$
170,924
$
9,013
$
(
64,138
)
$
210,962
At December 31, 2019
$ in millions
Level 1
Level 2
Level 3
Netting
1
Total
Assets at fair value
Trading assets:
U.S. Treasury and agency securities
$
36,866
$
28,992
$
22
$
—
$
65,880
Other sovereign government obligations
23,402
4,347
5
—
27,754
State and municipal securities
—
2,790
1
—
2,791
MABS
—
1,690
438
—
2,128
Loans and lending commitments
2
—
6,253
5,073
—
11,326
Corporate and other debt
—
22,124
1,396
—
23,520
Corporate equities
3
123,942
652
97
—
124,691
Derivative and other contracts:
Interest rate
1,265
182,977
1,239
—
185,481
Credit
—
6,658
654
—
7,312
Foreign exchange
15
64,260
145
—
64,420
Equity
1,219
48,927
922
—
51,068
Commodity and other
1,079
7,255
2,924
—
11,258
Netting
1
(
2,794
)
(
235,947
)
(
993
)
(
47,804
)
(
287,538
)
Total derivative and other contracts
784
74,130
4,891
(
47,804
)
32,001
Investments
4
481
252
858
—
1,591
Physical commodities
—
1,907
—
—
1,907
Total trading assets
4
185,475
143,137
12,781
(
47,804
)
293,589
Investment securities—AFS
32,902
29,321
—
—
62,223
Securities purchased under agreements to resell
—
4
—
—
4
Total assets at fair value
$
218,377
$
172,462
$
12,781
$
(
47,804
)
$
355,816
At December 31, 2019
$ in millions
Level 1
Level 2
Level 3
Netting
1
Total
Liabilities at fair value
Deposits
$
—
$
1,920
$
179
$
—
$
2,099
Trading liabilities:
U.S. Treasury and agency securities
11,191
34
—
—
11,225
Other sovereign government obligations
21,837
1,332
1
—
23,170
Corporate and other debt
—
7,410
—
—
7,410
Corporate equities
3
63,002
79
36
—
63,117
Derivative and other contracts:
Interest rate
1,144
171,025
462
—
172,631
Credit
—
7,391
530
—
7,921
Foreign exchange
6
67,473
176
—
67,655
Equity
1,200
49,062
2,606
—
52,868
Commodity and other
1,194
7,118
1,312
—
9,624
Netting
1
(
2,794
)
(
235,947
)
(
993
)
(
42,531
)
(
282,265
)
Total derivative and other contracts
750
66,122
4,093
(
42,531
)
28,434
Total trading liabilities
96,780
74,977
4,130
(
42,531
)
133,356
Securities sold under agreements to repurchase
—
733
—
—
733
Other secured financings
—
7,700
109
—
7,809
Borrowings
—
60,373
4,088
—
64,461
Total liabilities at fair value
$
96,780
$
145,703
$
8,506
$
(
42,531
)
$
208,458
MABS
—
Mortgage- and asset-backed securities
1.
For positions with the same counterparty that cross over the levels of the fair value hierarchy, both counterparty netting and cash collateral netting are included in the column titled “Netting.” Positions classified within the same level that are with the same counterparty are netted within that level. For further information on derivative instruments and hedging activities,
see
Note 6
.
2.
For a further breakdown by type, see the following Detail of Loans and Lending Commitments at Fair Value table.
3.
For trading purposes, the Firm holds or sells short equity securities issued by entities in diverse industries and of varying sizes.
4.
Amounts exclude certain investments that are measured based on NAV per share, which are not classified in the fair value hierarchy. For additional disclosure about such investments, see “Net Asset Value Measurements” herein.
Detail of Loans and Lending Commitments at Fair Value
$ in millions
At
March 31,
2020
At
December 31, 2019
Corporate
$
7,711
$
8,036
Residential real estate
1,154
1,192
Commercial real estate
1,197
2,098
Total
$
10,062
$
11,326
Unsettled Fair Value of Futures Contracts
1
$ in millions
At
March 31,
2020
At
December 31, 2019
Customer and other receivables, net
$
935
$
365
1.
These contracts are primarily Level 1, actively traded, valued based on quoted prices from the exchange and are excluded from the previous recurring fair value tables.
For a description of the valuation techniques applied to the Firm’s major categories of assets and liabilities measured at fair value on a recurring basis, see Note 3 to the financial statements in the
2019 Form 10-K
. During the current quarter, there were no significant revisions made to the Firm’s valuation techniques.
March 2020 Form 10-Q
48
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis
Three Months Ended
March 31,
$ in millions
2020
2019
U.S. Treasury and agency securities
Beginning balance
$
22
$
54
Realized and unrealized gains (losses)
5
—
Purchases
85
—
Sales
(
21
)
(
50
)
Net transfers
8
3
Ending balance
$
99
$
7
Unrealized gains (losses)
$
5
$
—
Other sovereign government obligations
Beginning balance
$
5
$
17
Realized and unrealized gains (losses)
1
—
Purchases
10
2
Sales
—
(
2
)
Net transfers
1
(
12
)
Ending balance
$
17
$
5
Unrealized gains (losses)
$
1
$
—
State and municipal securities
Beginning balance
$
1
$
148
Realized and unrealized gains (losses)
—
1
Purchases
—
10
Sales
—
(
44
)
Net transfers
—
(
103
)
Ending balance
$
1
$
12
Unrealized gains (losses)
$
—
$
1
MABS
Beginning balance
$
438
$
354
Realized and unrealized gains (losses)
(
89
)
(
7
)
Purchases
158
19
Sales
(
140
)
(
83
)
Settlements
—
(
3
)
Net transfers
116
21
Ending balance
$
483
$
301
Unrealized gains (losses)
$
(
92
)
$
(
14
)
Loans and lending commitments
Beginning balance
$
5,073
$
6,870
Realized and unrealized gains (losses)
(
102
)
—
Purchases and originations
1,952
1,255
Sales
(
529
)
(
108
)
Settlements
(
1,387
)
(
820
)
Net transfers
1
973
(
854
)
Ending balance
$
5,980
$
6,343
Unrealized gains (losses)
$
(
101
)
$
(
7
)
Three Months Ended
March 31,
$ in millions
2020
2019
Corporate and other debt
Beginning balance
$
1,396
$
1,076
Realized and unrealized gains (losses)
(
92
)
43
Purchases
585
204
Sales
(
177
)
(
127
)
Settlements
—
(
3
)
Net transfers
(
4
)
(
132
)
Ending balance
$
1,708
$
1,061
Unrealized gains (losses)
$
(
90
)
$
41
Corporate equities
Beginning balance
$
97
$
95
Realized and unrealized gains (losses)
(
60
)
6
Purchases
22
51
Sales
(
40
)
(
9
)
Net transfers
127
9
Ending balance
$
146
$
152
Unrealized gains (losses)
$
(
54
)
$
7
Investments
Beginning balance
$
858
$
757
Realized and unrealized gains (losses)
(
63
)
10
Purchases
15
10
Sales
(
8
)
(
4
)
Net transfers
(
77
)
201
Ending balance
$
725
$
974
Unrealized gains (losses)
$
(
64
)
$
14
Net derivatives: Interest rate
Beginning balance
$
777
$
618
Realized and unrealized gains (losses)
156
(
48
)
Purchases
61
24
Issuances
(
7
)
(
19
)
Settlements
(
42
)
(
12
)
Net transfers
(
72
)
(
12
)
Ending balance
$
873
$
551
Unrealized gains (losses)
$
111
$
(
43
)
Net derivatives: Credit
Beginning balance
$
124
$
40
Realized and unrealized gains (losses)
131
162
Purchases
26
26
Issuances
(
21
)
(
442
)
Settlements
(
24
)
(
33
)
Net transfers
(
38
)
(
14
)
Ending balance
$
198
$
(
261
)
Unrealized gains (losses)
$
123
$
167
49
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Three Months Ended
March 31,
$ in millions
2020
2019
Net derivatives: Foreign exchange
Beginning balance
$
(
31
)
$
75
Realized and unrealized gains (losses)
(
62
)
(
113
)
Purchases
3
1
Issuances
(
8
)
—
Settlements
(
8
)
8
Net transfers
(
44
)
34
Ending balance
$
(
150
)
$
5
Unrealized gains (losses)
$
(
164
)
$
3
Net derivatives: Equity
Beginning balance
$
(
1,684
)
$
(
1,485
)
Realized and unrealized gains (losses)
635
(
191
)
Purchases
97
34
Issuances
(
144
)
(
193
)
Settlements
(
167
)
139
Net transfers
(
113
)
(
64
)
Ending balance
$
(
1,376
)
$
(
1,760
)
Unrealized gains (losses)
$
566
$
(
203
)
Net derivatives: Commodity and other
Beginning balance
$
1,612
$
2,052
Realized and unrealized gains (losses)
75
43
Purchases
3
5
Issuances
(
3
)
(
1
)
Settlements
157
(
81
)
Net transfers
5
88
Ending balance
$
1,849
$
2,106
Unrealized gains (losses)
$
22
$
(
25
)
Deposits
Beginning balance
$
179
$
27
Realized and unrealized losses (gains)
(
6
)
6
Issuances
12
24
Settlements
(
5
)
(
1
)
Net transfers
(
63
)
43
Ending balance
$
117
$
99
Unrealized losses (gains)
$
(
6
)
$
6
Nonderivative trading liabilities
Beginning balance
$
37
$
16
Realized and unrealized losses (gains)
(
43
)
(
1
)
Purchases
(
82
)
(
6
)
Sales
52
23
Net transfers
100
11
Ending balance
$
64
$
43
Unrealized losses (gains)
$
(
43
)
$
(
1
)
Other secured financings
Beginning balance
$
109
$
208
Realized and unrealized losses (gains)
(
12
)
4
Issuances
2
—
Settlements
(
115
)
(
7
)
Net transfers
405
(
52
)
Ending balance
$
389
$
153
Unrealized losses (gains)
$
(
12
)
$
4
Three Months Ended
March 31,
$ in millions
2020
2019
Borrowings
Beginning balance
$
4,088
$
3,806
Realized and unrealized losses (gains)
(
897
)
287
Issuances
701
264
Settlements
(
234
)
(
115
)
Net transfers
340
(
467
)
Ending balance
$
3,998
$
3,775
Unrealized losses (gains)
$
(
895
)
$
276
Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA
(
398
)
59
1.
Net transfers in the current quarter include the transfer of
$
857
million
of equity margin loans from Level 2 to Level 3 as the unobservable input became significant.
Level 3 instruments may be hedged with instruments classified in Level 1 and Level 2. The realized and unrealized gains (losses) for assets and liabilities within the Level 3 category presented in the previous tables do not reflect the related realized and unrealized gains (losses) on hedging instruments that have been classified by the Firm within the Level 1 and/or Level 2 categories.
The unrealized gains (losses) during the period for assets and liabilities within the Level 3 category may include changes in fair value during the period that were attributable to both observable and unobservable inputs. Total realized and unrealized gains (losses) are primarily included in Trading revenues in the income statements.
Additionally, in the previous tables, consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements.
March 2020 Form 10-Q
50
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements
Valuation Techniques and Unobservable Inputs
Balance / Range (Average)
1
$ in millions, except inputs
At March 31, 2020
At December 31, 2019
Assets Measured at Fair Value on a Recurring Basis
U.S. Treasury and agency securities
$
99
$
22
Comparable pricing:
Bond price
18 to 117 points (86 points)
N/M
MABS
$
483
$
438
Comparable pricing:
Bond price
0 to 87 points (43 points)
0 to 96 points (47 points)
Loans and lending commitments
$
5,980
$
5,073
Margin loan model:
Discount rate
1% to 10% (2%)
1% to 9% (2%)
Volatility skew
13% to 89% (58%)
15% to 80% (28%)
Credit Spread
12 to 109 bps (41 bps)
9 to 39 bps (19 bps)
Comparable pricing:
Loan price
71 to 100 points (92 points)
69 to 100 points (93 points)
Corporate and other debt
$
1,708
$
1,396
Comparable pricing:
Bond price
10 to 108 points (85 points)
11 to 108 points (84 points)
Discounted cash flow:
Recovery rate
51% to 62% (54% / 51%)
35
%
Option model:
At the money volatility
21
%
21
%
Corporate equities
$
146
$
97
Comparable pricing:
Equity price
100
%
100
%
Investments
$
725
$
858
Discounted cash flow:
WACC
11% to 16% (14%)
8% to 17% (15%)
Exit multiple
7 to 17 times (12 times)
7 to 16 times (11 times)
Market approach:
EBITDA multiple
7 to 22 times (9 times)
7 to 24 times (11 times)
Comparable pricing:
Equity price
50% to 100% (99%)
75% to 100% (99%)
Net derivative and other contracts:
Interest rate
$
873
$
777
Option model:
IR volatility skew
2% to 183% (68% / 70%)
24% to 156% (63% / 59%)
IR curve correlation
46% to 88% (71% / 73%)
47% to 90% (72% / 72%)
Bond volatility
6% to 35% (25% / 25%)
4% to 15% (13% / 14%)
Inflation volatility
24% to 63% (44% / 41%)
24% to 63% (44% / 41%)
IR curve
0
%
1
%
Balance / Range (Average)
1
$ in millions, except inputs
At March 31, 2020
At December 31, 2019
Credit
$
198
$
124
Credit default swap model:
Cash-synthetic basis
6 points
6 points
Bond price
0 to 98 points (52 points)
0 to 104 points (45 points)
Credit spread
20 to 488 bps (114 bps)
9 to 469 bps (81 bps)
Funding spread
204 to 278 bps (267 bps)
47 to 117 bps (84 bps)
Correlation model:
Credit correlation
40% to 78% (50%)
29% to 62% (36%)
Foreign exchange
2
$
(
150
)
$
(
31
)
Option model:
IR - FX correlation
21% to 58% (38% / 38%)
32% to 56% (46% / 46%)
IR volatility skew
2% to 183% (68% / 70%)
24% to 156% (63% / 59%)
IR curve
10
%
10% to 11% (10% / 10%)
Contingency probability
95
%
85% to 95% (94% / 95%)
Equity
2
$
(
1,376
)
$
(
1,684
)
Option model:
At the money volatility
17% to 78% (45%)
9% to 90% (36%)
Volatility skew
-4% to 0% (-1%)
-2% to 0% (-1%)
Equity correlation
5% to 96% (76%)
5% to 98% (70%)
FX correlation
-79% to 55% (-39%)
-79% to 60% (-37%)
IR correlation
-7% to 44% (19% / 18%)
-11% to 44% (18% / 16%)
Commodity and other
$
1,849
$
1,612
Option model:
Forward power price
$1 to $137 ($26) per MWh
$3 to $182 ($28) per MWh
Commodity volatility
8% to 145% (18%)
7% to 183% (18%)
Cross-commodity correlation
5% to 99% (93%)
43% to 99% (93%)
Liabilities Measured at Fair Value on a Recurring Basis
Deposits
$
117
$
179
Option Model:
At the money volatility
7% to 24% (7%)
16% to 37% (20%)
Other secured financings
$
389
$
109
Discounted cash flow:
Funding spread
106 to 161 bps (121 bps)
111 to 124 bps (117 bps)
Comparable pricing:
Loan price
30 to 101 points (86 points)
N/M
Borrowings
$
3,998
$
4,088
Option model:
At the money volatility
5% to 55% (31%)
5% to 44% (21%)
Volatility skew
-2% to 0% (0%)
-2% to 0% (0%)
Equity correlation
39% to 98% (81%)
38% to 94% (78%)
Equity - FX correlation
-75% to 17% (-32%)
-75% to 26% (-25%)
IR - FX Correlation
-27% to 7% (-5% / -5%)
-26% to 10% (-7% / -7%)
51
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Balance / Range (Average)
1
$ in millions, except inputs
At March 31, 2020
At December 31, 2019
Nonrecurring Fair Value Measurement
Loans
$
3,901
$
1,500
Corporate loan model:
Credit spread
44 to 600 bps (367 bps)
69 to 446 bps (225 bps)
Warehouse model:
Credit spread
159 to 743 bps (313 bps)
287 to 318 bps (297 bps)
Points—Percentage of par
IR—Interest rate
FX—Foreign exchange
1.
A single amount is disclosed for range and average when there is no significant difference between the minimum, maximum and average. Amounts represent weighted averages except where simple averages and the median of the inputs are more relevant.
2.
Includes derivative contracts with multiple risks (
i.e.
, hybrid products)
.
The previous tables provide information on the valuation techniques, significant unobservable inputs, and the ranges and averages for each major category of assets and liabilities measured at fair value on a recurring and nonrecurring basis with a significant Level 3 balance. The level of aggregation and breadth of products cause the range of inputs to be wide and not evenly distributed across the inventory of financial instruments. Further, the range of unobservable inputs may differ across firms in the financial services industry because of diversity in the types of products included in each firm’s inventory. There are no predictable relationships between multiple significant unobservable inputs attributable to a given valuation technique.
For a description of the Firm’s significant unobservable inputs and qualitative information about the effect of hypothetical changes in the values of those inputs, see Note 3 to the financial statements in the
2019 Form 10-K
. During the current quarter, there were no significant revisions made to the descriptions of the Firm’s significant unobservable inputs.
Net Asset Value Measurements
Fund Interests
At March 31, 2020
At December 31, 2019
$ in millions
Carrying
Value
Commitment
Carrying
Value
Commitment
Private equity
$
2,219
$
557
$
2,078
$
450
Real estate
1,280
147
1,349
150
Hedge
1
91
—
94
4
Total
$
3,590
$
704
$
3,521
$
604
1.
Investments in hedge funds may be subject to initial period lock-up or gate provisions, which restrict an investor from withdrawing from the fund during a certain initial period or restrict the redemption amount on any redemption date, respectively.
Amounts in the previous table represent the Firm’s carrying value of general and limited partnership interests in fund investments, as well as any related performance-based fees in the form of carried interest. The carrying amounts are measured based on the NAV of the fund taking into account the distribution terms applicable to the interest held. This same measurement applies whether the fund investments are accounted for under the equity method or fair value.
For a description of the Firm’s investments in private equity funds, real estate funds and hedge funds, which are measured based on NAV, see Note 3 to the financial statements in the
2019 Form 10-K
.
See
Note 13
for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received.
See
Note 19
for information regarding unrealized carried interest at risk of reversal.
Nonredeemable Funds by Contractual Maturity
Carrying Value at March 31, 2020
$ in millions
Private Equity
Real Estate
Less than 5 years
$
1,409
$
431
5-10 years
759
173
Over 10 years
51
676
Total
$
2,219
$
1,280
Nonrecurring Fair Value Measurements
Carrying and Fair Values
At March 31, 2020
Fair Value
$ in millions
Level 2
Level 31
Total
Assets
Loans
$
5,823
$
3,901
$
9,724
Liabilities
Other liabilities and accrued expenses—Lending commitments
$
321
$
247
$
568
At December 31, 2019
Fair Value
$ in millions
Level 2
Level 3
1
Total
Assets
Loans
$
1,543
$
1,500
$
3,043
Other assets—Other investments
$
—
$
113
$
113
Total
$
1,543
$
1,613
$
3,156
Liabilities
Other liabilities and accrued expenses—Lending commitments
$
132
$
69
$
201
Total
$
132
$
69
$
201
1.
For significant Level 3 balances, refer to “Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements” section herein for details of the significant unobservable inputs used for nonrecurring fair value measurement.
March 2020 Form 10-Q
52
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Gains (Losses) from Fair Value Remeasurements
1
Three Months Ended
March 31,
$ in millions
2020
2019
Assets
Loans
2
$
(
713
)
$
36
Other assets—Other investments
3
—
(
5
)
Other assets—Premises, equipment and software
4
(
3
)
(
2
)
Total
$
(
716
)
$
29
Liabilities
Other liabilities and accrued expenses—Lending commitments
2
$
(
316
)
$
67
Total
$
(
316
)
$
67
1.
Gains and losses for Loans and Other assets—Other investments are classified in Other revenues. For other items, gains and losses are recorded in Other revenues if the item is held for sale; otherwise, they are recorded in Other expenses.
2.
Nonrecurring changes in the fair value of loans and lending commitments were calculated as follows: for the held-for-investment category, based on the value of the underlying collateral; and for the held-for-sale category, based on recently executed transactions, market price quotations, valuation models that incorporate market observable inputs where possible, such as comparable loan or debt prices and CDS spread levels adjusted for any basis difference between cash and derivative instruments, or default recovery analysis where such transactions and quotations are unobservable.
3.
Losses related to Other assets—Other investments were determined using techniques that included discounted cash flow models, methodologies that incorporate multiples of certain comparable companies and recently executed transactions.
4.
Losses related to Other assets—Premises, equipment and software generally include write-offs related to the disposal of certain assets.
Financial Instruments Not Measured at Fair Value
At March 31, 2020
Carrying
Value
Fair Value
$ in millions
Level 1
Level 2
Level 3
Total
Financial assets
Cash and cash equivalents
$
131,509
$
131,509
$
—
$
—
$
131,509
Investment securities—HTM
47,286
32,207
17,149
777
50,133
Securities purchased under agreements to resell
104,795
—
103,451
1,426
104,877
Securities borrowed
72,300
—
72,303
—
72,303
Customer and other receivables
1
69,923
—
67,086
2,852
69,938
Loans
2
148,697
—
32,529
114,841
147,370
Other assets
461
—
461
—
461
Financial liabilities
Deposits
$
231,187
$
—
$
231,555
$
—
$
231,555
Securities sold under agreements to repurchase
45,041
—
45,077
—
45,077
Securities loaned
11,631
—
11,633
—
11,633
Other secured financings
6,161
—
6,167
—
6,167
Customer and other payables
1
195,211
—
195,211
—
195,211
Borrowings
137,694
—
135,148
10
135,158
Commitment
Amount
Lending commitments
3
$
105,466
$
—
$
1,668
$
1,089
$
2,757
At December 31, 2019
Carrying
Value
Fair Value
$ in millions
Level 1
Level 2
Level 3
Total
Financial assets
Cash and cash equivalents
$
82,171
$
82,171
$
—
$
—
$
82,171
Investment securities—HTM
43,502
30,661
12,683
789
44,133
Securities purchased under agreements to resell
88,220
—
86,794
1,442
88,236
Securities borrowed
106,549
—
106,551
—
106,551
Customer and other receivables
1
51,134
—
48,215
2,872
51,087
Loans
2
130,637
—
22,293
108,059
130,352
Other assets
495
—
495
—
495
Financial liabilities
Deposits
$
188,257
$
—
$
188,639
$
—
$
188,639
Securities sold under agreements to repurchase
53,467
—
53,486
—
53,486
Securities loaned
8,506
—
8,506
—
8,506
Other secured financings
6,889
—
6,800
92
6,892
Customer and other payables
1
195,035
—
195,035
—
195,035
Borrowings
128,166
—
133,563
10
133,573
Commitment
Amount
Lending commitments
3
$
119,004
$
—
$
748
$
338
$
1,086
1.
Accrued interest and dividend receivables and payables have been excluded. Carrying value approximates fair value for these receivables and payables. As of March 31, 2020 and December 31, 2019, accrued interest receivable was
$
2.4
billion
and
$
1.7
billion
, respectively.
2.
Amounts include loans measured at fair value on a nonrecurring basis.
3.
Represents Lending commitments accounted for as Held for Investment and Held for Sale. For a further discussion on lending commitments, see
Note 13
.
The previous tables exclude certain financial instruments such as equity method investments and all non-financial assets and liabilities such as the value of the long-term relationships with the Firm’s deposit customers.
53
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
5
.
Fair Value Option
The Firm has elected the fair value option for certain eligible instruments that are risk managed on a fair value basis to mitigate income statement volatility caused by measurement basis differences between the elected instruments and their associated risk management transactions or to eliminate complexities of applying certain accounting models.
Borrowings Measured at Fair Value on a Recurring Basis
$ in millions
At
March 31,
2020
At
December 31,
2019
Business Unit Responsible for Risk Management
Equity
$
25,089
$
30,214
Interest rates
25,195
27,298
Commodities
4,681
4,501
Credit
1,179
1,246
Foreign exchange
1,018
1,202
Total
$
57,162
$
64,461
Net Revenues from Borrowings under the Fair Value Option
Three Months Ended
March 31,
$ in millions
2020
2019
Trading revenues
$
3,447
$
(
2,903
)
Interest expense
83
93
Net revenues
1
$
3,364
$
(
2,996
)
1.
Amounts do not reflect any gains or losses from related economic hedges.
Gains (losses) from changes in fair value are recorded in Trading revenues and are mainly attributable to movements in the reference price or index, interest rates or foreign exchange rates.
Gains (Losses) Due to Changes in Instrument-Specific Credit Risk
Three Months Ended March 31,
2020
2019
$ in millions
Trading
Revenues
OCI
Trading
Revenues
OCI
Borrowings
$
(
5
)
$
4,948
$
(
4
)
$
(
816
)
Loans and other debt
1
(
281
)
—
93
—
Lending commitments
2
—
(
1
)
—
Deposits
—
72
—
(
4
)
$ in millions
At
March 31,
2020
At
December 31,
2019
Cumulative pre-tax DVA gain (loss) recognized in AOCI
$
3,022
$
(
1,998
)
1.
Loans and other debt instrument-specific credit gains (losses) were determined by excluding the non-credit components of gains and losses.
Difference Between Contractual Principal and Fair Value
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Loans and other debt
2
$
13,654
$
13,037
Nonaccrual loans
2
11,014
10,849
Borrowings
3
798
(
1,665
)
1.
Amounts indicate contractual principal greater than or (less than) fair value.
2.
The majority of the difference between principal and fair value amounts for loans and other debt relates to distressed debt positions purchased at amounts well below par.
3.
Excludes borrowings where the repayment of the initial principal amount fluctuates based on changes in a reference price or index.
The previous tables exclude non-recourse debt from consolidated VIEs, liabilities related to transfers of financial assets treated as collateralized financings, pledged commodities and other liabilities that have specified assets attributable to them.
Fair Value Loans on Nonaccrual Status
$ in millions
At
March 31,
2020
At
December 31,
2019
Nonaccrual loans
$
1,150
$
1,100
Nonaccrual loans 90 or more days past due
$
262
$
330
March 2020 Form 10-Q
54
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
6
.
Derivative Instruments and Hedging Activities
Fair Values of Derivative Contracts
At
March 31, 2020
Assets
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
1,295
$
7
$
—
$
1,302
Foreign exchange
152
83
—
235
Total
1,447
90
—
1,537
Not designated as accounting hedges
Interest rate
252,956
13,730
1,050
267,736
Credit
10,204
3,154
—
13,358
Foreign exchange
109,212
3,191
175
112,578
Equity
44,289
—
51,487
95,776
Commodity and other
17,778
—
4,489
22,267
Total
434,439
20,075
57,201
511,715
Total gross derivatives
$
435,886
$
20,165
$
57,201
$
513,252
Amounts offset
Counterparty netting
(
328,104
)
(
16,673
)
(
54,079
)
(
398,856
)
Cash collateral netting
(
59,531
)
(
1,855
)
—
(
61,386
)
Total in Trading assets
$
48,251
$
1,637
$
3,122
$
53,010
Amounts not offset
1
Financial instruments collateral
(
23,868
)
—
—
(
23,868
)
Other cash collateral
(
83
)
—
—
(
83
)
Net amounts
$
24,300
$
1,637
$
3,122
$
29,059
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
3,984
Liabilities
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
—
$
—
$
—
$
—
Foreign exchange
54
2
—
56
Total
54
2
—
56
Not designated as accounting hedges
Interest rate
245,978
10,698
1,313
257,989
Credit
9,556
3,630
—
13,186
Foreign exchange
109,225
3,336
181
112,742
Equity
39,606
—
53,764
93,370
Commodity and other
13,661
—
4,592
18,253
Total
418,026
17,664
59,850
495,540
Total gross derivatives
$
418,080
$
17,666
$
59,850
$
495,596
Amounts offset
Counterparty netting
(
328,104
)
(
16,673
)
(
54,079
)
(
398,856
)
Cash collateral netting
(
55,307
)
(
564
)
—
(
55,871
)
Total in Trading liabilities
$
34,669
$
429
$
5,771
$
40,869
Amounts not offset
1
Financial instruments collateral
(
8,357
)
—
(
3,825
)
(
12,182
)
Other cash collateral
(
34
)
(
37
)
—
(
71
)
Net amounts
$
26,278
$
392
$
1,946
$
28,616
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
5,601
At
December 31, 2019
Assets
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
673
$
—
$
—
$
673
Foreign exchange
41
1
—
42
Total
714
1
—
715
Not designated as accounting hedges
Interest rate
179,450
4,839
519
184,808
Credit
4,895
2,417
—
7,312
Foreign exchange
62,957
1,399
22
64,378
Equity
27,621
—
23,447
51,068
Commodity and other
9,306
—
1,952
11,258
Total
284,229
8,655
25,940
318,824
Total gross derivatives
$
284,943
$
8,656
$
25,940
$
319,539
Amounts offset
Counterparty netting
(
213,710
)
(
7,294
)
(
24,037
)
(
245,041
)
Cash collateral netting
(
41,222
)
(
1,275
)
—
(
42,497
)
Total in Trading assets
$
30,011
$
87
$
1,903
$
32,001
Amounts not offset
1
Financial instruments collateral
(
15,596
)
—
—
(
15,596
)
Other cash collateral
(
46
)
—
—
(
46
)
Net amounts
$
14,369
$
87
$
1,903
$
16,359
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
1,900
Liabilities
$ in millions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
1
$
—
$
—
$
1
Foreign exchange
121
38
—
159
Total
122
38
—
160
Not designated as accounting hedges
Interest rate
168,597
3,597
436
172,630
Credit
4,798
3,123
—
7,921
Foreign exchange
65,965
1,492
39
67,496
Equity
30,135
—
22,733
52,868
Commodity and other
7,713
—
1,911
9,624
Total
277,208
8,212
25,119
310,539
Total gross derivatives
$
277,330
$
8,250
$
25,119
$
310,699
Amounts offset
Counterparty netting
(
213,710
)
(
7,294
)
(
24,037
)
(
245,041
)
Cash collateral netting
(
36,392
)
(
832
)
—
(
37,224
)
Total in Trading liabilities
$
27,228
$
124
$
1,082
$
28,434
Amounts not offset
1
Financial instruments collateral
(
7,747
)
—
(
287
)
(
8,034
)
Other cash collateral
(
14
)
—
—
(
14
)
Net amounts
$
19,467
$
124
$
795
$
20,386
Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable
$
3,680
1.
Amounts relate to master netting agreements and collateral agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.
See
Note 4
for information related to the unsettled fair value of futures contracts not designated as accounting hedges, which are excluded from the previous tables.
55
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Notionals of Derivative Contracts
At
March 31, 2020
Assets
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
10
$
144
$
—
$
154
Foreign exchange
5
2
—
7
Total
15
146
—
161
Not designated as accounting hedges
Interest rate
4,261
8,028
615
12,904
Credit
173
111
—
284
Foreign exchange
3,054
104
10
3,168
Equity
426
—
453
879
Commodity and other
111
—
72
183
Total
8,025
8,243
1,150
17,418
Total gross derivatives
$
8,040
$
8,389
$
1,150
$
17,579
Liabilities
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
—
$
43
$
—
$
43
Foreign exchange
6
—
—
6
Total
6
43
—
49
Not designated as accounting hedges
Interest rate
5,085
8,023
545
13,653
Credit
164
124
—
288
Foreign exchange
2,981
104
9
3,094
Equity
352
—
541
893
Commodity and other
89
—
69
158
Total
8,671
8,251
1,164
18,086
Total gross derivatives
$
8,677
$
8,294
$
1,164
$
18,135
At
December 31, 2019
Assets
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
14
$
94
$
—
$
108
Foreign exchange
2
—
—
2
Total
16
94
—
110
Not designated as accounting hedges
Interest rate
4,230
7,398
732
12,360
Credit
136
79
—
215
Foreign exchange
2,667
91
10
2,768
Equity
429
—
419
848
Commodity and other
99
—
61
160
Total
7,561
7,568
1,222
16,351
Total gross derivatives
$
7,577
$
7,662
$
1,222
$
16,461
Liabilities
$ in billions
Bilateral
OTC
Cleared
OTC
Exchange-
Traded
Total
Designated as accounting hedges
Interest rate
$
—
$
71
$
—
$
71
Foreign exchange
9
2
—
11
Total
9
73
—
82
Not designated as accounting hedges
Interest rate
4,185
6,866
666
11,717
Credit
153
84
—
237
Foreign exchange
2,841
91
14
2,946
Equity
455
—
515
970
Commodity and other
85
—
61
146
Total
7,719
7,041
1,256
16,016
Total gross derivatives
$
7,728
$
7,114
$
1,256
$
16,098
The Firm believes that the notional amounts of derivative contracts generally overstate its exposure. In most circumstances, notional amounts are used only as a reference point from which to calculate amounts owed between the parties to the contract. Furthermore, notional amounts do not reflect the benefit of legally enforceable netting arrangements or risk mitigating transactions.
For a discussion of the Firm's derivative instruments and hedging activities, see
Note 5
to the financial statements in the
2019 Form 10-K
.
March 2020 Form 10-Q
56
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Gains (Losses) on Accounting Hedges
Three Months Ended
March 31,
$ in millions
2020
2019
Fair value hedges—Recognized in Interest income
Interest rate contracts
$
(
64
)
$
(
5
)
Investment Securities—AFS
65
5
Fair value hedges—Recognized in Interest expense
Interest rate contracts
$
6,667
$
1,577
Deposits
1
(
261
)
—
Borrowings
(
6,432
)
(
1,621
)
Net investment hedges—Foreign exchange contracts
Recognized in OCI
$
410
$
64
Forward points excluded from hedge effectiveness testing—Recognized in Interest income
33
35
Fair Value Hedges—Hedged Items
$ in millions
At
March 31,
2020
At
December 31,
2019
Investment Securities—AFS
Carrying amount
2
currently or previously hedged
$
1,969
$
917
Basis adjustments included in carrying amount
3
$
77
$
14
Deposits
1
Carrying amount
currently or previously hedged
18,335
5,435
Basis adjustments included in carrying amount
3
254
(
7
)
Borrowings
Carrying amount currently or previously hedged
$
109,810
$
102,456
Basis adjustments included in carrying amount
3
$
9,007
$
2,593
1.
The Firm began designating interest rate swaps as fair value hedges of certain Deposits in the fourth quarter of 2019.
2.
Carrying amount represents amortized cost basis for AFS securities.
3.
Hedge accounting basis adjustments are primarily related to outstanding hedges.
Net Derivative Liabilities and Collateral Posted
$ in millions
At
March 31,
2020
At
December 31,
2019
Net derivative liabilities with credit risk-related contingent features
$
33,064
$
21,620
Collateral posted
28,502
17,392
The previous table presents the aggregate fair value of certain derivative contracts that contain credit risk-related contingent features that are in a net liability position for which the Firm has posted collateral in the normal course of business.
Incremental Collateral and Termination Payments upon Potential Future Ratings Downgrade
$ in millions
At
March 31,
2020
One-notch downgrade
$
325
Two-notch downgrade
377
Bilateral downgrade agreements included in the amounts above
1
$
614
1.
Amount represents arrangements between the Firm and other parties where upon the downgrade of one party, the downgraded party must deliver collateral to the other party. These bilateral downgrade arrangements are used by the Firm to manage the risk of counterparty downgrades.
The additional collateral or termination payments that may be called in the event of a future credit rating downgrade vary by contract and can be based on ratings by either or both of Moody’s Investors Service, Inc. (“Moody’s”) and S&P Global Ratings. The previous table shows the future potential collateral amounts and termination payments that could be called or required by counterparties or exchange and clearing organizations in the event of one-notch or two-notch downgrade scenarios based on the relevant contractual downgrade triggers.
Maximum Potential Payout/Notional of Credit Protection Sold
1
Years to Maturity at March 31, 2020
$ in billions
< 1
1-3
3-5
Over 5
Total
Single-name CDS
Investment grade
$
13
$
17
$
34
$
13
$
77
Non-investment grade
9
9
16
5
39
Total
$
22
$
26
$
50
$
18
$
116
Index and basket CDS
Investment grade
$
5
$
8
$
65
$
34
$
112
Non-investment grade
7
5
21
17
50
Total
$
12
$
13
$
86
$
51
$
162
Total CDS sold
$
34
$
39
$
136
$
69
$
278
Other credit contracts
—
—
—
—
—
Total credit protection sold
$
34
$
39
$
136
$
69
$
278
CDS protection sold with identical protection purchased
$
242
Years to Maturity at December 31, 2019
$ in billions
< 1
1-3
3-5
Over 5
Total
Single-name CDS
Investment grade
$
16
$
17
$
33
$
9
$
75
Non-investment grade
9
9
16
1
35
Total
$
25
$
26
$
49
$
10
$
110
Index and basket CDS
Investment grade
$
4
$
7
$
46
$
11
$
68
Non-investment grade
7
4
17
10
38
Total
$
11
$
11
$
63
$
21
$
106
Total CDS sold
$
36
$
37
$
112
$
31
$
216
Other credit contracts
—
—
—
—
—
Total credit protection sold
$
36
$
37
$
112
$
31
$
216
CDS protection sold with identical protection purchased
$
187
57
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Fair Value Asset (Liability) of Credit Protection Sold
1
$ in millions
At
March 31,
2020
At
December 31,
2019
Single-name CDS
Investment grade
$
(
963
)
$
1,057
Non-investment grade
(
3,350
)
(
540
)
Total
$
(
4,313
)
$
517
Index and basket CDS
Investment grade
$
(
693
)
$
1,052
Non-investment grade
(
4,849
)
134
Total
$
(
5,542
)
$
1,186
Total CDS sold
$
(
9,855
)
$
1,703
Other credit contracts
(
4
)
(
17
)
Total credit protection sold
$
(
9,859
)
$
1,686
1.
Investment grade/non-investment grade determination is based on the internal credit rating of the reference obligation. Internal credit ratings serve as the Credit Risk Management Department’s assessment of credit risk and the basis for a comprehensive credit limits framework used to control credit risk. The Firm uses quantitative models and judgment to estimate the various risk parameters related to each obligor.
Protection Purchased with CDS
Notional
$ in billions
At
March 31,
2020
At
December 31,
2019
Single name
$
123
$
118
Index and basket
153
103
Tranched index and basket
18
15
Total
$
294
$
236
Fair Value Asset (Liability)
$ in millions
At
March 31,
2020
At
December 31,
2019
Single name
$
4,152
$
(
723
)
Index and basket
5,176
(
1,139
)
Tranched index and basket
699
(
450
)
Total
$
10,027
$
(
2,312
)
The Firm enters into credit derivatives, principally CDS, under which it receives or provides protection against the risk of default on a set of debt obligations issued by a specified reference entity or entities. A majority of the Firm’s counterparties for these derivatives are banks, broker-dealers, and insurance and other financial institutions.
The fair value amounts as shown in the previous tables are prior to cash collateral or counterparty netting.
For further information on credit derivatives and other contracts, see
Note 5
to the financial statements in the
2019 Form 10-K
.
March 2020 Form 10-Q
58
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
7
.
Investment Securities
AFS and HTM Securities
At March 31, 2020
$ in millions
Amortized
Cost
1
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities
$
34,600
$
1,298
$
—
$
35,898
U.S. agency securities
2
22,687
717
82
23,322
Total U.S. government and agency securities
57,287
2,015
82
59,220
Corporate and other debt:
Agency CMBS
4,765
244
8
5,001
Corporate bonds
1,828
16
35
1,809
State and municipal securities
1,453
48
48
1,453
FFELP student loan ABS
3
1,535
—
147
1,388
Total corporate and other debt
9,581
308
238
9,651
Total AFS securities
66,868
2,323
320
68,871
HTM securities
U.S. government and agency securities:
U.S. Treasury securities
29,951
2,256
—
32,207
U.S. agency securities
2
16,542
607
—
17,149
Total U.S. government and agency securities
46,493
2,863
—
49,356
Corporate and other debt:
Non-agency CMBS
793
4
20
777
Total HTM securities
47,286
2,867
20
50,133
Total investment securities
$
114,154
$
5,190
$
340
$
119,004
At December 31, 2019
$ in millions
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
AFS securities
U.S. government and agency securities:
U.S. Treasury securities
$
32,465
$
224
$
111
$
32,578
U.S. agency securities
2
20,725
249
100
20,874
Total U.S. government and agency securities
53,190
473
211
53,452
Corporate and other debt:
Agency CMBS
4,810
55
57
4,808
Corporate bonds
1,891
17
1
1,907
State and municipal securities
481
22
—
503
FFELP student loan ABS
3
1,580
1
28
1,553
Total corporate and other debt
8,762
95
86
8,771
Total AFS securities
61,952
568
297
62,223
HTM securities
U.S. government and agency securities:
U.S. Treasury securities
30,145
568
52
30,661
U.S. agency securities
2
12,589
151
57
12,683
Total U.S. government and agency securities
42,734
719
109
43,344
Corporate and other debt:
Non-agency CMBS
768
22
1
789
Total HTM securities
43,502
741
110
44,133
Total investment securities
$
105,454
$
1,309
$
407
$
106,356
1.
Amounts are net of any allowance for credit losses.
2.
U.S. agency securities consist mainly of agency-issued debt, agency mortgage pass-through pool securities and CMOs.
3.
Underlying loans are backed by a guarantee, ultimately from the U.S. Department of Education, of at least
95
%
of the principal balance and interest outstanding.
In the current quarter, the Firm transferred certain municipal securities from Trading assets into AFS securities as a result of a change in intent due to the severe deterioration in liquidity for these instruments.
At March 31, 2020
, these securities had a fair value of
$
441
million
.
59
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
I
nvestment Securities in an Unrealized Loss Position
At March 31, 2020
Less than 12 Months
12 Months or Longer
Total
$ in millions
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
AFS securities
U.S. agency securities
$
931
$
7
$
3,892
$
75
$
4,823
$
82
Corporate and other debt:
Agency CMBS
30
—
670
8
700
8
Corporate bonds
747
24
58
11
805
35
State and municipal securities
678
48
—
—
678
48
FFELP student loan ABS
349
29
1,038
118
1,387
147
Total corporate and other debt
1,804
101
1,766
137
3,570
238
Total AFS securities
$
2,735
$
108
$
5,658
$
212
$
8,393
$
320
At December 31, 2019
Less than 12 Months
12 Months or Longer
Total
$ in millions
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
Fair Value
Gross
Unrealized
Losses
AFS securities
U.S. government and agency securities:
U.S. Treasury securities
$
4,793
$
28
$
7,904
$
83
$
12,697
$
111
U.S. agency securities
2,641
20
7,697
80
10,338
100
Total U.S. government and agency securities
7,434
48
15,601
163
23,035
211
Corporate and other debt:
Agency CMBS
2,294
26
681
31
2,975
57
Corporate bonds
194
1
44
—
238
1
FFELP student loan ABS
91
—
1,165
28
1,256
28
Total corporate and other debt
2,579
27
1,890
59
4,469
86
Total AFS securities
10,013
75
17,491
222
27,504
297
HTM securities
U.S. government and agency securities:
U.S. Treasury securities
6,042
52
651
—
6,693
52
U.S. agency securities
2,524
18
2,420
39
4,944
57
Total U.S. government and agency securities
8,566
70
3,071
39
11,637
109
Corporate and other debt:
Non-agency CMBS
167
1
65
—
232
1
Total HTM securities
8,733
71
3,136
39
11,869
110
Total investment securities
$
18,746
$
146
$
20,627
$
261
$
39,373
$
407
For AFS securities, t
he Firm believes there are no securities in an unrealized loss position that have credit losses after performing the analysis described in
Note 2
.
Additionally, the Firm does not intend to sell the securities and is not likely to be required to sell the securities prior to recovery of the amortized cost basis. Furthermore, the securities have not experienced credit losses as they are predominantly investment-grade and the Firm expects to recover the amortized cost basis.
As of March 31, 2020, the HTM securities net carrying amount reflects an amortized cost of
$
47,312
million
less an allowance for credit losses of
$
26
million
related to Non-agency CMBS. See Note 2 for a description of the ACL methodology used beginning in 2020 following the Firm's adoption of CECL and see Note 2 to the financial statements in the 2019 Form 10-K for prior period credit loss considerations. There were no securities in an unrealized loss position as of December 31, 2019 that had credit losses. As of March 31, 2020, and December 31, 2019, Non-Agency CMBS HTM securities were all on accrual status and were predominantly investment-grade.
See
Note 14
for additional information on securities issued by VIEs, including U.S. agency mortgage-backed securities, non-agency CMBS and FFELP student loan ABS
.
March 2020 Form 10-Q
60
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Investment Securities by Contractual Maturity
At March 31, 2020
$ in millions
Amortized
Cost
1
Fair
Value
Annualized
Average
Yield
AFS securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year
$
3,728
$
3,770
2.0
%
After 1 year through 5 years
27,748
28,791
1.7
%
After 5 years through 10 years
3,124
3,337
1.6
%
Total
34,600
35,898
U.S. agency securities:
Due within 1 year
235
236
0.8
%
After 1 year through 5 years
78
78
1.4
%
After 5 years through 10 years
1,293
1,322
1.8
%
After 10 years
21,081
21,686
2.3
%
Total
22,687
23,322
Total U.S. government and agency securities
57,287
59,220
1.9
%
Corporate and other debt:
Agency CMBS:
After 1 year through 5 years
599
605
1.8
%
After 5 years through 10 years
3,273
3,488
2.5
%
After 10 years
893
908
2.0
%
Total
4,765
5,001
Corporate bonds:
Due within 1 year
44
44
2.3
%
After 1 year through 5 years
1,439
1,439
2.6
%
After 5 years through 10 years
345
326
2.9
%
Total
1,828
1,809
State and municipal securities:
After 1 year through 5 years
2
2
3.4
%
After 5 years through 10 years
139
142
3.1
%
After 10 Years
1,312
1,309
2.8
%
Total
1,453
1,453
FFELP student loan ABS:
After 1 year through 5 years
98
87
0.8
%
After 5 years through 10 years
307
270
0.9
%
After 10 years
1,130
1,031
1.2
%
Total
1,535
1,388
Total corporate and other debt
9,581
9,651
2.3
%
Total AFS securities
66,868
68,871
2.0
%
At March 31, 2020
$ in millions
Amortized
Cost
1
Fair
Value
Annualized
Average
Yield
HTM securities
U.S. government and agency securities:
U.S. Treasury securities:
Due within 1 year
3,282
3,332
2.6
%
After 1 year through 5 years
17,769
18,733
2.0
%
After 5 years through 10 years
7,818
8,777
2.2
%
After 10 years
1,082
1,365
2.5
%
Total
29,951
32,207
U.S. agency securities:
After 5 years through 10 years
50
51
1.8
%
After 10 years
16,492
17,098
2.4
%
Total
16,542
17,149
Total U.S. government and agency securities
46,493
49,356
2.2
%
Corporate and other debt:
Non-agency CMBS:
Due within 1 year
100
99
4.8
%
After 1 year through 5 years
107
104
3.7
%
After 5 years through 10 years
549
536
3.9
%
After 10 years
37
38
4.4
%
Total corporate and other debt
793
777
4.0
%
Total HTM securities
47,286
50,133
2.3
%
Total investment securities
$
114,154
$
119,004
2.1
%
1.
Amounts are net of any allowance for credit losses.
Gross Realized Gains (Losses) on Sales of AFS Securities
Three Months Ended
March 31,
$ in millions
2020
2019
Gross realized gains
$
49
$
19
Gross realized (losses)
(
8
)
(
9
)
Total
1
$
41
$
10
1.
Realized gains and losses are recognized in Other revenues in the income statements
.
61
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
8
.
Collateralized Transactions
Offsetting of Certain Collateralized Transactions
At March 31, 2020
$ in millions
Gross
Amounts
Amounts
Offset
Net
Amounts
Presented
Amounts
Not Offset
1
Net
Amounts
Assets
Securities purchased under agreements to resell
$
249,124
$
(
144,324
)
$
104,800
$
(
98,800
)
$
6,000
Securities borrowed
76,276
(
3,976
)
72,300
(
67,384
)
4,916
Liabilities
Securities sold under agreements to repurchase
$
189,937
$
(
144,121
)
$
45,816
$
(
39,114
)
$
6,702
Securities loaned
15,810
(
4,179
)
11,631
(
11,241
)
390
Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell
$
5,403
Securities borrowed
1,010
Securities sold under agreements to repurchase
5,325
Securities loaned
134
At December 31, 2019
$ in millions
Gross
Amounts
Amounts
Offset
Net
Amounts
Presented
Amounts
Not Offset
1
Net
Amounts
Assets
Securities purchased under agreements to resell
$
247,545
$
(
159,321
)
$
88,224
$
(
85,200
)
$
3,024
Securities borrowed
109,528
(
2,979
)
106,549
(
101,850
)
4,699
Liabilities
Securities sold under agreements to repurchase
$
213,519
$
(
159,319
)
$
54,200
$
(
44,549
)
$
9,651
Securities loaned
11,487
(
2,981
)
8,506
(
8,324
)
182
Net amounts for which master netting agreements are not in place or may not be legally enforceable
Securities purchased under agreements to resell
$
2,255
Securities borrowed
1,181
Securities sold under agreements to repurchase
8,033
Securities loaned
101
1.
Amounts relate to master netting agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance.
For further discussion of the Firm’s collateralized transactions, see
Note 7
to the financial statements in the
2019 Form 10-K
. For information related to offsetting of derivatives, see
Note 6
.
Gross Secured Financing Balances by Remaining Contractual Maturity
At March 31, 2020
$ in millions
Overnight
and Open
Less than
30 Days
30-90
Days
Over
90 Days
Total
Securities sold under agreements to repurchase
$
65,591
$
60,940
$
25,746
$
37,660
$
189,937
Securities loaned
6,824
214
2,034
6,738
15,810
Total included in the offsetting disclosure
$
72,415
$
61,154
$
27,780
$
44,398
$
205,747
Trading liabilities—
Obligation to return securities received as collateral
15,270
—
—
—
15,270
Total
$
87,685
$
61,154
$
27,780
$
44,398
$
221,017
At December 31, 2019
$ in millions
Overnight
and Open
Less than
30 Days
30-90
Days
Over
90 Days
Total
Securities sold under agreements to repurchase
$
67,158
$
81,300
$
26,904
$
38,157
$
213,519
Securities loaned
2,378
3,286
516
5,307
11,487
Total included in the offsetting disclosure
$
69,536
$
84,586
$
27,420
$
43,464
$
225,006
Trading liabilities—
Obligation to return securities received as collateral
23,877
—
—
—
23,877
Total
$
93,413
$
84,586
$
27,420
$
43,464
$
248,883
Gross Secured Financing Balances by Class of Collateral Pledged
$ in millions
At
March 31,
2020
At
December 31,
2019
Securities sold under agreements to repurchase
U.S. Treasury and agency securities
$
77,557
$
68,895
State and municipal securities
689
905
Other sovereign government obligations
88,871
109,414
ABS
2,278
2,218
Corporate and other debt
7,369
6,066
Corporate equities
12,710
25,563
Other
463
458
Total
$
189,937
$
213,519
Securities loaned
Other sovereign government obligations
$
4,876
$
3,026
Corporate equities
10,277
8,422
Other
657
39
Total
$
15,810
$
11,487
Total included in the offsetting disclosure
$
205,747
$
225,006
Trading liabilities—Obligation to return securities received as collateral
Corporate equities
$
15,263
$
23,873
Other
7
4
Total
$
15,270
$
23,877
Total
$
221,017
$
248,883
March 2020 Form 10-Q
62
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge
$ in millions
At
March 31,
2020
At
December 31,
2019
Trading assets
$
40,345
$
41,201
Loans (before allowance for credit losses)
1,158
750
Total
$
41,503
$
41,951
The Firm pledges certain of its trading assets and loans to collateralize securities sold under agreements to repurchase, securities loaned, other secured financings and derivatives and to cover customer short sales. Counterparties may or may not have the right to sell or repledge the collateral.
Pledged financial instruments that can be sold or repledged by the secured party are identified as Trading assets (pledged to various parties) in the balance sheets.
Fair Value of Collateral Received with Right to Sell or Repledge
$ in millions
At
March 31,
2020
At
December 31,
2019
Collateral received with right to sell
or repledge
$
604,450
$
679,280
Collateral that was sold or repledged
1
483,708
539,412
1.
Does not include securities used to meet federal regulations for the Firm’s U.S. broker-dealers.
Segregated Securities
$ in millions
At
March 31,
2020
At
December 31,
2019
Segregated securities
1
35,491
25,061
1.
Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are sourced from Securities purchased under agreements to resell and Trading assets in the balance sheets.
The Firm receives collateral in the form of securities in connection with securities purchased under agreements to resell, securities borrowed, securities-for-securities transactions, derivative transactions, customer margin loans and securities-based lending. In many cases, the Firm is permitted to sell or repledge this collateral to secure securities sold under agreements to repurchase, to enter into securities lending and derivative transactions or for delivery to counterparties to cover short positions.
Customer Margin Lending
$ in millions
At
March 31,
2020
At
December 31,
2019
Customer receivables representing margin loans
$
26,181
$
31,916
The Firm provides margin lending arrangements which allow customers to borrow against the value of qualifying securities. Receivables under margin lending arrangements are included
within Customer and other receivables in the balance sheets. Under these agreements and transactions, the Firm receives collateral, which includes U.S. government and agency securities, other sovereign government obligations, corporate and other debt, and corporate equities. Customer receivables generated from margin lending activities are collateralized by customer-owned securities held by the Firm. The Firm monitors required margin levels and established credit terms daily and, pursuant to such guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary.
For a further discussion of the Firm’s margin lending activities, see
Note 7
to the financial statements in the
2019 Form 10-K
.
The Firm has additional secured liabilities. For a further discussion of other secured financings, see
Note 12
.
9
.
Loans, Lending Commitments and Related Allowance for Credit Losses
Loans by Type
At March 31, 2020
$ in millions
Loans Held
for Investment
Loans Held
for Sale
Total Loans
Corporate
1
$
61,474
$
15,525
$
76,999
Consumer
2
31,948
—
31,948
Residential real estate
31,100
14
31,114
Commercial real estate
7,430
1,823
9,253
Total loans, before allowance
131,952
17,362
149,314
Allowance for credit losses
(
617
)
—
(
617
)
Total loans, net
$
131,335
$
17,362
$
148,697
Fixed rate loans, net
$
25,155
Floating or adjustable rate loans, net
123,542
Loans to non-U.S. borrowers, net
24,633
63
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
At December 31, 2019
$ in millions
Loans Held
for Investment
Loans Held
for Sale
Total Loans
Corporate
1
$
48,756
$
10,515
$
59,271
Consumer
2
31,610
—
31,610
Residential real estate
30,184
13
30,197
Commercial real estate
7,859
2,049
9,908
Total loans, before allowance
118,409
12,577
130,986
Allowance for credit losses
(
349
)
—
(
349
)
Total loans, net
$
118,060
$
12,577
$
130,637
Fixed rate loans, net
$
22,716
Floating or adjustable rate loans, net
107,921
Loans to non-U.S. borrowers, net
21,617
1.
Institutional Securities business segment Corporate loans include relationship and event-driven loans, secured lending facilities and securities-based lending and other loans. Wealth Management business segment Corporate loans include securities-based and other loans, which are classified as Corporate based on the nature of the borrowing entity or the intended use of the loan proceeds.
2.
Wealth Management business segment Consumer loans include securities-based lending and other loans.
Loans Held for Investment before Allowance by Origination Year
At March 31, 2020
Corporate
$ in millions
AA-A
BBB
BB
Other NIG
Total
Revolving Loans
$
3,418
$
16,474
$
19,772
$
8,193
$
47,857
2020 YTD
122
671
456
23
1,272
2019
631
1,234
1,940
444
4,249
2018
37
2,083
1,096
493
3,709
2017
358
639
500
82
1,579
2016
74
547
505
60
1,186
Prior
641
311
595
75
1,622
Total
$
5,281
$
21,959
$
24,864
$
9,370
$
61,474
At March 31, 2020
$ in millions
Consumer
1
Revolving Loans
$
31,362
2020 YTD
62
2019
382
2018
—
2017
16
2016
57
Prior
69
Total
$
31,948
1.
Consumer loans primarily comprise securities-based loans, which are subject to collateral maintenance provisions, and at March 31, 2020, these loans are predominantly over-collateralized. For more information on the ACL methodology related to Consumer loans, see Note 2.
At March 31, 2020
Residential Real Estate
by FICO Scores
by LTV Ratio
Total
$ in millions
≥ 740
680-739
≤ 679
≤ 80%
> 80%
Revolving Loans
$
103
$
40
$
6
$
149
$
—
$
149
2020 YTD
1,865
369
35
2,143
126
2,269
2019
6,239
1,397
179
7,290
525
7,815
2018
2,699
770
90
3,277
282
3,559
2017
3,248
817
116
3,882
299
4,181
2016
3,924
1,074
152
4,804
346
5,150
Prior
5,659
1,963
355
7,101
876
7,977
Total
$
23,737
$
6,430
$
933
$
28,646
$
2,454
$
31,100
At March 31, 2020
Commercial Real Estate
$ in millions
AA-A
BBB
BB
Other NIG
Total
Revolving Loans
$
5
$
—
$
—
$
—
$
5
2020 YTD
—
—
167
23
190
2019
—
539
2,056
360
2,955
2018
10
723
764
421
1,918
2017
—
217
577
344
1,138
2016
134
100
352
172
758
Prior
10
—
285
171
466
Total
$
159
$
1,579
$
4,201
$
1,491
$
7,430
YTD–Year to date
Past Due Status of Loans Held for Investment before Allowance
At March 31, 2020
$ in millions
Corporate
Consumer
Residential Real Estate
Commercial Real Estate
Current
$
61,466
$
31,948
$
30,883
$
7,430
Past due
1
8
—
217
—
Total
$
61,474
$
31,948
$
31,100
$
7,430
1.
The majority of the amounts are less than 60 days past due as of March 31, 2020.
See Note 2 for a description of the ACL calculated under the CECL methodology, including credit quality indicators, used for HFI loans beginning in 2020.
Loans Held for Investment before Allowance
1
At December 31, 2019
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial
Real Estate
Total
Pass
$
47,681
$
31,605
$
30,060
$
7,664
$
117,010
Special mention
464
—
28
3
495
Substandard
605
5
96
192
898
Doubtful
6
—
—
—
6
Total
$
48,756
$
31,610
$
30,184
$
7,859
$
118,409
1.
There were
no
loans held for investment considered Loss as of December 31, 2019.
March 2020 Form 10-Q
64
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Impaired Loans and Lending Commitments before Allowance
At December 31, 2019
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial Real Estate
Total
Loans
With allowance
$
268
$
—
$
—
$
85
$
353
Without allowance
1
32
5
87
—
124
Total impaired loans
$
300
$
5
$
87
$
85
$
477
UPB
309
5
90
85
489
Lending commitments
With allowance
$
4
$
—
$
—
$
14
$
18
Without allowance
1
32
—
—
—
32
Total impaired lending commitments
$
36
$
—
$
—
$
14
$
50
1.
No allowance was recorded for these loans and lending commitments as the present value of the expected future cash flows or value of the collateral equaled or exceeded the carrying value.
Loans and lending commitments in the previous table were evaluated for a specific allowance. All remaining loans and lending commitments were assessed under the inherent allowance methodology.
Impaired Loans before Allowance and Total Allowance by Region
At December 31, 2019
$ in millions
Americas
EMEA
Asia
Total
Impaired loans
$
392
$
85
$
—
$
477
Total Allowance for credit losses
270
76
3
349
Troubled Debt Restructurings
$ in millions
At
March 31,
2020
At
December 31,
2019
Loans, before allowance
$
132
$
92
Lending commitments
33
32
Allowance for credit losses on Loans and Lending commitments
26
16
Troubled debt restructurings typically include modifications of interest rates, collateral requirements, other loan covenants and payment extensions. As of December 31, 2019, impaired loans and lending commitments classified as held for investment within corporate loans include TDRs.
See Note 2 for further information on TDR guidance issued by Congress in the CARES Act as well as by the U.S. banking agencies.
For a discussion of the Firm’s ACL methodology under the prior incurred loss model, including credit quality indicators, used for HFI loans as of December 31, 2019, and a further discussion of the Firm's loans, including loan types and categories, see Notes 2 and 8 in the 2019 Form 10-K.
Allowance for Credit Losses Rollforward—Loans
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial
Real Estate
Total
December 31, 2019
$
241
$
8
$
25
$
75
$
349
Effect of CECL adoption
(
31
)
(
6
)
21
25
9
Gross charge-offs
(
32
)
—
—
—
(
32
)
Provision (release)
215
1
1
75
292
Other
—
—
—
(
1
)
(
1
)
March 31, 2020
$
393
$
3
$
47
$
174
$
617
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial
Real Estate
Total
December 31, 2018
$
144
$
7
$
20
$
67
$
238
Provision (release)
26
(
1
)
2
—
27
Other
(
6
)
—
—
—
(
6
)
March 31, 2019
$
164
$
6
$
22
$
67
$
259
Inherent
$
150
$
6
$
22
$
67
$
245
Specific
14
—
—
—
14
Allowance for Credit Losses Rollforward—Lending Commitments
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial
Real Estate
Total
December 31, 2019
$
232
$
2
$
—
$
7
$
241
Effect of CECL adoption
(
53
)
(
1
)
3
1
(
50
)
Provision (release)
110
—
—
5
115
Other
(
1
)
—
—
(
1
)
(
2
)
March 31, 2020
$
288
$
1
$
3
$
12
$
304
$ in millions
Corporate
Consumer
Residential
Real Estate
Commercial
Real Estate
Total
December 31, 2018
$
198
$
2
$
—
$
3
$
203
Provision (release)
8
—
—
1
9
Other
—
(
1
)
—
—
(
1
)
March 31, 2019
$
206
$
1
$
—
$
4
$
211
Inherent
$
202
$
1
$
—
$
4
$
207
Specific
4
—
—
—
4
The aggregate allowance for loans and lending commitments
increased
in the current quarter
, principally reflecting a provision for credit losses within the Institutional Securities business segment resulting from the economic impact of COVID-19. This provision was primarily the result of higher actual and expected future downgrades, an increase in funded balances, principally in Corporate relationship and event-driven loans, as well as revisions to our forecasts in light of current and expected future market and macroeconomic conditions
. For a further discussion of the Firm’s loans, including loan types and categories, as well as the Firm’s allowance methodology prior to the adoption of CECL, refer to
Notes 2
and
8
to the financial statements in the
2019 Form 10-K
. See
Note 4
for further
65
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
information regarding Loans and lending commitments held at fair value. See
Note 13
for details of current commitments to lend in the future.
Employee Loans
$ in millions
At
March 31,
2020
At
December 31,
2019
Currently employed by the Firm
1
$
2,867
N/A
No longer employed by the Firm
2
150
N/A
Balance
$
3,017
$
2,980
Allowance for credit losses
3
(
180
)
(
61
)
Balance, net
$
2,837
$
2,919
Remaining repayment term, weighted average in years
5.0
4.8
1.
These loans are predominantly current.
2.
These loans are predominantly past due for a period of 90 days or more.
3.
The change in Allowance for credit losses includes a
$
124
million
increase due to the adoption of CECL in the first quarter of 2020.
Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives, are full recourse and generally require periodic repayments, and are due in full upon termination of employment with the Firm. These loans are recorded in Customer and other receivables in the balance sheets.
The allowance for credit losses as of March 31, 2020 was calculated under the CECL methodology, while the allowance for credit losses at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 for a description of the CECL allowance methodology, including credit quality indicators, for employee loans.
March 2020 Form 10-Q
66
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
10
.
Other Assets—Equity Method Investments
Equity Method Investments
$ in millions
At
March 31,
2020
At
December 31,
2019
Investments
$
2,413
$
2,363
Three Months Ended
March 31,
$ in millions
2020
2019
Income (loss)
$
29
$
(
10
)
Equity method investments, other than investments in certain fund interests, are summarized above and are included in Other assets in the balance sheets with related income or loss included in Other revenues in the income statements.
See “Net Asset Value Measurements—Fund Interests” in
Note 4
for the carrying value of certain of the Firm’s fund interests, which are comprised of general and limited partnership interests, as well as any related carried interest.
Japanese Securities Joint Venture
Three Months Ended
March 31,
$ in millions
2020
2019
Income (loss) from investment in MUMSS
$
32
$
3
The Firm and Mitsubishi UFJ Financial Group, Inc. (“MUFG”) formed a joint venture in Japan comprising their respective investment banking and securities businesses by forming two joint venture companies, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (“MUMSS”) and Morgan Stanley MUFG Securities Co., Ltd. (“MSMS”) (the “Joint Venture”). The Firm owns a
40
%
economic interest in the Joint Venture and MUFG owns the other
60
%
.
The Firm’s
40
%
voting interest in MUMSS is accounted for under the equity method within the Institutional Securities business segment, and is included in the equity method investment balances above. The Firm consolidates MSMS into the Institutional Securities business segment, based on its
51
%
voting interest.
The Firm engages in transactions in the ordinary course of business with MUFG and its affiliates, for example investment banking, financial advisory, sales and trading, derivatives, investment management, lending, securitization and other financial services transactions. Such transactions are on substantially the same terms as those that would be available to unrelated third parties for comparable transactions.
11
.
Deposits
Deposits
$ in millions
At
March 31,
2020
At
December 31,
2019
Savings and demand deposits
$
188,504
$
149,465
Time deposits
46,735
40,891
Total
$
235,239
$
190,356
Deposits subject to FDIC insurance
$
176,034
$
149,966
Time deposits that equal or exceed the FDIC insurance limit
$
12
$
12
Time Deposit Maturities
$ in millions
At
March 31,
2020
2020
$
16,656
2021
16,836
2022
4,883
2023
4,070
2024
2,788
Thereafter
1,502
Total
$
46,735
12
.
Borrowings and Other Secured Financings
Borrowings
$ in millions
At
March 31,
2020
At
December 31,
2019
Original maturities of one year or less
$
2,211
$
2,567
Original maturities greater than one year
Senior
$
181,477
$
179,519
Subordinated
11,168
10,541
Total
$
192,645
$
190,060
Total borrowings
$
194,856
$
192,627
Weighted average stated maturity, in years
1
7.6
6.9
1.
Only includes borrowings with original maturities greater than one year.
67
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Other Secured Financings
$ in millions
At
March 31,
2020
At
December 31,
2019
Original maturities:
One year or less
$
7,304
$
7,103
Greater than one year
4,682
6,480
Transfers of assets accounted for as secured financings
1,072
1,115
Total
$
13,058
$
14,698
Other secured financings include the liabilities related to certain ELNs, transfers of financial assets that are accounted for as financings rather than sales, pledged commodities, consolidated VIEs where the Firm is deemed to be the primary beneficiary and other secured borrowings. These liabilities are generally payable from the cash flows of the related assets accounted for as Trading assets.
See
Note 14
for further information on other secured financings related to VIEs and securitization activities.
For transfers of assets that fail to meet accounting criteria for a sale, the Firm continues to record the assets and recognizes the associated liabilities in the balance sheets.
13
.
Commitments, Guarantees and Contingencies
Commitments
Years to Maturity at March 31, 2020
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Lending:
Corporate
$
23,055
$
28,998
$
41,269
$
3,174
$
96,496
Consumer
8,112
23
3
—
8,138
Residential and commercial
real estate
163
1,179
49
252
1,643
Forward-starting secured financing receivables
80,666
219
—
—
80,885
Central counterparty
1
300
—
—
12,344
12,644
Underwriting
206
—
—
—
206
Investment activities
992
226
58
265
1,541
Letters of credit and other financial guarantees
174
2
—
2
178
Total
$
113,668
$
30,647
$
41,379
$
16,037
$
201,731
Corporate lending commitments participated to third parties
$
7,226
Forward-starting secured financing receivables settled within three business days
$
71,096
1.
Beginning in the first quarter of 2020, commitments to central counterparties are presented separately; these commitments were previously included in Corporate Lending commitments and Forward-starting secured financing receivables depending on the type of agreement. These commitments relate to the Firm's membership in certain clearinghouses and are contingent upon the default of a clearinghouse member or other stress events.
Since commitments associated with these instruments may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements.
For a further description of these commitments, refer to
Note 13
to the financial statements in the
2019 Form 10-K
.
Guarantees
Maximum Potential Payout/Notional of Obligations under Guarantee Arrangements
Years to Maturity at March 31, 2020
$ in millions
Less than 1
1-3
3-5
Over 5
Total
Credit derivatives
$
33,900
$
38,934
$
136,167
$
68,581
$
277,582
Other credit contracts
—
—
—
107
107
Non-credit derivatives
1,571,566
1,474,498
902,550
769,204
4,717,818
Standby letters of credit and other financial guarantees issued
1
1,200
1,006
1,301
3,840
7,347
Market value guarantees
102
35
—
—
137
Liquidity facilities
4,047
—
—
—
4,047
Whole loan sales guarantees
—
—
2
23,193
23,195
Securitization representations and warranties
—
—
—
68,881
68,881
General partner guarantees
59
137
12
92
300
Client clearing guarantees
17
—
—
—
17
$ in millions
Carrying Amount Asset (Liability)
Credit derivatives
2
$
(
9,855
)
Other credit contracts
(
4
)
Non-credit derivatives
2
(
146,854
)
Standby letters of credit and other financial guarantees issued
1
111
Market value guarantees
—
Liquidity facilities
6
Whole loan sales guarantees
—
Securitization representations and warranties
3
(
42
)
General partner guarantees
(
62
)
Client clearing guarantees
—
1.
These amounts include certain issued standby letters of credit participated to third parties, totaling
$
0.7
billion
of notional and collateral/recourse, due to the nature of the Firm’s obligations under these arrangements.
As of March 31, 2020, the carrying amount of standby letters of credit and other financial guarantees issued includes an allowance for credit losses of
$
57
million
.
2.
The carrying amounts of derivative contracts that meet the accounting definition of a guarantee are shown on a gross basis.
For further information on derivatives contracts, see
Note 6
.
3.
Primarily related to residential mortgage securitizations.
The Firm has obligations under certain guarantee arrangements, including contracts and indemnification agreements, that contingently require the Firm to make payments to the guaranteed party based on changes in an underlying measure (such as an interest or foreign exchange rate, security or commodity price, an index, or the occurrence or non-occurrence of a specified event) related to an asset, liability or equity security of a guaranteed party. Also included as guarantees are
March 2020 Form 10-Q
68
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
contracts that contingently require the Firm to make payments to the guaranteed party based on another entity’s failure to perform under an agreement, as well as indirect guarantees of the indebtedness of others.
Client Clearing Guarantees.
In the first quarter of 2020, FICC’s sponsored clearing model was updated such that the Firm could be responsible for liquidation of a sponsored member’s account and guarantees any resulting loss to the FICC in the event the sponsored member fails to fully pay any net liquidation amount due from the sponsored member to the FICC. Accordingly, the Firm’s maximum potential payout amount as of March 31, 2020 reflects the total of the estimated net liquidation amounts for sponsored member accounts.
For more information on the nature of the obligations and related business activities for our guarantees, see
Note 13
to the financial statements in the
2019 Form 10-K
.
Other Guarantees and Indemnities
In the normal course of business, the Firm provides guarantees and indemnifications in a variety of transactions. These provisions generally are standard contractual terms. Certain of these guarantees and indemnifications related to indemnities, exchange and clearinghouse member guarantees and merger and acquisition guarantees are described in
Note 13
to the financial statements in the
2019 Form 10-K
.
In addition, in the ordinary course of business, the Firm guarantees the debt and/or certain trading obligations (including obligations associated with derivatives, foreign exchange contracts and the settlement of physical commodities) of certain subsidiaries. These guarantees generally are entity or product specific and are required by investors or trading counterparties. The activities of the Firm’s subsidiaries covered by these guarantees (including any related debt or trading obligations) are included in the financial statements.
Finance Subsidiary
The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary.
Contingencies
Legal
In addition to the matters described in the following paragraphs, in the normal course of business, the Firm has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with its activities as a global diversified financial services institution. Certain of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of
damages. In some cases, the entities that would otherwise be the primary defendants in such cases are bankrupt or are in financial distress. These actions have included, but are not limited to, residential mortgage and credit crisis-related matters.
While the Firm has identified below any individual proceedings where the Firm believes a material loss to be reasonably possible and reasonably estimable, there can be no assurance that material losses will not be incurred from claims that have not yet been asserted or are not yet determined to be probable or possible and reasonably estimable losses.
The Firm contests liability and/or the amount of damages as appropriate in each pending matter. Where available information indicates that it is probable a liability had been incurred at the date of the financial statements and the Firm can reasonably estimate the amount of that loss, the Firm accrues the estimated loss by a charge to income.
In many proceedings and investigations, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss.
For certain legal proceedings and investigations, the Firm cannot reasonably estimate such losses, particularly for proceedings and investigations where the factual record is being developed or contested or where plaintiffs or government entities seek substantial or indeterminate damages, restitution, disgorgement or penalties. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, determination of issues related to class certification and the calculation of damages or other relief, and by addressing novel or unsettled legal questions relevant to the proceedings or investigations in question, before a loss or additional loss or range of loss or additional range of loss can be reasonably estimated for a proceeding or investigation.
For certain other legal proceedings and investigations, the Firm can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued but does not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on the Firm’s financial statements as a whole, other than the matters referred to in the following paragraphs.
On
July 15, 2010
, China Development Industrial Bank (“CDIB”) filed a complaint against the Firm, styled
China
Development Industrial Bank v. Morgan Stanley & Co. Incorporated et al.
, which is pending in the Supreme Court of the State of New York, New York County (“Supreme Court of
69
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
NY”). The complaint relates to a
$
275
million
CDS referencing the super senior portion of the STACK 2006-1 CDO. The complaint asserts claims for common law fraud, fraudulent inducement and fraudulent concealment and alleges that the Firm misrepresented the risks of the STACK 2006-1 CDO to CDIB, and that the Firm knew that the assets backing the CDO were of poor quality when it entered into the CDS with CDIB. The complaint seeks compensatory damages related to the approximately
$
228
million
that CDIB alleges it has already lost under the CDS, rescission of CDIB’s obligation to pay an additional
$
12
million
, punitive damages, equitable relief, fees and costs. On February 28, 2011, the court denied the Firm’s motion to dismiss the complaint. On December 21, 2018, the court denied the Firm’s motion for summary judgment and granted in part the Firm’s motion for sanctions relating to spoliation of evidence. On January 24, 2019, CDIB filed a notice of appeal from the court’s December 21, 2018 order, and on January 25, 2019, the Firm filed a notice of appeal from the same order. On March 7, 2019, the court denied the relief that CDIB sought in a motion to clarify and resettle the portion of the court’s December 21, 2018 order granting spoliation sanctions. On December 5, 2019, the Appellate Division, First Department (“First Department”) heard the parties’ cross appeals. Based on currently available information, the Firm believes it could incur a loss in this action of up to approximately
$
240
million
plus pre- and post-judgment interest, fees and costs.
On
July 8, 2013
, U.S. Bank National Association, in its capacity as trustee, filed a complaint against the Firm styled
U.S. Bank National Association, solely in its capacity as
Trustee of the Morgan Stanley Mortgage Loan Trust 2007-2AX (MSM 2007-2AX) v. Morgan Stanley Mortgage Capital Holdings LLC, Successor-by-Merger to Morgan
Stanley Mortgage
Capital Inc. and GreenPoint Mortgage Funding, Inc.
, pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately
$
650
million
, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, unspecified damages and interest. On November 24, 2014, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On April 4, 2019, the court denied the Firm’s motion to renew its motion to dismiss. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately
$
240
million
, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands that it did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.
On September 23, 2014, Financial Guaranty Insurance Company (“FGIC”) filed a complaint against the Firm in the Supreme Court of NY styled
Financial Guaranty Insurance
Company v. Morgan Stanley ABS Capital I Inc. et al.
relating to the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4. The complaint asserts claims for breach of contract and fraudulent inducement and alleges, among other things, that the loans in the trust breached various representations and warranties and defendants made untrue statements and material omissions to induce FGIC to issue a financial guaranty policy on certain classes of certificates that had an original balance of approximately
$
876
million
. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential and punitive damages, attorneys’ fees and interest. On January 23, 2017, the court denied the Firm’s motion to dismiss the complaint. On September 13, 2018, the First Department affirmed in part and reversed in part the lower court’s order denying the Firm’s motion to dismiss. On December 20, 2018, the First Department denied plaintiff’s motion for leave to appeal its decision to the New York Court of Appeals ("Court of Appeals") or, in the alternative, for re-argument. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately
$
277
million
, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and FGIC that the Firm did not repurchase, plus pre- and post- judgment interest, fees and costs, as well as claim payments that FGIC has made and will make in the future. In addition, plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.
On January 23, 2015, Deutsche Bank National Trust Company, in its capacity as trustee, filed a complaint against the Firm styled
Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc.
, pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately
$
1.05
billion
, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential, rescissory, equitable and punitive damages, attorneys’ fees, costs and other related expenses, and interest. On December 11, 2015, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On October 19, 2018, the court granted the Firm’s motion for leave to amend its answer and to stay the case pending resolution of Deutsche Bank National Trust Company’s appeal to the Court of Appeals in another case, styled
Deutsche Bank National Trust Company v. Barclays Bank PLC
, regarding the applicable statute of limitations. On January 17, 2019, the First Department reversed the trial court’s order to the extent that it had granted in part the Firm’s motion to dismiss the complaint. On June 4, 2019, the First Department granted the Firm’s motion for leave
March 2020 Form 10-Q
70
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
to appeal to the Court of Appeals. On March 19, 2020, the Firm filed a motion for partial summary judgment. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately
$
277
million
, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and a monoline insurer that the Firm did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase.
Tax
In matters styled Case number 15/3637 and Case number 15/4353, the Dutch Tax Authority (“Dutch Authority”) has challenged, in the District Court in Amsterdam, the prior set-off by the Firm of approximately
€
124
million
(approximately
$
137
million
) plus accrued interest of withholding tax credits against the Firm’s corporation tax liabilities for the tax years 2007 to 2013. The Dutch Authority alleges that the Firm was not entitled to receive the withholding tax credits on the basis, inter alia, that a Firm subsidiary did not hold legal title to certain securities subject to withholding tax on the relevant dates. The Dutch Authority has also alleged that the Firm failed to provide certain information to the Dutch Authority and keep adequate books and records. On April 26, 2018, the District Court in Amsterdam issued a decision dismissing the Dutch Authority’s claims. On June 4, 2018, the Dutch Authority filed an appeal before the Court of Appeal in Amsterdam in matters re-styled
Case number
18
/00
318
and
Case number
18
/00
319
. On June 26 and July 2, 2019, a hearing of the Dutch Authority’s appeal was held. Based on currently available information,
the Firm
believes that it could incur a loss in this action of up to approximately
€
124
million
(approximately
$
137
million
) plus accrued interest.
14
.
Variable Interest Entities and Securitization Activities
Consolidated VIE Assets and Liabilities by Type of Activity
At March 31, 2020
At December 31, 2019
$ in millions
VIE Assets
VIE Liabilities
VIE Assets
VIE Liabilities
OSF
$
728
$
415
$
696
$
391
MABS
1
368
108
265
4
Other
2
934
44
987
66
Total
$
2,030
$
567
$
1,948
$
461
OSF—Other structured financings
1.
Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets and may be in loan or security form. The value of assets is determined based on the fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair values for the liabilities and interests owned are more observable.
2.
Other primarily includes operating entities, investment funds and structured transactions.
Consolidated VIE Assets and Liabilities by Balance Sheet Caption
$ in millions
At
March 31,
2020
At
December 31,
2019
Assets
Cash and cash equivalents
$
328
$
488
Trading assets at fair value
1,234
943
Customer and other receivables
16
18
Intangible assets
107
111
Other assets
345
388
Total
$
2,030
$
1,948
Liabilities
Other secured financings
$
519
$
422
Other liabilities and accrued expenses
48
39
Total
$
567
$
461
Noncontrolling interests
$
245
$
192
Consolidated VIE assets and liabilities are presented in the previous tables after intercompany eliminations. Generally, most assets owned by consolidated VIEs cannot be removed unilaterally by the Firm and are not available to the Firm while the related liabilities issued by consolidated VIEs are non-recourse to the Firm. However, in certain consolidated VIEs, the Firm either has the unilateral right to remove assets or provides additional recourse through derivatives such as total return swaps, guarantees or other forms of involvement.
In general, the Firm’s exposure to loss in consolidated VIEs is limited to losses that would be absorbed on the VIE net assets recognized in its financial statements, net of amounts absorbed by third-party variable interest holders.
71
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Non-consolidated VIEs
At March 31, 2020
$ in millions
MABS
1
CDO
MTOB
OSF
Other
2
VIE assets (UPB)
$
124,211
$
1,881
$
6,585
$
2,263
$
51,280
Maximum exposure to loss
3
Debt and equity interests
$
15,173
$
254
$
277
$
1,086
$
10,468
Derivative and other contracts
—
—
4,047
—
3,659
Commitments, guarantees and other
572
—
—
—
334
Total
$
15,745
$
254
$
4,324
$
1,086
$
14,461
Carrying value of variable interests—Assets
Debt and equity interests
$
15,173
$
254
$
277
$
1,084
$
10,468
Derivative and other contracts
—
—
6
—
835
Total
$
15,173
$
254
$
283
$
1,084
$
11,303
Additional VIE assets owned
4
$
11,024
Carrying value of variable interests—Liabilities
Derivative and other contracts
$
—
$
—
$
—
$
—
$
272
At December 31, 2019
$ in millions
MABS
1
CDO
MTOB
OSF
Other
2
VIE assets (UPB)
$
125,603
$
2,976
$
6,965
$
2,288
$
51,305
Maximum exposure to loss
3
Debt and equity interests
$
16,314
$
240
$
—
$
1,009
$
11,977
Derivative and other contracts
—
—
4,599
—
2,995
Commitments, guarantees and other
631
—
—
—
266
Total
$
16,945
$
240
$
4,599
$
1,009
$
15,238
Carrying value of variable interests
–
Assets
Debt and equity interests
$
16,314
$
240
$
—
$
1,008
$
11,977
Derivative and other contracts
—
—
6
—
388
Total
$
16,314
$
240
$
6
$
1,008
$
12,365
Additional VIE assets owned
4
$
11,453
Carrying value of variable interests—Liabilities
Derivative and other contracts
$
—
$
—
$
—
$
—
$
444
MTOB—Municipal tender option bonds
1.
Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets. and may be in loan or security form.
2.
Other primarily includes exposures to commercial real estate property and investment funds.
3.
Where notional amounts are utilized in quantifying the maximum exposure related to derivatives, such amounts do not reflect changes in fair value recorded by the Firm.
4.
Additional VIE assets owned represents the carrying value of total exposure to non-consolidated VIEs for which the maximum exposure to loss is less than specific thresholds, primarily interests issued by securitization SPEs. The Firm’s primary risk exposure is to the most subordinate class of beneficial interest and maximum exposure to loss generally equals the fair value of the assets owned. These assets are primarily included in Trading assets and Investment securities and are measured at fair value
(see Note 3).
The Firm does not provide additional support in these transactions through contractual facilities, guarantees or similar derivatives.
The majority of the VIEs included in the previous tables are sponsored by unrelated parties; examples of the Firm’s involvement with these VIEs include its secondary market-making activities and the securities held in its Investment securities portfolio
(see
Note 7
).
The Firm’s maximum exposure to loss is dependent on the nature of the Firm’s variable interest in the VIE and is limited to the notional amounts of certain liquidity facilities and other credit support, total return swaps and written put options, as well as the fair value of certain other derivatives and investments the Firm has made in the VIE.
The Firm’s maximum exposure to loss in the previous tables does not include the offsetting benefit of hedges or any reductions associated with the amount of collateral held as part of a transaction with the VIE or any party to the VIE directly against a specific exposure to loss.
Liabilities issued by VIEs generally are non-recourse to the Firm.
Detail of Mortgage- and Asset-Backed Securitization Assets
At March 31, 2020
At December 31, 2019
$ in millions
UPB
Debt and
Equity
Interests
UPB
Debt and
Equity
Interests
Residential mortgages
$
20,460
$
3,298
$
30,353
$
3,993
Commercial mortgages
52,672
3,677
53,892
3,881
U.S. agency collateralized mortgage obligations
45,958
6,257
36,366
6,365
Other consumer or commercial loans
5,121
1,941
4,992
2,075
Total
$
124,211
$
15,173
$
125,603
$
16,314
Transferred Assets with Continuing Involvement
1
At March 31, 2020
$ in millions
RML
CML
U.S. Agency
CMO
CLN and
Other
3
SPE assets (UPB)
4
$
9,501
$
79,516
$
15,480
$
11,109
Retained interests
Investment grade
$
26
$
780
$
763
$
—
Non-investment grade
13
238
—
87
Total
$
39
$
1,018
$
763
$
87
Interests purchased in the secondary market
Investment grade
$
—
$
65
$
78
$
—
Non-investment grade
29
68
—
—
Total
$
29
$
133
$
78
$
—
Derivative assets
$
—
$
—
$
—
$
830
Derivative liabilities
—
—
—
186
March 2020 Form 10-Q
72
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
At December 31, 2019
2
$ in millions
RML
CML
U.S. Agency
CMO
CLN and
Other
3
SPE assets (UPB)
4
$
9,850
$
86,203
$
19,132
$
8,410
Retained interests
Investment grade
$
29
$
720
$
2,376
$
1
Non-investment grade
17
254
—
92
Total
$
46
$
974
$
2,376
$
93
Interests purchased in the secondary market
Investment grade
$
6
$
197
$
77
$
—
Non-investment grade
75
51
—
—
Total
$
81
$
248
$
77
$
—
Derivative assets
$
—
$
—
$
—
$
339
Derivative liabilities
—
—
—
145
Fair Value At March 31, 2020
$ in millions
Level 2
Level 3
Total
Retained interests
Investment grade
$
790
$
—
$
790
Non-investment grade
7
83
90
Total
$
797
$
83
$
880
Interests purchased in the secondary market
Investment grade
$
141
$
2
$
143
Non-investment grade
85
12
97
Total
$
226
$
14
$
240
Derivative assets
$
820
$
10
$
830
Derivative liabilities
185
1
186
Fair Value at December 31, 2019
$ in millions
Level 2
Level 3
Total
Retained interests
Investment grade
$
2,401
$
4
$
2,405
Non-investment grade
6
97
103
Total
$
2,407
$
101
$
2,508
Interests purchased in the secondary market
Investment grade
$
278
$
2
$
280
Non-investment grade
68
58
126
Total
$
346
$
60
$
406
Derivative assets
$
337
$
2
$
339
Derivative liabilities
144
1
145
RML—Residential mortgage loans
CML—Commercial mortgage loans
1.
The Transferred Assets with Continuing Involvement tables include transactions with SPEs in which the Firm, acting as principal, transferred financial assets with continuing involvement and received sales treatment.
2.
As permitted by applicable guidance, certain transfers of assets where the Firm’s only continuing involvement is a derivative are only reported in the following Assets Sold with Retained Exposure table.
3.
Amounts include CLO transactions managed by unrelated third parties.
4.
Amounts include assets transferred by unrelated transferors.
Transferred assets are carried at fair value prior to securitization, and any changes in fair value are recognized in the income statements. The Firm may act as underwriter of the beneficial interests issued by these securitization vehicles, for which Investment banking revenues are recognized. The Firm may retain interests in the securitized financial assets as one or more tranches of the securitization. These retained interests are generally carried at fair value in the balance sheets with changes in fair value recognized in the income statements. Fair value for
these interests is measured using techniques that are consistent with the valuation techniques applied to the Firm’s major categories of assets and liabilities as described in Note 2 in the 2019 Form 10-K and Note 4 herein.
Proceeds from New Securitization Transactions and Sales of Loans
Three Months Ended
March 31,
$ in millions
2020
2019
New transactions
1
$
8,471
$
4,733
Retained interests
4,088
2,887
Sales of corporate loans to CLO SPEs
1, 2
66
—
1.
Net gains on new transactions and sales of corporate loans to CLO entities at the time of the sale were not material for all periods presented.
2.
Sponsored by non-affiliates.
The Firm has provided, or otherwise agreed to be responsible for, representations and warranties regarding certain assets transferred in securitization transactions sponsored by the Firm
(see
Note 13
).
Assets Sold with Retained Exposure
$ in millions
At
March 31,
2020
At
December 31,
2019
Gross cash proceeds from sale of assets
1
$
28,213
$
38,661
Fair value
Assets sold
$
28,068
$
39,137
Derivative assets recognized
in the balance sheets
862
647
Derivative liabilities recognized
in the balance sheets
1,004
152
1.
The carrying value of assets derecognized at the time of sale approximates gross cash proceeds.
The Firm enters into transactions in which it sells securities, primarily equities and contemporaneously enters into bilateral OTC derivatives with the purchasers of the securities, through which it retains exposure to the sold securities.
For a discussion of the Firm’s VIEs, the determination and structure of VIEs and securitization activities, see
Note 14
to the financial statements in the
2019 Form 10-K
.
15
.
Regulatory Requirements
Regulatory Capital Framework and Requirements
For a discussion of the Firm’s regulatory capital framework, see
Note 15
to the financial statements in the
2019 Form 10-K
.
The Firm is required to maintain minimum risk-based and leverage-based capital ratios under regulatory capital requirements. A summary of the calculations of regulatory capital and RWA follows.
Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital
73
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
(which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios.
At
March 31, 2020
and
December 31, 2019
, the Firm's ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively.
In the current quarter, the U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital rules, the required adoption time period for CECL. As of March 31, 2020, the risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period in accordance with the interim final rule.
In addition to the minimum risk-based capital ratio requirements, the Firm is subject to the following Common Equity Tier 1 buffers:
•
A greater than
2.5
%
capital conservation buffer;
•
The G-SIB capital surcharge, currently at
3
%
; and
•
Up to a
2.5
%
CCyB, currently set by U.S. banking agencies at
zero
.
The Firm’s Regulatory Capital and Capital Ratios
At March 31, 2020
$ in millions
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
10.0
%
$
65,195
15.2
%
Tier 1 capital
11.5
%
73,896
17.3
%
Total capital
13.5
%
83,847
19.6
%
Total RWA
427,782
Leverage-based capital
Tier 1 leverage
4.0
%
$
73,896
8.1
%
Adjusted average assets
2
910,499
SLR
5.0
%
73,896
6.2
%
Supplementary leverage exposure
3
1,185,734
At December 31, 2019
$ in millions
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
10.0
%
$
64,751
16.4
%
Tier 1 capital
11.5
%
73,443
18.6
%
Total capital
13.5
%
82,708
21.0
%
Total RWA
394,177
Leverage-based capital
Tier 1 leverage
4.0
%
$
73,443
8.3
%
Adjusted average assets
2
889,195
SLR
5.0
%
73,443
6.4
%
Supplementary leverage exposure
3
1,155,177
1.
Required ratios are inclusive of any buffers applicable as of the date presented.
Failure to maintain the buffers would result in restrictions on the Firm’s ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers.
2.
Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in the Firm's own capital instruments, certain defined tax assets and other capital deductions.
3.
Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures.
U.S. Bank Subsidiaries’ Regulatory Capital and Capital Ratios
The OCC establishes capital requirements for the Firm’s U.S. Bank Subsidiaries and evaluates their compliance with such capital requirements. Regulatory capital requirements for the U.S. Bank Subsidiaries are calculated in a similar manner to the Firm’s regulatory capital requirements, although G-SIB capital surcharge requirements do not apply to the U.S. Bank Subsidiaries.
The OCC’s regulatory capital framework includes Prompt Corrective Action (“PCA”) standards, including “well-capitalized” PCA standards that are based on specified regulatory capital ratio minimums. For the Firm to remain an FHC, the U.S. Bank Subsidiaries must remain well-capitalized in accordance with the OCC’s PCA standards. In addition, failure by the U.S. Bank Subsidiaries to meet minimum capital requirements may result in certain mandatory and discretionary actions by regulators that, if undertaken, could have a direct material effect on the U.S. Bank Subsidiaries’ and the Firm’s financial statements.
At
March 31, 2020
and
December 31, 2019
,
the U.S. Bank Subsidiaries’ risk-based capital ratios are based on the Standardized Approach rules.
At March 31, 2020, the risk-based
March 2020 Form 10-Q
74
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
and leverage-based capital amounts and ratios are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period.
MSBNA’s Regulatory Capital
At March 31, 2020
$ in millions
Well-Capitalized Requirement
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
6.5
%
7.0
%
$
16,839
18.2
%
Tier 1 capital
8.0
%
8.5
%
16,839
18.2
%
Total capital
10.0
%
10.5
%
17,349
18.7
%
Leverage-based capital
Tier 1 leverage
5.0
%
4.0
%
$
16,839
11.2
%
SLR
6.0
%
3.0
%
16,839
8.8
%
At December 31, 2019
$ in millions
Well-Capitalized Requirement
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
6.5
%
7.0
%
$
15,919
18.5
%
Tier 1 capital
8.0
%
8.5
%
15,919
18.5
%
Total capital
10.0
%
10.5
%
16,282
18.9
%
Leverage-based capital
Tier 1 leverage
5.0
%
4.0
%
$
15,919
11.3
%
SLR
6.0
%
3.0
%
15,919
8.7
%
MSPBNA’s Regulatory Capital
At March 31, 2020
$ in millions
Well-Capitalized Requirement
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
6.5
%
7.0
%
$
8,487
22.9
%
Tier 1 capital
8.0
%
8.5
%
8,487
22.9
%
Total capital
10.0
%
10.5
%
8,556
23.0
%
Leverage-based capital
Tier 1 leverage
5.0
%
4.0
%
$
8,487
9.7
%
SLR
6.0
%
3.0
%
8,487
9.3
%
At December 31, 2019
$ in millions
Well-Capitalized Requirement
Required
Ratio
1
Amount
Ratio
Risk-based capital
Common Equity Tier 1 capital
6.5
%
7.0
%
$
7,962
24.8
%
Tier 1 capital
8.0
%
8.5
%
7,962
24.8
%
Total capital
10.0
%
10.5
%
8,016
25.0
%
Leverage-based capital
Tier 1 leverage
5.0
%
4.0
%
$
7,962
9.9
%
SLR
6.0
%
3.0
%
7,962
9.4
%
1.
Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the U.S. Bank Subsidiaries' ability to make capital distributions, including the payment of dividends.
U.S. Broker-Dealer Regulatory Capital Requirements
MS&Co. Regulatory Capital
$ in millions
At March 31, 2020
At December 31, 2019
Net capital
$
10,887
$
13,708
Excess net capital
6,620
10,686
MS&Co. is a registered U.S. broker-dealer and registered futures commission merchant and, accordingly, is subject to the minimum net capital requirements of the SEC and the CFTC. MS&Co. has consistently operated with capital in excess of its regulatory capital requirements.
As an Alternative Net Capital broker-dealer, and in accordance with Securities Exchange Act of 1934 (“Exchange Act”) Rule 15c3-1, Appendix E, MS&Co. is subject to minimum net capital and tentative net capital requirements. In addition, MS&Co. must notify the SEC if its tentative net capital falls below certain levels.
At
March 31, 2020
and
December 31, 2019
,
MS&Co. has exceeded its net capital requirement and has tentative net capital in excess of the minimum and notification requirements.
MSSB Regulatory Capital
$ in millions
At March 31, 2020
At December 31, 2019
Net capital
$
2,924
$
3,387
Excess net capital
2,774
3,238
MSSB is a registered U.S. broker-dealer and introducing broker for the futures business and, accordingly, is subject to the minimum net capital requirements of the SEC. MSSB has consistently operated with capital in excess of its regulatory capital requirements.
Other Regulated Subsidiaries
MSIP, a London-based broker-dealer subsidiary, is subject to the capital requirements of the PRA, and MSMS, a Tokyo-based broker-dealer subsidiary, is subject to the capital requirements of the Financial Services Agency. MSIP and MSMS have consistently operated with capital in excess of their respective regulatory capital requirements.
Certain other U.S. and non-U.S. subsidiaries of the Firm are subject to various securities, commodities and banking regulations, and capital adequacy requirements promulgated by the regulatory and exchange authorities of the countries in which they operate. These subsidiaries have consistently operated with capital in excess of their local capital adequacy requirements.
75
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
16
.
Total Equity
Share Repurchases
Three Months Ended March 31,
$ in millions
2020
2019
Repurchases of common stock under the Firm's Share Repurchase Program
$
1,347
$
1,180
The Firm’s 2019 Capital Plan (“Capital Plan”) includes the share repurchase of up to
$
6.0
billion
of outstanding common stock for the period beginning
July 1, 2019
through
June 30, 2020
. Additionally, the Capital Plan includes quarterly common stock dividends of up to
$
0.35
per share, beginning with the common stock dividend announced on July 18, 2019.
On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs.
For information about the Firm's 2019 Capital Plan, see
Note 16
to the financial statements in the
2019 Form 10-K
.
A portion of common stock repurchases was conducted under a sales plan with MUFG, whereby MUFG sold shares of the Firm’s common stock to the Firm, as part of the Firm’s Share Repurchase Program. The sales plan is only intended to maintain MUFG’s ownership percentage below
24.9
%
in order to comply with MUFG’s passivity commitments to the Board of Governors of the Federal Reserve System and has no impact on the strategic alliance between MUFG and the Firm, including the joint ventures in Japan.
Common Stock Dividends per Share
Three Months Ended March 31,
2020
2019
Dividends declared per common share
$
0.35
$
0.30
Common Shares Outstanding for Basic and Diluted EPS
Three Months Ended
March 31,
in millions
2020
2019
Weighted average common shares outstanding, basic
1,555
1,658
Effect of dilutive Stock options, RSUs and PSUs
18
19
Weighted average common shares outstanding and common stock equivalents, diluted
1,573
1,677
Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS)
12
6
Preferred Stock
Shares
Outstanding
Carrying Value
$ in millions, except per share data
At
March 31,
2020
Liquidation
Preference
per Share
At
March 31,
2020
At
December 31,
2019
Series
A
44,000
$
25,000
$
1,100
$
1,100
C
1
519,882
1,000
408
408
E
34,500
25,000
862
862
F
34,000
25,000
850
850
H
52,000
25,000
1,300
1,300
I
40,000
25,000
1,000
1,000
J
60,000
25,000
1,500
1,500
K
40,000
25,000
1,000
1,000
L
20,000
25,000
500
500
Total
$
8,520
$
8,520
Shares authorized
30,000,000
1.
Series C is composed of the issuance of
1,160,791
shares of Series C Preferred Stock to MUFG for an aggregate purchase price of
$
911
million
, less the redemption of
640,909
shares of Series C Preferred Stock of
$
503
million
, which were converted to common shares of approximately
$
705
million
in 2009.
For a description of Series A through Series L preferred stock issuances, see
Note 16
to the financial statements in the
2019 Form 10-K
.
The preferred stock has a preference over the common stock upon liquidation. The Firm’s preferred stock qualifies as and is included in Tier 1 capital in accordance with regulatory capital requirements
(see
Note 15
).
Preferred Stock Dividends
$ in millions, except per
share data
Three Months Ended
March 31, 2020
Three Months Ended
March 31, 2019
Per Share
1
Total
Per Share
1
Total
Series
A
$
253
$
11
$
250
$
11
C
25
13
25
13
E
445
15
445
15
F
430
14
430
15
G
2
—
—
414
8
H
3
344
18
—
—
I
398
16
398
16
J
4
—
—
—
—
K
366
15
366
15
L
305
6
—
—
Total
$
108
$
93
1.
Dividends on all series are payable quarterly, unless otherwise noted.
2.
Series G preferred stock was redeemed during the first quarter of 2020. For further information, see Note 16 to the 2019 Form 10-K.
3.
Series H was payable semiannually until July 15, 2019, and is now payable quarterly.
4.
Series J is payable semiannually until July 15, 2020, and then quarterly thereafter.
March 2020 Form 10-Q
76
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Accumulated Other Comprehensive Income (Loss)
1
$ in millions
CTA
AFS
Securities
Pension,
Postretirement
and Other
DVA
Total
December 31, 2019
$
(
897
)
$
207
$
(
644
)
$
(
1,454
)
$
(
2,788
)
OCI during the period
(
141
)
1,325
25
3,674
4,883
March 31, 2020
$
(
1,038
)
$
1,532
$
(
619
)
$
2,220
$
2,095
December 31, 2018
$
(
889
)
$
(
930
)
$
(
578
)
$
105
$
(
2,292
)
OCI during the period
(
12
)
429
1
(
599
)
(
181
)
March 31, 2019
$
(
901
)
$
(
501
)
$
(
577
)
$
(
494
)
$
(
2,473
)
CTA—Cumulative foreign currency translation adjustments
1.
Amounts are net of tax and noncontrolling interests.
Components of Period Changes in OCI
Three Months Ended
March 31, 2020
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
(
20
)
$
(
112
)
$
(
132
)
$
9
$
(
141
)
Reclassified to earnings
—
—
—
—
—
Net OCI
$
(
20
)
$
(
112
)
$
(
132
)
$
9
$
(
141
)
Change in net unrealized gains (losses) on AFS securities
OCI activity
$
1,773
$
(
416
)
$
1,357
$
—
$
1,357
Reclassified to earnings
(
41
)
9
(
32
)
—
(
32
)
Net OCI
$
1,732
$
(
407
)
$
1,325
$
—
$
1,325
Pension, postretirement and other
OCI activity
$
25
$
(
4
)
$
21
$
—
$
21
Reclassified to earnings
5
(
1
)
4
—
4
Net OCI
$
30
$
(
5
)
$
25
$
—
$
25
Change in net DVA
OCI activity
$
5,015
$
(
1,216
)
$
3,799
$
129
$
3,670
Reclassified to earnings
5
(
1
)
4
—
4
Net OCI
$
5,020
$
(
1,217
)
$
3,803
$
129
$
3,674
Three Months Ended
March 31, 2019
$ in millions
Pre-tax
Gain
(Loss)
Income
Tax Benefit
(Provision)
After-tax
Gain
(Loss)
Non-
controlling
Interests
Net
CTA
OCI activity
$
(
4
)
$
(
18
)
$
(
22
)
$
(
10
)
$
(
12
)
Reclassified to earnings
—
—
—
—
—
Net OCI
$
(
4
)
$
(
18
)
$
(
22
)
$
(
10
)
$
(
12
)
Change in net unrealized gains (losses) on AFS securities
OCI activity
$
570
$
(
133
)
$
437
$
—
$
437
Reclassified to earnings
(
10
)
2
(
8
)
—
(
8
)
Net OCI
$
560
$
(
131
)
$
429
$
—
$
429
Pension, postretirement and other
OCI activity
$
—
$
(
1
)
$
(
1
)
$
—
$
(
1
)
Reclassified to earnings
3
(
1
)
2
—
2
Net OCI
$
3
$
(
2
)
$
1
$
—
$
1
Change in net DVA
OCI activity
$
(
824
)
$
201
$
(
623
)
$
(
21
)
$
(
602
)
Reclassified to earnings
4
(
1
)
3
—
3
Net OCI
$
(
820
)
$
200
$
(
620
)
$
(
21
)
$
(
599
)
Cumulative Adjustments to Beginning Retained Earnings Related to the Adoption of Accounting Updates
Three Months Ended
$ in millions
March 31, 2020
Financial Instruments—Credit Losses
$
(
100
)
Three Months Ended
$ in millions
March 31, 2019
Leases
$
63
77
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
17
.
Interest Income and Interest Expense
Three Months Ended
March 31,
$ in millions
2020
2019
Interest income
Investment securities
$
445
$
475
Loans
1,154
1,195
Securities purchased under agreements to resell and Securities borrowed
1
398
947
Trading assets, net of Trading liabilities
749
713
Customer receivables and Other
2
757
960
Total interest income
$
3,503
$
4,290
Interest expense
Deposits
$
406
$
462
Borrowings
997
1,380
Securities sold under agreements to repurchase and Securities loaned
3
509
600
Customer payables and Other
4
235
834
Total interest expense
$
2,147
$
3,276
Net interest
$
1,356
$
1,014
1.
Includes fees paid on Securities borrowed.
2.
Includes interest from Cash and cash equivalents.
3.
Includes fees received on Securities loaned.
4.
Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.
Interest income and Interest expense are classified in the income statements based on the nature of the instrument and related market conventions. When included as a component of the instrument’s fair value, interest is included within Trading revenues or Investments revenues. Otherwise, it is included within Interest income or Interest expense.
k
18
.
Income Taxes
The Firm is under continuous examination by the IRS and other tax authorities in certain countries, such as Japan and the U.K., and in states and localities in which it has significant business operations, such as New York.
The Firm believes that the resolution of these tax examinations will not have a material effect on the annual financial statements, although a resolution could have a material impact in the income statements and on the effective tax rate for any period in which such resolutions occur.
The Firm has established a liability for unrecognized tax benefits, and associated interest, if applicable (“tax liabilities”), that it believes is adequate in relation to the potential for additional assessments. Once established, the Firm adjusts such tax liabilities only when new information is available or when an event occurs necessitating a change.
It is reasonably possible that significant changes in the balance of unrecognized tax benefits may occur within the next 12 months. At this time, however, it is not possible to reasonably
estimate the expected change to the total amount of unrecognized tax benefits and the impact on the Firm’s effective tax rate over the next 12 months.
See
Note 13
regarding the Dutch Tax Authority’s challenge, in the District Court in Amsterdam (matters styled
Case number 15/3637
and
Case number 15/4353)
, of the Firm’s entitlement to certain withholding tax credits, which may impact the balance of unrecognized tax benefits.
Net Discrete Tax Provisions/(Benefits)
Three Months Ended March 31,
$ in millions
2020
2019
Recurring
1
$
(
99
)
$
(
107
)
Intermittent
(
31
)
(
101
)
1. Recurring discrete tax items are related to conversion of employee share-based awards.
The current quarter includes intermittent net discrete tax benefits associated with the remeasurement of prior years’ tax liabilities. The prior year quarter includes intermittent net discrete tax benefits
primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations.
19
.
Segment, Geographic and Revenue Information
Selected Financial Information by Business Segment
Three Months Ended March 31, 2020
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
1,144
$
158
$
—
$
(
31
)
$
1,271
Trading
3,416
(
347
)
(
37
)
24
3,056
Investments
(
25
)
—
63
—
38
Commissions and fees
1
874
588
—
(
102
)
1,360
Asset management
1
113
2,680
665
(
41
)
3,417
Other
(
1,079
)
62
7
(
1
)
(
1,011
)
Total non-interest revenues
4,443
3,141
698
(
151
)
8,131
Interest income
2,423
1,193
8
(
121
)
3,503
Interest expense
1,961
297
14
(
125
)
2,147
Net interest
462
896
(
6
)
4
1,356
Net revenues
$
4,905
$
4,037
$
692
$
(
147
)
$
9,487
Income before provision for income taxes
$
950
$
1,055
$
143
$
(
2
)
$
2,146
Provision for income taxes
151
191
25
(
1
)
366
Net income
799
864
118
(
1
)
1,780
Net income applicable to noncontrolling interests
42
—
40
—
82
Net income applicable to Morgan Stanley
$
757
$
864
$
78
$
(
1
)
$
1,698
March 2020 Form 10-Q
78
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Three Months Ended March 31, 2019
$ in millions
IS
WM
IM
I/E
Total
Investment banking
$
1,151
$
109
$
—
$
(
18
)
$
1,242
Trading
3,130
302
(
3
)
12
3,441
Investments
81
1
191
—
273
Commissions and fees
1
621
406
—
(
61
)
966
Asset management
1
107
2,361
617
(
36
)
3,049
Other
222
80
3
(
4
)
301
Total non-interest revenues
5,312
3,259
808
(
107
)
9,272
Interest income
3,056
1,413
4
(
183
)
4,290
Interest expense
3,172
283
8
(
187
)
3,276
Net interest
(
116
)
1,130
(
4
)
4
1,014
Net revenues
$
5,196
$
4,389
$
804
$
(
103
)
$
10,286
Income before provision for income taxes
$
1,595
$
1,188
$
174
$
(
2
)
$
2,955
Provision for income taxes
190
264
33
—
487
Net income
1,405
924
141
(
2
)
2,468
Net income applicable to noncontrolling interests
34
—
5
—
39
Net income applicable to Morgan Stanley
$
1,371
$
924
$
136
$
(
2
)
$
2,429
I/E–Intersegment Eliminations
1.
Substantially all revenues are from contracts with customers.
For a discussion about the Firm’s business segments, see Note
21
to the financial statements in the
2019 Form 10-K
.
Detail of Investment Banking Revenues
Three Months Ended
March 31,
$ in millions
2020
2019
Institutional Securities Advisory
$
362
$
406
Institutional Securities Underwriting
782
745
Firm Investment banking revenues from contracts with customers
89
%
85
%
Trading Revenues by Product Type
Three Months Ended
March 31,
$ in millions
2020
2019
Interest rate
$
1,074
$
785
Foreign exchange
338
241
Equity security and index
1
1,072
1,451
Commodity and other
266
422
Credit
306
542
Total
$
3,056
$
3,441
1.
Dividend income is included within equity security and index contracts.
The previous table summarizes realized and unrealized gains and losses, from derivative and non-derivative financial instruments, included in Trading revenues in the income statements. The Firm generally utilizes financial instruments across a variety of product types in connection with its market-making and related risk management strategies. The trading
revenues presented in the table are not representative of the manner in which the Firm manages its business activities and are prepared in a manner similar to the presentation of trading revenues for regulatory reporting purposes.
Investment Management Investments Revenues—Net Cumulative Unrealized Carried Interest
$ in millions
At
March 31,
2020
At
December 31,
2019
Net cumulative unrealized performance-based fees at risk of reversing
$
714
$
774
The Firm’s portion of net cumulative performance-based fees in the form of unrealized carried interest (for which the Firm is not obligated to pay compensation) are at risk of reversing when the return in certain funds fall below specified performance targets. See
Note 13
for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received.
Investment Management Asset Management Revenues
—
Reduction of Fees Due to Fee Waivers
Three Months Ended
March 31,
$ in millions
2020
2019
Fee waivers
$
11
$
11
The Firm waives a portion of its fees in the Investment Management business segment from certain registered money market funds that comply with the requirements of Rule 2a-7 of the Investment Company Act of 1940.
Certain Other Fee Waivers
Separately, the Firm’s employees, including its senior officers, may participate on the same terms and conditions as other investors in certain funds that the Firm sponsors primarily for client investment, and the Firm may waive or lower applicable fees and charges for its employees.
Net Revenues by Region
Three Months Ended
March 31,
$ in millions
2020
2019
Americas
$
6,646
$
7,321
EMEA
1,148
1,702
Asia
1,693
1,263
Total
$
9,487
$
10,286
For a discussion about the Firm’s geographic net revenues, see
Note 21
to the financial statements in the
2019 Form 10-K
.
79
March 2020 Form 10-Q
Table of Contents
Notes to Consolidated Financial Statements
(Unaudited)
Revenue Recognized from Prior Services
Three Months Ended
March 31,
$ in millions
2020
2019
Non-interest revenues
$
614
$
671
The previous table includes revenue from contracts with customers recognized where some or all services were performed in prior periods and is primarily composed of
investment banking advisory fees and distribution fees.
Receivables from Contracts with Customers
$ in millions
At
March 31,
2020
At
December 31,
2019
Customer and other receivables
$
2,199
$
2,916
Receivables from contracts with customers, which are included within Customer and other receivables in the balance sheets, arise when the Firm has both recorded revenues and has the right per the contract to bill the customer.
Assets by Business Segment
$ in millions
At
March 31,
2020
At
December 31,
2019
Institutional Securities
$
707,489
$
691,201
Wealth Management
233,824
197,682
Investment Management
6,482
6,546
Total
1
$
947,795
$
895,429
1.
Parent assets have been fully allocated to the business segments.
March 2020 Form 10-Q
80
Table of Contents
Financial Data Supplement (Unaudited)
Average Balances and Interest Rates and Net Interest Income
Three Months Ended March 31,
2020
2019
$ in millions
Average
Daily Balance
Interest
Annualized
Average
Rate
Average
Daily
Balance
Interest
Annualized
Average
Rate
Interest earning assets
Investment securities
1
$
110,277
$
445
1.6
%
$
94,906
$
475
2.0
%
Loans
1
134,441
1,154
3.5
116,698
1,195
4.2
Securities purchased under agreements to resell and Securities borrowed
2
:
U.S.
121,106
378
1.3
141,806
934
2.7
Non-U.S.
56,865
20
0.1
77,256
13
0.1
Trading assets, net of Trading liabilities
3
:
U.S.
78,771
626
3.2
74,152
631
3.5
Non-U.S.
22,903
123
2.2
11,861
82
2.8
Customer receivables and Other
4
:
U.S.
68,772
555
3.2
63,649
697
4.4
Non-U.S.
60,787
202
1.3
55,142
263
1.9
Total
$
653,922
$
3,503
2.2
%
$
635,470
$
4,290
2.7
%
Interest bearing liabilities
Deposits
1
$
199,574
$
406
0.8
%
$
181,017
$
462
1.0
%
Borrowings
1, 5
192,061
997
2.1
189,181
1,380
3.0
Securities sold under agreements to repurchase and Securities loaned
6
:
U.S.
31,461
328
4.2
26,615
450
6.9
Non-U.S.
29,682
181
2.5
32,350
150
1.9
Customer payables and Other
7
:
U.S.
128,744
109
0.3
117,932
554
1.9
Non-U.S.
63,914
126
0.8
65,498
280
1.7
Total
$
645,436
$
2,147
1.3
%
$
612,593
$
3,276
2.2
%
Net interest income and net interest rate spread
$
1,356
0.9
%
$
1,014
0.5
%
1.
Amounts include primarily U.S. balances.
2.
Includes fees paid on Securities borrowed.
3.
Excludes non-interest earning assets and non-interest bearing liabilities, such as equity securities.
4.
Includes Cash and cash equivalents.
5.
Includes borrowings carried at fair value, whose interest expense is considered part of fair value and therefore is recorded within Trading revenues.
6.
Includes fees received on Securities loaned. The annualized average rate was calculated using (a) interest expense incurred on all securities sold under agreements to repurchase and securities loaned transactions, whether or not such transactions were reported in the balance sheets and (b) net average on-balance sheet balances, which exclude certain securities-for-securities transactions
.
7.
Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions.
81
March 2020 Form 10-Q
Table of Contents
Glossary of Common Terms and Acronyms
2019 Form 10-K
Annual report on Form 10-K for year ended December 31, 2019 filed with the SEC
ABS
Asset-backed securities
AFS
Available-for-sale
AML
Anti-money laundering
AOCI
Accumulated other comprehensive income (loss)
AUM
Assets under management or supervision
Balance sheets
Consolidated balance sheets
BEAT
Base erosion and anti-abuse tax
BHC
Bank holding company
bps
Basis points; one basis point equals 1/100th of 1%
Cash flow statements
Consolidated cash flow statements
CCAR
Comprehensive Capital Analysis and Review
CCyB
Countercyclical capital buffer
CDO
Collateralized debt obligation(s), including Collateralized loan obligation(s)
CDS
Credit default swaps
CECL
Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update
CFTC
U.S. Commodity Futures Trading Commission
CLN
Credit-linked note(s)
CLO
Collateralized loan obligation(s)
CMBS
Commercial mortgage-backed securities
CMO
Collateralized mortgage obligation(s)
CVA
Credit valuation adjustment
DVA
Debt valuation adjustment
EBITDA
Earnings before interest, taxes, depreciation and amortization
ELN
Equity-linked note(s)
EMEA
Europe, Middle East and Africa
EPS
Earnings per common share
E.U.
European Union
FDIC
Federal Deposit Insurance Corporation
FFELP
Federal Family Education Loan Program
FFIEC
Federal Financial Institutions Examination Council
FHC
Financial Holding Company
FICC
Fixed Income Clearing Corporation
FICO
Fair Isaac Corporation
Financial statements
Consolidated financial statements
FVA
Funding valuation adjustment
GILTI
Global Intangible Low-Taxed Income
G-SIB
Global systemically important banks
HELOC
Home Equity Line of Credit
HQLA
High-quality liquid assets
HTM
Held-to-maturity
I/E
Intersegment eliminations
IHC
Intermediate holding company
IM
Investment Management
Income statements
Consolidated income statements
IRS
Internal Revenue Service
IS
Institutional Securities
LCR
Liquidity coverage ratio, as adopted by the U.S. banking agencies
LIBOR
London Interbank Offered Rate
M&A
Merger, acquisition and restructuring transaction
MSBNA
Morgan Stanley Bank, N.A.
MS&Co.
Morgan Stanley & Co. LLC
MSIP
Morgan Stanley & Co. International plc
March 2020 Form 10-Q
82
Table of Contents
Glossary of Common Terms and Acronyms
MSMS
Morgan Stanley MUFG Securities Co., Ltd.
MSPBNA
Morgan Stanley Private Bank, National Association
MSSB
Morgan Stanley Smith Barney LLC
MUFG
Mitsubishi UFJ Financial Group, Inc.
MUMSS
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.
MWh
Megawatt hour
N/A
Not Applicable
NAV
Net asset value
N/M
Not Meaningful
Non-GAAP
Non-generally accepted accounting principles
NSFR
Net stable funding ratio, as proposed by the U.S. banking agencies
OCC
Office of the Comptroller of the Currency
OCI
Other comprehensive income (loss)
OIS
Overnight index swap
OTC
Over-the-counter
OTTI
Other-than-temporary impairment
PRA
Prudential Regulation Authority
PSU
Performance-based stock unit
RMBS
Residential mortgage-backed securities
ROE
Return on average common equity
ROTCE
Return on average tangible common equity
ROU
Right-of-use
RSU
Restricted stock unit
RWA
Risk-weighted assets
SEC
U.S. Securities and Exchange Commission
SLR
Supplementary leverage ratio
SOFR
Secured Overnight Financing Rate
S&P
Standard & Poor’s
SPE
Special purpose entity
SPOE
Single point of entry
TDR
Troubled debt restructuring
TLAC
Total loss-absorbing capacity
U.K.
United Kingdom
UPB
Unpaid principal balance
U.S.
United States of America
U.S. GAAP
Accounting principles generally accepted in the United States of America
VaR
Value-at-Risk
VIE
Variable interest entity
WACC
Implied weighted average cost of capital
WM
Wealth Management
83
March 2020 Form 10-Q
Table of Contents
Other Information
None.
Legal Proceedings
The following development has occurred since previously reporting certain matters in the Firm’s
2019 Form 10-K
. See also the disclosures set forth under “Legal Proceedings” in the
2019 Form 10-K
.
Residential Mortgage and Credit Crisis Related Matter
On March 19, 2020, the Firm filed a motion for partial summary judgment in
Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007- NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc
.
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Three Months Ended
March 31, 2020
$ in millions, except per share data
Total
Number of Shares Purchased
1
Average Price Paid Per Share
Total Shares
Purchased as Part of Share Repurchase Program
2,3
Dollar Value of Remaining Authorized Repurchase
January
11,966,543
$
55.82
4,860,960
$
2,733
February
7,624,176
$
52.63
7,135,908
$
2,354
March
17,552,911
$
40.65
17,278,471
$
1,653
Total
37,143,630
$
48.00
29,275,339
1.
Includes 7,868,291 shares acquired by the Firm in satisfaction of the tax withholding obligations on stock-based awards granted under the Firm’s stock-based compensation plans during the three months ended
March 31, 2020
.
2.
Share purchases under publicly announced programs are made pursuant to open-market purchases, Rule 10b5-1 plans or privately negotiated transactions (including with employee benefit plans) as market conditions warrant and at prices the Firm deems appropriate and may be suspended at any time. On April 18, 2018, the Firm entered into a sales plan with Mitsubishi UFJ Financial Group, Inc. (“MUFG”).
See
Note 16
to the financial statements for further information on the sales plan.
3.
The Firm’s Board of Directors has authorized the repurchase of the Firm’s outstanding stock under a share repurchase program (the “Share Repurchase Program”). The Share Repurchase Program is a program for capital management purposes that considers, among other things, business segment capital needs, as well as equity-based compensation and benefit plan requirements. The Share Repurchase Program has no set expiration or termination date.
Share repurchases by the Firm are subject to regulatory non-objection. On June 27, 2019, the Federal Reserve published summary results of CCAR and and the Firm received a non-objection to its 2019 Capital Plan. The Firm’s 2019 Capital Plan includes a share repurchase of up to $6.0 billion of its outstanding common stock during the period beginning July 1, 2019 through June 30, 2020.
On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs.
For further information, see “
Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests
.”
Controls and Procedures
Under the supervision and with the participation of the Firm’s management, including the Chief Executive Officer and Chief Financial Officer, the Firm conducted an evaluation of the effectiveness of the Firm’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Firm's disclosure controls and procedures were effective as of the end of the period covered by this report.
No change in the Firm’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) occurred during the period covered by this report that materially affected, or is reasonably likely to materially affect, the Firm’s internal control over financial reporting.
Exhibits
Exhibit Index
Exhibit No.
Description
15
Letter of awareness from Deloitte & Touche LLP, dated May 5, 2020, concerning unaudited interim financial information.
31.1
Rule 13a-14(a) Certification of Chief Executive Officer.
31.2
Rule 13a-14(a) Certification of Chief Financial Officer.
32.1
Section 1350 Certification of Chief Executive Officer.
32.2
Section 1350 Certification of Chief Financial Officer.
101
Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”).
104
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).
March 2020 Form 10-Q
84
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MORGAN STANLEY
(Registrant)
By:
/s/ J
ONATHAN
P
RUZAN
Jonathan Pruzan
Executive Vice President and
Chief Financial Officer
By:
/s/ P
AUL
C. W
IRTH
Paul C. Wirth
Deputy Chief Financial Officer
Date:
May 5, 2020
S-
1